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Dementia is a public health priority and its importance is projected to increase in 
coming decades, particularly in low- to middle-income countries. A description of the 
methodological challenges of observational studies and the limitations of previous 
attempts to combine the published literature leads me to discuss ascertainment of 
dementia cases and the suitability of dementia mortality as an outcome. I report the 
findings of a memory clinic study where 71.5% of 502 deceased individuals with 
probable Alzheimer dementia had dementia correctly recorded on their death certificate, 
which is an improvement on similar results from two decades earlier. 
I review the evidence for geographical variation in dementia and discuss the 
implication that such variation might point towards potentially modifiable risk or 
protective factors for dementia. I have attempted to overcome the methodological 
challenges alluded to above by only examining within-study comparisons. A meta-
analysis of rural-urban comparisons reveals some evidence of increased prevalence 
(odds ratio; 90% confidence interval (CI): 1.11; 0.79, 1.57) and incidence (1.20; 0.84, 
1.71) of dementia in rural areas. These associations were stronger for Alzheimer 
dementia and particularly so in studies which identified early life rural residence 
(prevalence 2.22; 1.19, 4.16; incidence 1.64; 1.08, 2.50). 
Since there are no effective treatments, there is an obvious need to focus on 
prevention and an urgent need to improve our understanding of the aetiology of 
dementia in order to attempt to prevent or delay its onset. However, it is clear that 
prevention must begin sufficiently early in life to have an effect – intervening in later life 
might be too late. I describe a body of work using the Health Survey for England cohort 
studies examining the association between a series of risk factors and later dementia-
related death, including cardiovascular disease risk factors, psychological distress, and 
socioeconomic status. For example, there is a dose-response relationship between 
increasing psychological distress and dementia death (12-item General Health 
Questionnaire score 1-3 vs 0 age- and sex-adjusted hazard ratio; 95% CI: 1.44; 1.17, 
1.78; score 4-12 vs 0: 1.74; 1.36, 2.22). I conclude by summarising the contribution these 
publications have made to the field of dementia epidemiology and by outlining  
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Dementia describes a cluster of neurodegenerative and cerebrovascular conditions 
amongst which Alzheimer disease is the most common, causing 60-80% of cases of 
dementia.1 It is characterised by progressive cognitive decline – often in a number of 
cognitive domains but commonly involving memory – and impairment in day-to-day 
functioning, resulting in substantial difficulties in activities of daily living.2  Interest has 
been growing in the field of dementia in recent years and increasing numbers of 
researchers are devoting their attention to this syndrome. It is estimated that  
approximately 820,000 people in the UK live with dementia, the vast majority over the 
age of 65 years (approximately 8% people in the UK with dementia are younger than 65 
years).3 This compares to approximately 2.3 million people in the UK with coronary 
heart disease.4 Worldwide the estimated number of people living with dementia in 2010 
was 36 million.5 To give an idea of scale, if the number of people worldwide with 
dementia were a single country, it would have a seat at the G20.* This condition has a 
large economic cost, including health care costs and also the care needs of these, often 
very vulnerable, individuals. Dementia costs the UK economy £23 billion, more than 
cardiovascular disease and cancer combined.3 However it is a condition which affects 
the person in a fundamental way and often places an enormous burden on friends and 
relatives who must also live with dementia. 
The first topic to be discussed will be the public health importance of dementia, 
considering the increasing numbers of people with the condition as a result of 
demographic changes, as well as previous attempts to synthesise the heterogeneous 
epidemiological literature on dementia.  
Following on from this, I will consider the methodologies used in observational 
dementia studies and discuss previous attempts to combine the literature. At the core of 
such syntheses is the method of dementia ascertainment and whether or not the 
methods used in separate studies are comparable. The different case-finding 
methodologies used in various studies will be reviewed, culminating in a discussion of 
record linkage and the ascertainment of dementia from mortality data, with the example 
                                                




of the first article in this thesis, “Cognitive and behavioural predictors of survival in 
Alzheimer disease: results from a sample of treated patients in a tertiary-referral memory 
clinic.”6  I will then go on to consider geographical variation in dementia in more detail 
to provide context for the second article, “Geographical variation in dementia: 
systematic review with meta-analysis.”7 The methodology used in this paper will be 
enlarged and discussed in more detail than was possible in the published version before 
considering the implications of non-random geographical variation in a disease. I will 
then discuss the findings of a recently completed study building on the work of this 
systematic review and meta-analysis modelling geographical variation in dementia in 
complementary models using the Swedish Twin Registry and the 1932 Scottish Mental 
Survey Cohort.8 
 Next, I will introduce life course epidemiology which suggests that factors at all 
stages of life could affect an individual’s disease risk. I will suggest that, in view of the 
failure of potentially disease-modifying treatments, greater attention should be paid to 
preventive strategies with a view to delaying or preventing the onset of dementia. But I 
will also argue that intervention to modify these risk or protective factors must occur at 
the correct time. Thus, treating risk factors for dementia in later life might be too late. 
The third article in this thesis, “Does the Framingham cardiovascular disease risk score 
also have predictive utility for dementia death? An individual participant meta-analysis 
of 11,887 men and women,” has similar findings showing that a risk score based on 
multiple cardiovascular risk factors is no better at predicting dementia than knowing a 
person’s age.9  
If examining traditional risk or protective factors seems to have ended in 
disappointment, the search for more unusual candidates has led us to psychological 
distress which is shown to be a risk factor for dementia death in the fourth article in this 
thesis, “Psychological distress as a risk factor for dementia death,”10 and for mortality 
from all causes and cardiovascular disease (which shares some aetiology with dementia) 
in the fifth article, “Association between psychological distress and mortality: an 
individual participant pooled analysis of the Health Survey for England prospective 
cohort studies.”11 The contrasting methodology of simple pooling in the former and 




Returning to the life course paradigm, the final article in this thesis, 
“Socioeconomic status as a risk factor for dementia death: an individual participant 
meta-analysis of 86 508 men and women from the United Kingdom,”12 will be discussed 
with measures of socioeconomic status at two stages of life, before briefly discussing 
ongoing and planned future work building on the articles presented in this thesis. I 
conclude by summarising the various integrated methodologies I have used in these 
articles to further research into risk factors for dementia. 
2. The Public Health Importance of Dementia 
The rising profile of dementia, mentioned in the introduction, partly relates to 
demographic changes – increasing fertility rates and declining death rates. Thus, in many 
countries there have never been as many older people as there are now. Since there are 
more older adults than ever before, clearly there are going to be more people with 
dementia, in spite of some suggestions that the incidence of dementia may be declining 
as a result of improvements in cardiovascular disease risk profiles, amongst other 
factors.13-15 Indeed, projected rates of dementia predict greater rises in  resource-poor 
countries than in the rest of the world, largely due to similar demographic changes.16 
Increases in life expectancy and the benefits of health promotion, combined with the 
post-war ‘baby boom,’ whose members are now in their seventh decade, have led to 
substantial changes in the age structure in the UK and elsewhere. Referred to as the 
‘greying population’ or ‘squaring’ of the population pyramid (Figure 1, p. 4), these 
changes have widespread ramifications for pension providers, health and social care 
services, as well as dementia epidemiologists. 
However the conclusions that can be drawn from the published literature at a 
global scale are limited by the poor coverage of some areas of the world. There has been 
very little attention paid to low- to middle-income countries by epidemiological studies 
of dementia (Figure 2a, p. 5) and this disparity becomes even more marked when the 
population resident in each country, rather than the land area, is considered (Figure 2b). 
Thus a small minority of research attention is applied to the majority of the world’s 
population. This may partly relate to governments prioritising basic needs – food, 




pay little research attention to the rest of the world, with some exceptions, such as the 
Ibadan-Indianapolis study.17-20 
   
 
 1980 (56.3 million; 13.9%) 2000 (58.9 million; 13.9%) 
 
   
 
 2020 (67.2 million; 16.0%) 2040 (75.0 million; 18.6%) 
 
Figure 1. Age structure of United Kingdom, 1980-2040, with total UK population and proportion 
aged 65 years or over also shown. The post-war ‘baby boom’ can be seen as a spike around the age 
of 30 years in 1980, 50 years in 2000, and 70 years in 2020. Individuals aged 85 years and over were 
not included in these ONS data. Source: Office for National Statistics 
(http://www.neighbourhood.statistics.gov.uk/ HTMLDocs/dvc1/UKPyramid.html) 
 
This neglect of a large proportion of the globe has become such a noticeable 
problem that a dedicated research group – the 10/66 Dementia Research Group – has 
been set up to remedy the situation.21-24 The group’s name refers to the 10% of research 
attention paid to the 66% of the population of the world with the lowest income. They 
have focussed their research attention on areas previously unstudied and have made 






Figure 2a. Dementia prevalence studies worldwide 




2b. World population cartogram (2002). The size of each territory shows the relative proportion of 
the world’s population living there Source (figure and rubric - adapted): http://www.worldmapper.org;  
Original data: United Nations Development Programme Human Development Report 200425 
 
3. Ascertainment of Dementia Cases 
There have been a number of attempts to combine data from different studies and 
locations over the last few decades. These have ranged from narrative reviews26, 27 to 
attempts to synthesise these data quantitatively.28 Perhaps the most well-known of these 
are the European Community Concerted Action Epidemiology of Dementia 
(EURODEM)29-31 and the more recent European Collaboration on Dementia 
(EuroCoDe).32 In fact, the latter is used by the Scottish Government to estimate the 
number of people with dementia in the community, in order to estimate the proportion 




interpretation of such syntheses are subject to a number of methodological difficulties 
which have not always been given the attention they deserve. 
The first question when considering combining the results of two studies 
conducted independently is whether the methodologies are sufficiently similar to allow 
them to be compared. For example, one study which found that the prevalence of 
dementia was x in a rural area and compared this to a study done by another research 
group with a prevalence of y in an urban area might not, in fact, tell us anything about 
the relative rates of dementia in those two areas; we might be comparing apples with 
oranges. There are a number of reasons why the methodology of the two studies might 
not be comparable which will be considered in turn: the age structures of the 
populations might be different; whether the whole population was studied or a sample; 
one study might have used a more thorough method of case-finding than the other; the 
diagnostic processes followed might not be comparable; and cross-sectional versus 
longitudinal designs. 
If the population structures of the two areas being compared or combined were 
vastly different, this would confound the results by age and, in itself, could explain 
differing rates of dementia between the areas. An extreme example would be an area 
exclusively occupied by young families being compared with another area with a large 
elderly population and a number of care homes. Thus the rate of dementia would be 
substantially higher in the latter area but this may be entirely explained by the different 
age structures of the populations. 
The study of an entire population, whether a town, an island, or a whole country, 
is also likely to yield different results from the study of a random sample, even if the 
sample is of a large enough size from which to make robust inferences. Thus it is 
advisable that a study of a sample is not compared with the study of a population. There 
might be circumstances under which it would be reasonable, for example matching a 





Thoroughness of case-finding is also likely to have an important effect of the 
findings of epidemiological studies in dementia. Missing data are a ubiquitous problem 
in observational research and missing data resulting from non-participation in a study of 
dementia are particularly likely to be missing in a non-random pattern, i.e. if an 
individual’s participation or otherwise in a study relates to their dementia status.33 This 
non-random missing data will consequently bias the results of the study. 
The diagnostic process will also affect the findings of a study. Whether the case 
definitions used are comparable is the first difficulty – different diagnostic criteria, such 
as the World Health Organization’s International Classification of Diseases (ICD) or the 
American Psychiatric Association’s Diagnostic and Statistical Manual of Mental 
Disorders (DSM), will identify different numbers of cases because they set the bar for 
having or not having a condition at different levels. The 10/66 Dementia Research 
Group is one of the few to have compared different diagnostic criteria in the same study 
– the narrower DSM-IV criteria and their own, broader, consensus criteria.34, 35 They 
found that their results were substantially altered by using either DSM-IV or their own 
criteria. These data were displayed graphically in article 2, reproduced as Figure 3 (p. 8).7 
Some diagnostic criteria, for example DSM-IV, are not fully operationalized.35 Thus, in 
some cases, even if the same diagnostic criteria were used in two studies, they might be 
differently operationalized, thus reducing their perceived comparability.  
A proportion of the individuals diagnosed by the 10/66 consensus criteria, but 
not by DSM-IV, is likely to be at the milder end of severity. While the controversial 
category of ‘mild cognitive impairment’ (MCI) will hopefully become better defined in 
the future when reliable biomarkers for dementia are identified, as discussed below, the 
decision whether or not to include these individuals in an observational study of 
dementia prevalence or incidence is extremely important. Their prognosis is variable 
with between 10 and 20% converting to dementia each year36, 37 but, importantly, up to 
44% returning to normal each year.38 The concept of MCI remains unclear and this lack 
of clarity could be ascribed to the lack of agreement on the criteria required for the 
value judgement inherent in its diagnosis – what should one be able to do as one gets 
older? Value judgements are ubiquitous in medical diagnoses yet the extent to which 




criteria for the value judgements involved are settled.39 For example, pain is almost 
universally agreed to be unwelcome and painful conditions are similarly seen to be 
illnesses without controversy. Anxiety is a more equivocal symptom since some people 
seek it out, for example in extreme sports, and so anxiety disorders are less clearly seen 
as illnesses than painful conditions. Expectations of what an eighty-year-old person 
should be able to do in terms of day-to-day functioning will probably vary even more 
and thus the status of MCI as an illness – which in the majority of definitions has 
function as the crucial component, the cognitive element being merely a matter of 
degree of impairment – is still less clear. 
 
 
Figure 3. Comparison of standardised dementia prevalence (with accompanying 95% confidence 
intervals) using different diagnostic criteria. DR = Dominican Republic, U = Urban, R = Rural 
Source: Constructed from 10/66 Dementia Research Group data34 & presented in Russ et al. (2012)7 
 
Diagnostic practice with regard to how to label equivocal cases of possible 
dementia varies widely. Indeed, some argue for a longitudinal assessment, rather than a 
single appointment, in order to determine with more certainty whether such an 
individual is likely to progress to dementia, remain the same, or return to normal 
cognition.40 Due to the uncertainty surrounding a clinical diagnosis of dementia, which 
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precursor of a mystery (i.e. MCI) could be suggested to be even more mysterious. 
However, it is not a mystery that we can simply ignore. The decision of whether or not 
to include individuals with MCI is an important one in this context – two of the studies 
identified in article 2 found that the variation between sites differed depending either on 
whether or not ‘mild’ cases of dementia were included (likely to overlap with the 
concept of MCI) or if a different cognitive test cut-off was used;42, 43 geographical 
variation reduced with narrower diagnostic criteria. Once again, if two independent 
studies differed in their practice, MCI is another factor which makes them not 
comparable. 
Finally, whether a study uses a cross-sectional or a longitudinal design will also 
affect the completeness of case-identification. This is probably more of theoretical 
interest as it is unlikely that a prevalence study would be directly compared with an 
incidence study. However, if they were, the problem of survival is introduced, which is 
known to vary between regions, notably across the UK.44-46 Prevalence is related to 
incidence and survival and so if survival is different between two regions, prevalence 
and incidence – while not directly comparable in any case – are less related than they 
would otherwise be. Furthermore, longitudinal studies often suffer from attrition which 
introduces its own biases to which cross-sectional studies are not subject. 
I will now outline a variety of potentially useful methodologies for observational 
studies of dementia. Clearly, the chosen method for identifying individuals with 
dementia is crucial to the quality of the study and its findings. Perhaps the most robust – 
only really a practical option in a relatively small area – is studying the entire population. 
Researchers would actively seek out all older adults living in an area (or even all adults of 
any age) and assess whether or not they have dementia. This methodology is resource-
intensive and thus is used relatively rarely. Thus, a slightly modified version is used for 
robust, large-scale studies – two-phase screening. All individuals deemed to be at risk 
will be approached and screened, either face-to-face or by a telephone call. Those whose 
responses are suggestive of a possible dementia are then invited to undergo a full clinical 
assessment. However, in order not to miss people who might have dementia but who, 
perhaps because of superior premorbid abilities, were not picked up by the screening 




clinical assessment in order to estimate the specificity of the screening procedure. The 
majority of the studies included in article 2 (“Geographical variation in dementia: 
systematic review with meta-analysis”7) are a variation on this theme and this 
methodology has been shown to give accurate diagnoses for prevalence studies.47 
However, two-phase screening studies are not without their own biases and are subject 
to their own challenges and limitations, including non-participation in screening 
resulting in selection bias, difficulties if the screening process is not sufficiently sensitive, 
and the importance that validation of the screening procedure – such as clinical 
assessment of a sample who screened negative – is sufficiently rigorous.33 
An interesting and powerful alternative to face-to-face follow up of research 
participants is using record linkage to follow their progress after recruitment. The way 
that medical records were viewed changed in the second half of the last century from an 
event-based paradigm to the idea that an individual’s medical records formed a ‘personal 
record.’48 More recently this approach has become more sophisticated and is now a 
widely used approach in research.49 The basic idea is that all contacts that a person has 
with the health service (and theoretically with any agency) can be collated together under 
their unique identifier to provide a timeline of their contacts, appointments, procedures, 
hospital admissions, and, ultimately, death. If each individual is uniquely identified, for 
example by the Community Health Index number in Scotland, deterministic linkage 
methods can be used, which are the most robust. Alternatively, if an individual is 
identified by a combination of details including name, date of birth, and sex, 
probabilistic linkage methods are used and an algorithm provides a linkage score and all 
records above a certain threshold will be allocated to that person. Since a large 
proportion of this methodology can be automated, it is applicable to large projects to 
provide ‘passive follow up,’ overcoming potential drawbacks of small studies, including 
limited power, and large studies can be conducted at relatively little cost. 
Furthermore, using record linkage allows follow up to be added to cross-sectional 
studies in order to convert them into longitudinal cohort studies. This is the approach 
taken below with the annual, cross-sectional Health Surveys for England in articles 3-6.9-12 
These were designed as cross-sectional snapshots of the nation’s health at a series of 




consenting participants could be subsequently traced and the causes of death recorded on 
the death certificates of deceased individuals examined, allowing cause-specific mortality 
to be investigated.  
However, it is also possible to apply this methodology to surveys or groups for 
which research was not the primary reason for the collection of the data. This was the 
case with the Lothian Memory Treatment Centre (LMTC) cohort study (article 1).6 The 
data were initially collected for the purposes of clinical audit in order to evaluate the 
service. After the initial collection of the data they were also used for research purposes in 
a number of cross-sectional analyses.50-53 However, since approximately a decade had 
passed since the data were collected, it was possible to follow up the clinic attenders 
passively and identify who had died and when. Since all the patients were or had been 
under the care of one clinician (JMS) the approval process for the linkage was greatly 
simplified and merely required the approval of the NHS Lothian Caldicott Guardian. The 
record linkage was conducted by the Information Services Division of NHS National 
Services Scotland (ISD), converting this cross-sectional sample into a longitudinal cohort 
study. 
Using dementia mortality as an outcome in an observational study begs the 
question whether dementia is correctly recorded on the death certificate of every 
deceased person who was diagnosed with dementia. This is certainly not the case. In 
fact, in the past, dementia recording on death certificates was not felt to be adequate for 
epidemiological purposes, at least in terms of investigating geographical patterns and 
time trends.54 In the two decades since the publication of Martyn & Pippard’s paper this 
situation does seem to have been improving, as article 2 demonstrates.6 The main focus 
of the article was on predicting survival after diagnosis in a group of people diagnosed 
with Alzheimer dementia and receiving treatment in the form of a cholinesterase 
inhibitor. However, since it was known how many of these individuals who had 
subsequently died, we could examine how many of them had dementia correctly 
recorded on their death certificate. It is likely that the clinical diagnoses will have been 
robust since they had had an extensive assessment at a tertiary-referral memory clinic. 
The fact that 71.5% of the 502 people who died had dementia correctly recorded in any 




reported in 1988.54 The validity of using dementia mortality as an outcome in 
observational studies will be discussed further below. 
However, we are left with the intriguing question of what might determine 
whether someone has their diagnosis correctly recorded on their death certificate. In 
terms of the covariates available in the dataset, we were able to demonstrate that there 
were no differences between those who had dementia correctly recorded on their death 
certificate and those who did not in terms of their premorbid IQ (p=0.98; premorbid IQ 
was estimated using the National Adult Reading Test55 which has been shown to 
adequately estimate premorbid intelligence in people with dementia56) or area-based 
deprivation (the Scottish Index of Multiple Deprivation;† p=0.39). Therefore people 
with dementia who have their diagnosis correctly recorded on their death certificate are 
representative of the general population of people with dementia, at least in terms of 
intelligence and socioeconomic status. 
Another factor might be the extent of the medical history known to the certifying 
doctor at the death of the patient. If someone is admitted to hospital as an emergency 
and dies soon afterwards, it may be that a junior doctor who does not know the 
patient’s medical history in detail completes the death certificate. Another person with 
dementia who remains relatively well and whose death is certified by their GP who 
knows them well might be more likely to have their diagnosis of dementia correctly 
recorded. An additional analysis using the LMTC cohort study not included in the 
published article shows that the survival of people with treated Alzheimer dementia who 
do not subsequently have dementia correctly recorded on their death certificate is 
poorer than those who do have dementia recorded (age- and sex-adjusted hazard ratio; 
95% confidence interval: 1.76; 1.44, 2.14; Figure 4, p. 13), adding weight to this 
conjecture.  
                                                
† SIMD is a measure of small area multiple deprivation encompassing seven domains: income, 
employment, health, education, skills and training, housing, geographic access to services, and crime. 






Figure 4. Kaplan-Meier survival plot of the Lothian Memory Treatment Centre cohort study showing 
better survival in patients with treated probable Alzheimer dementia who had dementia correctly 
recorded on their death certificate than those who did not have dementia correctly recorded 
 
Since having dementia correctly recorded on a death certificate is associated with 
better survival, one could infer that it is the fitter people – that is, people with fewer 
comorbidities – who might be the ones to have their dementia diagnosis correctly 
recorded on their death certificate. In reality this is an under-researched area and, 
crucially, there are no published studies comparing the outcome of dementia death 
compared to incident dementia diagnoses in observational studies. 
Studies using linkage to clinical sources of data, in contrast to screening studies of 
the population, are further subject to the unavoidable problems of underdiagnosis of 
dementia in the community with approximately half of all people with dementia thought 
to have been given a diagnosis. Estimates for 2012 are that between 31.9% and 75.4% 
of the total number of cases of dementia are diagnosed appropriately in the community 
(64.4% overall in Scotland and 46.0% overall in the UK).57 A recent study at the Royal 
Free Hospital found that the prevalence of dementia was 42% of all acute medical 
admissions of adults over 70 years old but that only half of these had received a formal 




dementia registers.59 However the method used to calculate the expected number of 
people with dementia from which to estimate the proportion who are diagnosed is 
complicated and this choice is likely to have a substantial effect on the outcome. 
Connolly et al. (2012)59 used national prevalence estimates from the MRC Cognitive 
Function and Ageing Study to estimate their expected numbers of people with 
dementia.60 The Scottish Government and Alzheimer Scotland, on the other hand, use 
the EuroCoDe synthesised estimated prevalence rates.32 
4. Geographical Variation in Dementia 
It can be seen that there are numerous factors complicating the seemingly simple 
process of comparing disease rates reported in two studies. One could even argue that it 
is meaningless to compare such studies, given the likely huge methodological differences 
between them. One way to overcome the majority of these problems is to restrict our 
attention to within-study comparisons – studies which have used identical 
methodologies in two or more geographical areas at the same time. This was the 
approach taken in the systematic review and meta-analysis published in the International 
Journal of Epidemiology in 2012 (article 2).7 
Since it was not possible to formulate the research question in the familiar form 
of ‘intervention x for condition y’ as in systematic reviews of interventions,61 a more 
fluid approach had to be taken, as is common in systematic reviews in the social 
sciences.62 Thus the research question was formulated as simply: is there evidence, based 
on within-study comparisons, of geographical variation in dementia, at any scale? In 
consultation with an information scientist at the MRC Social and Public Health Sciences 
Unit, Glasgow, it was decided to make the literature search similarly inclusive. 
Therefore, in addition to the traditional biomedical databases, we included geographical 
and international sources, likely to include articles of relevance, as well as theses and 
grey literature. The intention, given the broad research question, was to capture as many 
relevant articles as possible for inclusion in the final review. 
The wide net that was cast resulted in a very large number of records to be 




used was systematic, rigorous and reproducible. The inclusion criteria used were also 
inclusive, encompassing any methodology whether cross-sectional or longitudinal 
(though the final review was stratified into prevalence and incidence studies). Studies of 
all types of dementia were included, apart from conditions where the dementia either 
resulted from external causes, for example alcohol or a head injury, or was a late feature 
of the condition, for example Parkinson’s disease. An exception to this latter rule was 
the Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia complex on Guam.63, 64 
Since this condition, and similar clusters on the Kii peninsula of Japan65 and in West 
New Guinea,66 was a clear example of the phenomenon of interest – disease clustering – 
it was included by selecting a representative paper from the large number which have 
been published. 
One important challenge in writing this article was the multitude of possible ways 
of structuring and organising the included studies, each of which made sense and could 
theoretically be justified.‡ Articles could be reported in chronological order, either 
according to the dates the studies were conducted or publication date. They could be 
organised according to geography, perhaps dividing them up by continent – though 
studies comparing areas in different continents, for example the Ibadan-Indianapolis 
study17-20 would be difficult to fit into such a schema. Methodological quality of study 
would be another candidate, perhaps giving more weight to the more robustly designed 
and conducted studies. Finally, one could choose to arrange the article by geographical 
scale of the comparisons made. Since the practical implications of the article in terms of 
investigating potential reasons why the geographical distribution of dementia might be 
non-random were most related to the latter approach to organising the included studies, 
I chose to arrange them according to that criterion into five groups: (1) Comparisons 
between countries (or studies of a defined area where country of birth was used as a 
proxy geographical variable); (2) rural-urban comparisons (which included some studies 
also included in the other groups); (3) comparisons between regions (defined as larger 
than a town or city but smaller than a country); (4) comparisons between towns or 
                                                
‡ Foucault (1966/1970)67 refers to ‘a certain Chinese encyclopaedia’ which classifies animals into the 
following categories: ‘(a) belonging to the Emperor, (b) embalmed, (c) tame, (d) sucking pigs, (e) sirens,  
(f) fabulous, (g) stray dogs, (h) included in the present classification, (i) frenzied, (j) innumerable, (k) drawn 
with a very fine camelhair brush, (l) et cetera, (m) having just broken the water pitcher, (n) that from a long 




cities; and (5) small area comparisons, for example postcode or zipcode areas. With 
regard to identifying putative risk or protective factors for dementia, it is the last of 
these – large-scale comparisons – which are potentially the most informative. However, 
as I note in the article, these are the least studied in the published literature. 
I decided, a priori, to write a narrative review of comparisons at the various scales 
mentioned above, with the exception of rural-urban comparisons. I felt that these might 
be sufficiently homogeneous to lend themselves to quantitative combination in a meta-
analysis. This was indeed the case but the distinction between rural and urban areas was 
by no means uniformly dealt with between studies. In fact, as discussed in the article, 
the definition of rurality is probably responsible for a large proportion of the 
heterogeneity in the meta-analyses of prevalence and incidence. Some studies even failed 
to define what constituted a rural area and what constituted an urban area. 
This article was the first review on the topic based on within-study comparisons 
which, as outlined above, is essential when comparing observational studies and the very 
first meta-analysis of rural-urban effects on dementia. It has a number of important 
implications. First, it is a robust attempt to synthesise the literature on geographical 
variation in dementia taking into account the various methodological difficulties 
outlined above. 
Second, since it shows geographical variation in dementia at all scales, though 
admittedly not in every study, this leads one to speculate as to what might be 
responsible for this non-random geographical distribution of disease? It is likely that 
both genetic and environmental factors are responsible but very few studies have 
attempted to separate these effects; this systematic review identified only two. A study in 
Newfoundland which identified a difference in dementia risk in those born on the north 
side of Bonavista bay compared to the south suggested that genetic relatedness might 
account for a proportion of the effect by examining the number of surnames in each 
group.68 A Scottish study of young-onset Alzheimer disease examined the number of 
common ancestors in order to estimate case kinship and concluded that familial factors 




Third, the article is the first step in a process of hypothesis generation to identify 
possible risk or protective factors for dementia which might similarly vary with 
geography. For example, the finding that Alzheimer dementia prevalence and incidence 
was higher in rural areas than urban areas should prompt questions about what might be 
the differences between such areas that increase risk in rural areas or reduce it in urban 
areas. It should be pointed out that not all risk or protective factors for dementia will 
vary by place – some may have the same effect on individuals regardless of where they 
are located. 
Studying the geography of disease is a powerful route to identifying putative risk 
factors. The legend of John Snow is being reassessed in the bicentenary of his birth.70 It 
has been argued that, in addition to careful recording of data, it was his visualisation of 
these data (Figure 5, p. 18) which was crucial in identifying the source of the 1854 
London cholera epidemic.71 The substantial impact of the mythical removal of the pump 
handle is also a lesson to us that simple interventions resulting from careful research can 
have substantial public health benefits. At the very least, this geographical approach is 
useful in hypothesis generation. Estimates suggest that delaying the onset of dementia, 
even by one year, could have substantial effects on the number of people with dementia 
in the future.72, 73 With further, more detailed investigation of possible risk factors, it 
might well lead to advances in understanding of the aetiology of dementia, with 
potentially important public health implications. 
Building on the systematic review of geographical variation in dementia (article 
2),7 I have applied Bayesian disease mapping methodology to two complementary 
datasets – dementia in Swedish Twins and in the 1932 Scottish Mental Survey cohort 
(see Appendix C for the manuscript, currently submitted for publication).8 These studies 
showed substantial variation in dementia odds – approximately two-fold variation 
between the south of Sweden (low risk) and the north after removing twin-level random 
effects (which will approximately correspond to genetic and shared environmental 
factors). Furthermore, this variation is not observed in Scotland when location at age 11 
is used but is in later adult life, suggesting that different factors might have their effects 
at different points in life. The findings are generally replicated when Alzheimer dementia 






Figure 5. Detail of John Snow’s disease map of the 1854 London cholera epidemic with Broad 
Street and the pump at the centre of the epidemic approximately at the centre of the map. 
Source: Snow (1855)74 
 
At first glance, these models seem to replicate the findings of the systematic 
review, in that the risk of dementia is greater in the rural north of Sweden and Scotland, 
at least as far as the Moray Firth. However, if this were the case, one would expect 
Stockholm to demonstrate a reduced risk of dementia, which is not the case. Similarly, 
dementia risk in the relatively rural Borders is reduced and in the urban central belt is 
approximately average, based on adult location. Furthermore, the increased effect of 
early life rural living seen in the meta-analysis7 is not borne out in the Scottish study as 
area of residence in early life does not seem to affect later dementia risk. Nevertheless, 




The implications of these findings are that geographical variation in dementia is 
explained by at least one environmental factor and that, if it could be identified and 
modified, it would be possible to halve dementia rates. We can infer that this 
environmental exposure has its effect in late adolescence or adulthood and that, given 
the pattern of risk seen, it may relate to latitude. It is hoped to continue this work by 
confirming an environmental effect by including a polygenic risk score for Alzheimer 
disease as a covariate and also examining the effect of incorporating other potential 
environmental risk or protective factors into the models to attempt to explain the 
observed variation. The final aim of this work is to identify potentially modifiable risk 
factors which could be tested in an interventional study. 
5. The Life Course Paradigm in Dementia Epidemiology 
In recent decades there has been increasing interest in the life course paradigm in 
epidemiology,75 arguably beginning with the Barker hypothesis or ‘foetal origins of adult 
disease.’76 The life course approach has been defined as the “study of long-term effects 
on chronic disease risk of physical and social exposures during gestation, childhood, 
adolescence, young adulthood and later adult life;”75 that is, during any period of life 
from conception to death. Clearly, within such a paradigm, the temporal ordering of 
exposures is extremely important and it is likely that chronic disease risk could relate to 
the cumulative effect of risk and protective factors along the life course. In addition to 
this ‘accumulation of risk,’ the other main conceptual life model is the ‘critical period 
model,’ which suggests that exposures at a particular point in life might have a crucial 
effect on later disease risk. If the exposure only has its effect on disease risk during a 
particular period, this is said to be a ‘critical period.’ However if the exposure is likely to 
have some effect at any point in life but that a particular period is associated with 
additional sensitivity to this effect, such a period of time is referred to as a ‘sensitive 
period.’ 
The life course paradigm has also been applied in dementia epidemiology and it is 
likely that factors at all stages of life affect dementia risk.77 This model is supported by 
neuropathological evidence suggesting that the pathogenesis of Alzheimer disease might 
begin decades before the disease becomes clinically manifest.78-80 However, the failure of 




still do not properly understand the pathophysiology of dementia. Such discoveries 
might shed light on the disease processes resulting in dementia but, in their absence, 
current clinical practice remains focussed on treating individuals after they have become 
symptomatic. 
This strategy has not been successful in terms of therapeutic discoveries.82 Indeed, 
there have been recent calls for a wholesale change of approach and the life course 
paradigm could be a useful model to guide future research. This clearly means that 
intervention would be necessary before the clinical onset of dementia. However, the 
obvious difficulty is that, in the absence of any symptoms, there are currently no reliable 
methods to identify if an individual will go on to develop dementia. There are 
biomarkers available for a number of the pathological processes associated with 
Alzheimer disease – primarily amyloid or tau – which are hypothesised to change at 
various times before dementia can be clinically diagnosed (Figure 6, p. 21) but no robust 
link has been shown between one or more biomarkers and later developing Alzheimer 
dementia. Work is currently underway to formalise this conceptual process83 and 
validate these proposed biomarkers in terms of quality control84 and diagnostic test 
accuracy85, 86 but we are still not in the position where Alzheimer disease can be 
confidently identified in asymptomatic individuals. The exception is carriers of familial 
mutations who can be identified by their genotype. However, until accurate preclinical 
diagnosis is possible, there is an urgent need to focus instead on prevention at a 
population level.  
We have already seen that a small delay in dementia onset could have a dramatic 
effect on the number of people with the condition.72, 73 Thus modification of risk factors 
to prevent dementia might have a substantial impact on disease rates. Given the findings 
mentioned above regarding the long preclinical course of Alzheimer disease, at least, 
later life is probably not the best time to attempt to modify dementia risk; it might be 







Figure 6. Hypothetical model of dynamic biomarkers of the AD expanded to explicate the 
preclinical phase: Aβ as identified by cerebrospinal fluid Aβ42 assay or PET amyloid imaging. Synaptic 
dysfunction evidenced by fluorodeoxyglucose (F18) positron emission tomography (FDG-PET) or 
functional magnetic resonance imaging (fMRI), with a dashed line to indicate that synaptic dysfunction 
may be detectable in carriers of the ɛ4 allele of the apolipoprotein E gene before detectable Aβ 
deposition. Neuronal injury is evidenced by cerebrospinal fluid tau or phospho-tau, brain structure is 
evidenced by structural magnetic resonance imaging. Biomarkers change from normal to maximally 
abnormal (y-axis) as a function of disease stage (x-axis). The temporal trajectory of two key 
indicators used to stage the disease clinically, cognitive and behavioral measures, and clinical function 
are also illustrated. Source (figure and rubric): Sperling et al. (2011)87 
 
Corroboration of this need for intervention sufficiently early in life comes from 
systematic reviews of trial evidence that neither lowering serum cholesterol with statins89 
or lowering blood pressure90 in later life has any beneficial effect on dementia risk. 
There are no aetiological trials of the effects of modifying cardiovascular disease risk 
factors in mid-life. However, there are observational data which suggest that there is an 
association between high mid-life total cholesterol,91, 92 obesity,93 and hypertension,92 
though there was a suggestion that treatment for hypertension might influence this 
association.94 There is also some evidence, again based on observational data, that 
individual cardiovascular disease risk factors might have a more complex relationship 
with dementia when more than one is present.92 It is possible that these associations 
between mid-life cardiovascular disease risk factors and dementia might be due to 
confounding. However, it is also a possibility that modification of these risk factors 




modification in later life does not.88 I am currently working on an observational study 
exploring these associations, described below.95 Looking even earlier in life, there are 
currently no studies directly linking prenatal factors with dementia risk but birth 
parameters are associated with cognitive function at age 1196, 97 (which is a risk factor for 
later dementia98, 99),  cognitive ability in later life,100 and late-life white matter integrity.101 
All of this evidence leads one to conclude that there is almost certainly a state 
when an individual has Alzheimer disease but not yet Alzheimer dementia. Indeed, as 
alluded to above, the most recent diagnostic criteria for Alzheimer dementia 
acknowledge this and attempt to conceive of states before Alzheimer dementia could be 
diagnosed including MCI, when minor symptoms are present but not sufficient to merit 
a diagnosis of dementia, and ‘preclinical AD’ when Alzheimer disease is hypothesised to 
be present without manifest dementia.40, 87, 102 
The life course paradigm and the early inception of Alzheimer disease suggest that 
merely thinking in terms of ‘midlife’ risk factors may not be sufficiently complex to do 
justice to the processes throughout the life course which result in an individual 
developing dementia.77, 103-108 However, the question of appropriate methodologies for 
investigating public health initiatives modifying midlife risk factors is not a 
straightforward one. First, observational data can only demonstrate an association and 
do not prove causality (Bradford Hill’s criteria for a causal association comprise 
strength, consistency, specificity, temporality, biological gradient, plausibility, coherence, 
experiment, and analogy109). Second, if one is to rely on dementia mortality data, as 
many of the papers included in this thesis do, this would require extremely long periods 
of follow up following an intervention in order to allow sufficient numbers of people to 
die with dementia. Thus, ideally a proxy endpoint should be used in such studies. The 
clinical onset of dementia would be better than dementia mortality, but would still 
require extended follow up. Cognitive decline could also be used, as has been the case in 
a number of studies, but this is only an element of dementia and it is unclear how risk 
factors for cognitive decline might relate to dementia. Further work on biomarkers for 
Alzheimer disease and other dementias might mean that these outcomes could be used 




However, at the moment, no biomarkers have sufficient predictive validity, either alone 
or in combination, for this use. 
 The remainder of this thesis will be devoted to summarising the work 
represented by articles 3-69-12 investigating risk factors for dementia and further research 
building on them. While some of this work may not fit within the classical life course 
paradigm, this approach, summarised above, has informed much of the thinking 
surrounding these analyses and much of my planned, future work, outlined below. 
6. Risk Factors for Dementia 
As mentioned above, record linkage provides a powerful methodology for observational 
studies. This section of the thesis outlines a number of articles examining potential risk 
factors for dementia and cardiovascular disease (which partially shares aetiology with 
dementia) using the Health Survey for England110 (HSE) cohort studies from 1994-2004. 
Passive follow up (through linkage to NHS mortality registries) until the first quarter of 
2008 turns these cross-sectional studies into longitudinal, prospective cohort studies. 
Through the combination of multiple studies, it is possible to have very large sample 
sizes. This allows one to examine the exposure-outcome association in detail, including 
conducting gender-specific analyses, examining the shape of the association (for 
example whether there is a linear dose-response relationship or if there is a threshold 
effect), and detailed investigation of alternative explanations for the observed 
association, including reverse causality.  
6.1. Cardiovascular disease risk factors 
The evidence for and against an association between cardiovascular disease risk factors 
and dementia has already been mentioned above. Article 3 investigated the possibility 
that a risk score comprising multiple cardiovascular disease risk factors, widely used in 
clinical practice – the Framingham cardiovascular disease risk score – might also have 
predictive utility in dementia.9 Since these conditions may partially share aetiological 
factors, this seems a reasonable hypothesis and could have substantial implications for 
public health and clinical practice. However, as the article and the results summarised in 




score is associated with a four-fold increase in the risk of dementia) is entirely explained 
by the age component. This merely reiterates the well-known fact that the greatest risk 
factor for dementia is age. However, Figure 7 also shows that the same could almost be 
said for cardiovascular disease itself – as is mentioned in the article, age explained 88% 
of the ability of the Framingham cardiovascular disease risk score to predict 
cardiovascular disease.  
 
 
Figure 7. Hazard ratios (with accompanying 95% confidence intervals) for the association between a 
10% increase in the Framingham Cardiovascular Disease (CVD) Risk Score and dementia and CVD. 
Unadjusted models as well as age-adjusted models are shown. Summary of results from article 39 
 
However, as alluded to above, the Framingham cardiovascular disease risk score 
comprises multiple risk factors: age, sex, systolic blood pressure, smoking, diabetes, total 
serum cholesterol, and serum HDL cholesterol (BMI can be substituted for the last two 
variables in an alternative version of the risk score which does not require blood to be 
drawn).111 While age accounts for the majority of the value of the Framingham 
cardiovascular disease risk score, it would be interesting to know the relative 
contributions of the other cardiovascular disease risk factors which make it up. Due to 
the short report format, it was not possible to describe this in article 3. Figure 8 shows a 
more recent piece of work, currently under review, which compares the association 
between individual risk factors and dementia and cardiovascular disease death.112 This 
study uses an updated dataset with linkage until the first quarter of 2011 providing 
longer follow up than in the dataset used in articles 3-6.9-12 It also includes a larger 
number of cohort studies, including the Scottish Health Survey113 (SHS) as well as the 
HSE. Thus this larger analysis was able to include data from ten cohort studies – the 








Figure 8a. Hazard ratios (HR with accompanying 95% confidence intervals) for the association 
between individual cardiovascular disease (CVD) risk factors (components of the Framingham CVD 
risk score111) and dementia and CVD death 
 
   
 
8b. HR (with accompanying 95% confidence intervals) for the association between individual CVD 
risk factors (components of the Framingham CVD risk score111) and dementia and CVD death with 
deaths occurring in the first five years of follow up dropped 
 
HR for age is per five-year increase. Systolic hypertension is defined as systolic blood pressure  
≥140 mmHg. Current smokers are compared to ex- or never-smokers. Ever smokers comprise 
current or ex-smokers and are compared to never smokers. High total serum cholesterol was defined 
as > 6.2 mmol/L or on lipid-lowering treatment. Non-HDL cholesterol  was calculated by subtraction 
of HDL-C from total cholesterol, yielding a measure that encompasses low-, intermediate-, and  
very-low-density lipoprotein cholesterol; HRs are per standard deviation increase (disadvantage; one 
SD = 1.2 mmol/L). Obesity is defined as BMI ≥30 kg/m2 (underweight participants – BMI <18.5 kg/m2  
– not included in this model). Diabetes was identified from a complex diabetes indicator comprising 
doctor-diagnosed diabetes, longstanding illness (diabetes), HbA1c, and diabetes medication 
 





In fact, while age and smoking are clearly associated with later dementia-related 
death (Figure 8a, p. 25), the status of other cardiovascular disease risk factors in relation 
to dementia death is less robust, particularly when deaths occurring in the first five years 
of follow up are excluded – a technique to investigate the possibility of reverse causality 
– as shown in Figure 8b (p. 25). The parallel results for cardiovascular disease-related 
death are shown on the right hand side of Figures 8a and 8b. These give us confidence 
in the dementia findings since they confirm the expected association between all of the 
cardiovascular disease risk factors, apart from non-HDL cholesterol, and cardiovascular 
disease mortality. Thus the relationship between cardiovascular disease risk factors and 
dementia, which has received a great deal of research attention,114 may not be such a 
fruitful avenue towards the prevention of dementia as has been previously thought. 
6.2. Psychological distress 
The above analyses of the association between cardiovascular disease risk factors and 
dementia suggest that ‘traditional’ risk factors may not be as clearly associated with 
dementia as has been previously thought. Therefore, the net for putative risk factors 
must be cast wider and more novel risk factors sought. One such risk factor, examined 
in articles 4 and 5, is psychological distress.10, 11 In these articles, the 12-item General 
Health Questionnaire115-117 (GHQ-12) was used as the measure of psychological distress, 
with one point scored for each answer to an item denoting distress, giving a score from 
zero to 12.§ These analyses involved ten of the HSE cohort studies (the GHQ-12 was 
not administered in 1996) and the two papers used different methodologies, reflecting 
my learning of new statistical techniques. In article 4 the data from all ten studies were 
simply pooled together and overall Cox proportional hazards models118 were 
calculated.10 However, it is unlikely that this methodology adequately allows for within-
study clustering and therefore the more sophisticated individual participant meta-
analysis (IPMA)119 was used in subsequent studies.11 These two methodologies are 
compared below as well as an empirical comparison of their effect on the observed 
association between psychological distress and dementia death (p. 30). 
                                                
§ Have you recently: 1. Been able to concentrate on whatever you are doing? 2. Lost much sleep over 
worry? 3. Felt that you are playing a useful part in things? 4. Felt capable of making decisions about things 
5. Felt constantly under strain? 6. Felt you couldn’t overcome your difficulties? 7. Been able to enjoy your 
normal day to day activities? 8. Been able to face up to your problems? 9. Been feeling unhappy and 
depressed? 10. Been losing confidence in yourself? 11. Been thinking of yourself as a worthless person? 




IPMA aggregates results from a number of different studies, in the same way as a 
traditional literature-based meta-analysis, but offers a number of advantages over the 
latter. Potential advantages outlined by Riley et al. (2010)119 include consistent inclusion 
and exclusion criteria, statistical analysis can be standardised for all studies, a variety of 
baseline characteristics may be incorporated into models – including multiple risk 
factors at once, sensitivity and subgroup analyses are possible, and a more sophisticated 
approach to missing data can be used. Other advantages of the IPMA methodology are 
outlined in the introduction to article 5.11  
 
 
Figure 9. Hazard ratios (with accompanying 95% confidence intervals) for the association between 
psychological distress (as measured by the 12-item General Health Questionnaire) and dementia 
death, cardiovascular disease (CVD) death, and all-cause mortality. Age- and sex-adjusted models as 
well as multivariable-adjusted models are shown. Summary of results from articles 4 and 510, 11 
 
These are the first IPMAs in the field of dementia research (though not the first in 
the area of mental health120) and also the first IPMAs in any field with a psychological 




cohort studies was used, since one purpose of these studies was proof of concept, as the 
fact that the HSE studies are methodologically very similar reduces the between-study 
heterogeneity. Results from articles 4 and 5 are summarised in Figure 9 (p. 27).10, 11 
Briefly, there was a dose-response association between psychological distress and all-
cause mortality, as well as mortality from cardiovascular disease and dementia. There 
was an increased mortality seen even at very low levels of distress, lower than the cut off 
used in most epidemiological studies (i.e. scores of one, two, or three) compared to 
those with no psychological distress. The IPMAs were conducted using the statistical 
language R,121 and example syntax for running such analyses is given in Appendix D. 
6.3. Socioeconomic status 
 
 
Figure 10. Multivariable-adjusted hazard ratios (with accompanying 95% confidence intervals) for 
the association between age upon leaving full time education (Education) and occupational social 
class (Occupation) and dementia death in men and women. Summary of results from article 612 
 
The final risk factor to be examined is socioeconomic status, a complex, multi-faceted 
entity which is particularly amenable to study from a life course perspective as it is likely 
to change during an individual’s life. In article 6 (“Socioeconomic Status as a Risk 




Women from the United Kingdom”)12 it is captured as age upon leaving full-time 
education and adult occupational social class, measures which relate to different periods 
of life, albeit with the former being based on distant recall of the age upon leaving 
school. Thus they offer some insight into the association between socioeconomic status 
in early and mid-life and later dementia death. Early life factors, in particular, are an 
element of the life course approach, even if this analysis does completely not fit into the 
paradigm, if strictly defined. The results from article 6 are summarised in Figure 10  
(p. 28).12 
The only positive association is between educational attainment and dementia 
death in women. Additionally, since we are able to incorporate adult occupational social 
class into the model we can show that this association is not mediated by adult 
socioeconomic status. Therefore there is something about education which influences 
dementia risk, possibly to a greater extent in women than men – though this gender 
difference might relate to statistical power. Given the limitations of the models it is 
difficult to comment further on the life course effects of socioeconomic status on 
dementia, but it would seem that an accumulation of risk model does not fit this 
association well. It might be that there is rather a critical or sensitive period for exposure 
to socioeconomic deprivation. Education may influence cognitive reserve122-124 which is 
hypothesised to relate to the extent to which impaired brain function can be tolerated 
without producing overt symptoms. More recently it has been shown that educational 
attainment is partially genetically determined125 which further complicates the 
interpretation of these findings. 
6.4. Strengths and limitations of these studies 
The relative strengths and limitations of these studies are considered in each article but 
an attempt will be made to consider these in more detail here. The generalizability of the 
results is likely to be high since these are general population samples. However, this 
requires some clarification since, as is the case in all sample-based research, the people 
who participate in studies are unlikely to be identical to the general population out in the 
real world. Research participants tend to be healthier than average and this indeed turns 
out to be the case in relation to the HSE and SHS surveys. In another analysis using the 




mortality in the cohort studies is 31% lower in HSE and 21% lower in SHS than the 
general population in each country, based on Office for National Statistics mortality 
data.44 
There are a number of things, with the benefit of hindsight – particularly in  
article 4 – which could have been done better. The later papers are methodologically 
sounder, using IPMA to take account of between-study heterogeneity, and it would have 
been better to use this approach in the psychological distress-dementia analysis. Table 1 
shows a comparison of simple pooling and IPMA on the association between 
psychological distress and dementia death using the updated HSE and SHS dataset. It 
can be seen that using IPMA does not alter the conclusions drawn from an analysis 
using simple pooling but that the effect estimate is slightly attenuated using pooling. The 
heterogeneity of the association in each study has been highlighted (for example, see 
Figure 2 from Article 5, p. 100) even though the surveys use very comparable 
methodologies from year to year. If a similar analysis were conducted using a number of 
less similar, more heterogeneous datasets, it might be that the difference between simple 
pooling and IPMA would be even more marked.  
Table 1. Comparison of simple pooling and IPMA techniques on the association 
between psychological distress and dementia death: the Health Survey for England 
1994, 1995, 1997-2006, 2008 and the Scottish Health Survey 1995, 1998, and 2003 
 
   GHQ-12 score 
   0 1-3 4-12 





Age- and sex-adjusted    





IPMA 166632 1049 1 1.45 (1.26, 1.67) 
1.75 
(1.48, 2.07) 
Multivariable-adjusted1    
Pooling 156974 986 1 1.39 (1.20, 1.60) 
1.59 
(1.33, 1.89) 
IPMA 156974 986 1 1.40 (1.21, 1.62) 
1.62 
(1.35, 1.94) 
      
 
1 Models adjusted for age, sex, occupational social class, age upon leaving full-time education, 




Furthermore, slightly different measures of socioeconomic status were used in 
this paper compared to later analyses. Three measures of socioeconomic status were 
used in article 4: individual occupational social class, head of household occupational 
social class (referred to as parental occupational social class in the article), and 
educational attainment (age upon leaving full-time education). It was later felt that this 
amounted to over-adjustment and subsequent analyses used only individual 
occupational social class and educational attainment as measures of socioeconomic 
status. 
However, the two major criticisms which can be levelled against all the analytic 
papers (articles 2-6) are (a) confounding and (b) the question of whether dementia 
mortality is a valid outcome for epidemiological research. Related to the former is the 
question of biological plausibility of the observed associations, which is one of Bradford 
Hill’s criteria for causation.109 In article 2,10 examining the association between 
psychological distress and dementia death, the possibility that this association could be 
mediated by cortisol was mooted – affective disorders are associated with 
hypercholesterolaemia which has been shown to be toxic to the hippocampus.126 
However, there are alternative possibilities, including reverse causality – as discussed in 
the article – or mediation by the identified association between psychological distress 
and cardiovascular disease,11 given the possibility of overlapping aetiology of the two 
conditions. Thanks to the detailed assessments of the HSE participants at baseline, we 
were able to incorporate a large number of important potential confounders into our 
models, including cardiovascular disease risk factors, diabetes, risk behaviours such as 
smoking and alcohol use, educational attainment, and occupational social class. Many of 
these risk factors are not independent and may vary throughout life. Therefore, it may 
be that simply measuring them at a single point in time and incorporating them into Cox 
models might not adequately reflect the complexity of these exposures throughout the 
lifecourse. Notwithstanding these caveats, none of these factors had a substantial effect 
on the observed association, suggesting that they do not explain the association. 
Nevertheless, the possibility of residual confounding remains. 
Given the low levels of dementia diagnosis in the community and the low – but 




consider whether it is valid to use dementia mortality as an outcome. In terms of cardiac 
disease, the only UK study comparing death certification with approximately 60 autopsy 
findings127 found correct recording on death certificates in all 21 cases examined. 
Elsewhere, in Norway, analyses of 1140 autopsies revealed that death certification of 
CVD is satisfactory for the purposes of epidemiological research.128 No such work has 
been published for dementia outcomes, but one could speculate that mortality reporting 
may be a less accurate marker of actual dementia pathology than is the case for 
cardiovascular disease, for example. This is partly due to the lack of clear 
correspondence between pathology and symptoms – the disconnect between Alzheimer 
disease and Alzheimer dementia, mentioned above. This disconnect may relate to cognitive 
reserve, in that individuals with higher cognitive reserve are likely to develop fewer 
symptoms for a given level of pathology.122 Another reason why clinical dementia might 
less perfectly correspond to pathology is the fact that, as alluded to above, a diagnosis of 
dementia in life is almost never more certain than ‘probable’ and the correlation 
between clinical and neuropathological diagnoses is less than perfect.129 
There are no studies comparing the results of an individual analysis using 
dementia mortality and incident cases as outcomes. Until this is the case, it will be very 
difficult to make a definitive decision whether dementia mortality is an adequate 
outcome for observational research. However, it is encouraging that dementia mortality 
reporting is improving and almost three quarters of people with Alzheimer dementia 
had dementia correctly recorded on their death certificates in article 2.6 Thus, dementia 
mortality reporting is not perfect but it is likely to be an adequate outcome for the 
purposes of observational research. 
Of course, dementia is not a single entity, but rather a complex of conditions all 
of which result in the dementia syndrome. Alzheimer disease is the most common 
disease causing dementia, followed by vascular dementia, dementia with Lewy bodies, 
fronto-temporal lobar degeneration, and alcohol-related brain damage.130, 131 This 
heterogeneous group of diseases is unlikely to have identical aetiologies and so it would 
be ideal to examine each condition separately, particularly when there is such an urgent 
need to identify modifiable risk or protective factors. Unfortunately, in the present 




substantial limitation. While reporting of dementia on death certificates is likely to be 
adequate, use of non-specific diagnostic codes is common so that reporting of specific 
dementia sub-types is likely to be much less reliable than dementia reporting overall. 
Using sub-type specific diagnoses would result in a very small number of disease events, 
greatly reducing the statistical power of the analyses, as well as the robustness of these 
diagnoses being questionable. Thus, while large-scale epidemiological studies using 
dementia death as an outcome are a useful place to start, much more detailed work 
looking at similarities and differences between robustly diagnosed dementia subtypes 
would be necessary before an intervention could be implemented at a population level.  
Dementia mortality data clearly have value in studying the epidemiology of 
dementia. However, more detailed information including markers for pre-dementia 
syndromes (cf. Figure 6,87 p. 21), the timing of onset of clinical symptoms, the point of 
diagnosis, and subsequent survival would be much more useful. However, dementia 
sub-type matters here too: the pre-dementia stage of Alzheimer disease is likely to be 
very different to the pre-diagnostic stages of vascular dementia, dementia with Lewy 
bodies, or fronto-temporal lobar degeneration.  
Only one study was able to consider a risk factor from early life, and then it was 
based on adult recall of early life experience – age upon leaving full-time education. This 
distant recall raises concern regarding reporting bias.132 It would have been useful to 
have had more risk factors measured early in life, to reduce the possibility of reverse 
causality which, since the pathological processes of dementia are likely to begin so long 
before the clinical onset of symptoms, is a substantial challenge in dementia research. 
Thus, only this study was able to approach dementia from a life course perspective – 
and then only in the case of socioeconomic status.12 Even then, the simple Cox 
proportional hazards models118 did not explicitly take into account the timing of the 
measurement of these risk factors and, when further work on life course risk factors is 
used, it may be necessary to use alternative, more sophisticated methods, such as 




Indeed this was the only occasion in any of these analyses when a risk factor was 
measured on more than one occasion. Risk behaviours are likely to alter over the course 
of an individual’s life and many risk factors – such as blood pressure, psychological 
distress, etc. – may fluctuate over much shorter periods of time. Furthermore, for some 
potential risk factors (though not those examined in the present analyses, for example 
cortisol levels) may have a relatively predictable diurnal or other pattern of variation, 
which would mean that the time of measurement of that particular risk factor is of 
importance. Similarly the order of measurement of particular factors in a battery of 
testing may also affect the results, for example measuring an individual’s blood pressure 
immediately after testing their cognition might yield unexpectedly elevated readings. 
Furthermore, the risk factors chosen in these articles were dictated by what had 
been used in the HSE. Thus, the 12-item General Health Questionnaire was used as the 
measure of psychological distress, since it had been administered in ten surveys, giving a 
large total sample size. This instrument is widely used in epidemiological research but its 
relationship with clinical anxiety and depression, or even symptoms of these conditions 
is unclear. Thus extrapolating conclusions from articles 4 and 5 to clinical populations is 
complicated. 
These articles also include no investigation of transgenerational, or indeed genetic, 
risk factors for dementia. The former would need datasets where the relationship 
between at least two generations of participants was known and would need substantial 
follow up to allow the younger generation to become sufficiently old to be at risk of 
developing dementia. The latter is a more practical approach and a new and interesting 
methodology of creating a polygenic risk score for Alzheimer disease133 for use as a 
covariate in analyses is becoming feasible in large-scale studies. 
7. Planned Future Work 
Investigating risk factors from early life often relies on distant recall. An alternative to 
this is to use parameters which are affected by experiences throughout development but 
which remain relatively stable thereafter. One such characteristic is height which 




adversity, nutrition or psychosocial stress,134 while there may be some loss of height in 
late life, it remains relatively stable from early to late adulthood. Therefore height may 
capture important environmental characteristics that act during brain development 
which may then influence dementia risk.99 Additionally, height is readily and commonly 
measured, leading to the possibility of large sample sizes. Further analyses, using the 
updated HSE and SHS datasets, have been conducted examining the association 
between height and later dementia death and show a dose-response association between 
shorter stature and risk of dementia-related death.135 
 
 
Figure 11. Scatterplot showing the secular trend (with 95% confidence interval) in height by birth 
year: individual participant meta-analysis of eighteen cohort studies from the Health Survey for 
England and the Scottish Health Survey (N = 181,800). Source: Russ et al. (Submitted)135 
 
Average height has generally increased in a secular fashion over the last hundred 
years, with particularly marked increase in the first quarter of the twentieth century 
(Figure 11). The fact that there has been a general improvement of early life 
circumstances over this period further supports the hypothesis that height captures 
something of early life experience relevant to later dementia risk. If the height-dementia 
association did indeed result from improved early life conditions, it might be that the 




account of secular changes in height. Therefore in the UK, at least, the forecasted 
increases in dementia prevalence could be overestimated.  
Another measurable parameter which captures the effects of exposures over a 
large proportion of the life course is pulmonary function (Figure 12). Illness and 
exposure to smoking and pollution throughout life affect lung function and forced 
expiratory volume in one second (FEV1) has been shown to be a predictor of 
mortality.136 Spirometry is available from six of the HSE and SHS cohort studies and is 
the focus of a further analysis which is currently under review. This study shows a dose-




Figure 12. Relative importance of exposures acting across different life course time windows in 
terms of the natural history of lung function. A = normal development and decline; B = exposure in 
early life reducing lung function potential; C = exposure acting in mid to later life accelerating age-
related decline. Source (figure and rubric): Ben-Shlomo & Kuh (2002)75  
 
Further plans include work building on the analyses of cardiovascular disease risk 
factors9, 112 by an analysis of the association between such risk factors measured early in 
life – for example in medical examinations at the start of University attendance – and 
later dementia death, again identified through record linkage. The advantage to such a 




association which might be observed since the baseline measurements would have been 
collected even before the initial pathological changes associated with dementia might 
have begun. Such linked datasets exist and an examination of this association is 
underway.95  
Further research, building on the epidemiological work outlined here, might also 
include using alternative methodologies to confirm the associations identified from 
population-based studies, providing further evidence for causality. This might take the 
form of animal studies or in vitro work to establish the biological plausibility of the 
association. Once plausible risk factors have been identified, intervention studies would 
be required before large-scale modification of these factors at a population level could 
be considered. However, the difficulties associated with midlife intervention studies in 
dementia have already been considered. Thus, either a proxy outcome, perhaps in the 
form of one or more biomarkers for Alzheimer disease (or another dementia subtype) 
could be used. However, until we have identified sufficiently accurate biomarkers, 
approaches such as Mendelian Randomisation could offer an alternative to traditional 
intervention studies, such as randomised, controlled trials, allowing us to investigate 
modifiable environmental risk factors for dementia.138  
The study in Appendix C suggests that if the modifiable risk factors for dementia 
could be identified and optimised, dementia rates could be halved.8  However, the 
traditional epidemiological work presented in this thesis suggests that we have yet to 
identify these risk factors, though psychological distress and education may relate to 
dementia risk. The relationship between dementia and cardiovascular disease is 
complicated but it may be that population measures to improve cardiovascular disease 
risk have resulted in the recently observed decrease in dementia rates.13-15 Another 
possible candidate suggested by the findings from the Swedish study8 is sunlight 






This thesis has approached the investigation of risk (or protective) factors for dementia 
from a number of angles and attempted to synthesise these into an integrated approach. 
Non-random geographical variation in dementia has been highlighted as a fruitful 
avenue for identifying potentially modifiable risk factors for dementia and I hope to 
pursue this line of work in the future. More traditional epidemiology has been used to 
examine possible risk factors using cross-sectional surveys converted to longitudinal 
cohort studies through linkage with mortality registries. The challenges of combining 
multiple studies have also been discussed and the advantages of IPMA over simple 
pooling highlighted. There is much left to be done and current plans of how I intend to 
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Cognitive and behavioural predictors of survival in
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Objective: This study examined the in!uence of cognitive and non-cognitive factors at the time of
diagnosis on the survival of patients with treated probable Alzheimer Disease (AD).
Methods:Consecutive patients seen at a regional, tertiary-referral clinic completed a battery of cognitive
tests and assessments of activities of daily living and neuropsychiatric symptoms. These clinic data were
linked with death certi"cate data for all individuals and survival from diagnosis was calculated. Cox
regression models were constructed using the baseline covariates.
Results: The sample comprised 653 patients (459 women), mean age 77.1 years (SD 7.6, range
48–94 years), diagnosed with probable AD and treated with a cholinesterase inhibitor. In the survival
analysis, age was a consistently signi"cant predictor of survival with a gender-adjusted hazard ratio of
1.35 (95% CI 1.23, 1.48) for one standard deviation increase in age. Men were at greater risk of death
than women (age-adjusted HR 1.44, 95% CI 1.19, 1.73). In a model adjusted for all study variables,
Paired-Associate Learning (Cambridge Automated Neuropsychological Test Assessment Battery) and
the psychotic factor of the Neuropsychiatric Inventory were signi"cant predictors of survival.
Conclusions: At diagnosis, in addition to the anticipated impact of age and gender, the presence of
psychotic symptoms and poor performance on paired-associate learning are also indicators of poor
prognosis. Copyright # 2011 John Wiley & Sons, Ltd.
Key words: survival; prognosis; Alzheimer disease; cognitive factors; neuropsychiatric symptoms; cause of death




The notion that capturing a series of patient charac-
teristics will aid in estimating prognosis is appealing
for clinicians, patients and their relatives as they plan
their future. With the number of cases of dementia
increasing rapidly (Ferri, et al. 2005), there is an
obvious need to understand prognosis in people with
this condition. Although it is known that mortality in
dementia increases with the severity of disease
(e.g. Andersen et al. 2010), there is a general paucity
of data about other predictors of survival and conclu-
sions are limited by the dif"culties in extrapolating
from populations to individuals. Apart from the
more general effect of delirium on survival in all
patients (Inouye, et al. 1993), comorbid medical con-
ditions (Van Dijk, et al. 1996)—particularly cerebro-
vascular and respiratory diseases (Helmer, et al. 2001;
Hicks, et al. 2010) but also falls, diabetes and cardio-
vascular disease (Larson, et al. 2004; Mielke, et al.





2007)—and socio-economic factors, such as educa-
tion (Musicco, et al. 2009) have been shown to affect
survival in dementia. Further potential candidates
for predictors of survival in people with dementia
have included baseline cognitive function (Landi,
et al. 1999; Andersen et al. 2010; Hötte, et al. 2010),
pre-morbid cognitive ability (cognitive reserve;
Stern, et al. 1999; Scarmeas, et al. 2006), dif!culties
with activities of daily living (ADLs; Agüero-Torres,
et al. 1998; Newcomer, et al. 2003) and the presence
of behavioural and psychological symptoms of
dementia (BPSDs; Tun, et al. 2007), particularly
psychotic symptoms (Scarmeas, et al. 2005).
Therefore, the aim of this study was to examine the
in"uence of cognitive status, ADLs and the presence of
BPSDs at the time of diagnosis on the survival of
patients with treated probable Alzheimer disease
(AD) seen in a tertiary-referral clinic. The objectives




As described in detail by Starr (2007) and Starr and
Lonie (2007a, 2007b, 2008), the sample comprises
consecutive patients seen at a tertiary-referral memory
treatment centre covering the Lothian region (Lothian
Memory Treatment Centre; LMTC) between February
2000 and July 2001. Routine assessment data were col-
lected as part of a service evaluation approved by the
Director of Public Health. The patients were included
if they were diagnosed with probable AD—diagnosis
was consensus-based involving two old age psychia-
trists, a geriatrician and a neuropsychologist using
NINCDS-ADRDA criteria (McKhann, et al. 1984)—
and commenced on a cholinesterase inhibitor (either
donepezil or rivastigmine).
Measures
The patients attending the LMTC completed a battery
of seven cognitive tests, shown in Box 1. ADLs were
measured using the instrumental activities of daily
living (IADL) and the physical self-maintenance scales
(PSMS; both Lawton and Brody 1969). The patients
and carers also completed the Neuropsychiatric Inven-
tory (NPI; Cummings, et al. 1994).
Data linkage
Permission for data linkage was obtained from the
National Health Service (NHS) Lothian Caldicott
Guardian. The Information Services Division of NHS
National Services Scotland linked the data with death
certi!cate data from the General Register Of!ce for
Scotland, providing date of death and all causes
mentioned on the death certi!cate for those who
had died. The data supplied did not distinguish
between immediate, underlying or contributory causes
of death.
Prior to the merging of the anonymised dataset
with the linked data, Scottish Index of Multiple
Text Box 1. Cognitive battery in the present samplea






The patient is asked to read
aloud a list of 50 irregularly-
pronounced words. McGurn
et al. (2004) validated this test
as an estimate of pre-morbid
full-scale IQ in a subgroup of








Tests a broad range of cognitive







The total score of the three
trials of free recall were used
from this test of recent verbal
memory/new learning ability.






This common test of executive
function also tests semantic
memory. The patient is asked
to name as many animals
(or fruit or vegetables or any
other category) as possible in






Similar to category fluency but
with the extra demand of set-
shifting. The patient is asked
to name as many words as
possible beginning with letter







Subtest from the Cambridge
Automated Neuropsychological
TestAssessmentBattery








Subtest from the CANTAB
visual and working memory
battery. Higher score=more
able.
aPreviously described in Starr (2007) and Starr and Lonie (2007b).
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Deprivation (SIMD) ranks were obtained for each
individual using their postcode (Scottish Government
National Statistics 2009).
Calculation of survival times
Survival was calculated inmonths from an estimated as-
sessment date using the patient’s date of birth and age
when assessed. The earliest and latest possible dates of
assessment were calculated, giving longest and shortest
possible survival times, respectively. A middle survival
using the midpoint of the year or the patient’s date of
death, whichever was earlier, was also calculated.
Sensitivity analyses
In order to test the robustness of conclusions, a num-
ber of sensitivity analyses were carried out. The youn-
ger half of the cohort were assigned the shortest
survival (i.e. worst prognosis) and compared with
the older half who were assigned the longest survival.
Similarly, post-hoc, the half with lower scores on PAL
were compared with the half with higher scores and
the half with lower scores on the NPI psychotic factor
were compared with the half with higher scores. Fur-
thermore, age by gender interaction was examined in
all univariate models.
Confounding
A potential confounder of survival in dementia is anti-
psychotic medication use, data for which were not
available for this cohort, because the patients with
more BPSD (and therefore higher NPI scores) might
be more likely to be prescribed antipsychotic medica-
tions that might affect their survival (Schneider, et al.
2005; Wang, et al. 2005). Therefore, the NPI scores
for the cases who had cerebrovascular disease men-
tioned on any part of their death certi!cate (n= 87,
17.3%) were compared with those without.
Statistical analysis
Data were analysed with the statistical package Predic-
tive Analytics SoftWare version 18.0 (SPSS Inc.,
Chicago, Illinois; SPSS Inc., 2010). All covariates,
apart from gender and drugs administered, were con-
tinuously scored. Age-adjusted univariate hazard ra-
tios for men and women were similar, so data were
pooled and gender-adjusted. The combined sample
size was suf!cient to detect hazard ratios of 1.31 at
80% power or 1.37 at 90% power (both with alpha
at 0.05). Median survival times were calculated using
the Kaplan–Meier method (Kaplan and Meier 1958).
Cox regression (Cox 1972) was performed using step-
wise entry of independent variables at p< 0.05 with
age and gender forced into all models. The predictive
capacity of each variable was examined separately.
Next, multivariate models with the following variables
were examined because they capture similar domains:
MMSE and NART-IQ; the standard bedside battery of
MMSE and tests of frontal lobe function; PAL and
DMTS; PSMS and IADL; NPI (patient) and NPI
(carer). The three NPI factors were also examined in
a multivariate model. Subsequently, the best predictive
model was constructed. Study members with missing
data were excluded from individual models but all
models were re-run using only cases with no missing
data and hazard ratios were compared with those
using the complete dataset.
Results
The analysis included 653 patients (459 women),
mean age 77.1 years (SD 7.6, range 48–94 years). All
the patients were treated with either donepezil (429,
66%) or rivastigmine (224, 34%). By the date of re-
cord linkage on 8 June 2010, 502 patients (77%) had
died and data from death certi!cates were available
for all of these. Baseline characteristics of the sample
are shown in Table 1. All cognitive tests correlated
Table 1 Baseline characteristics of the present sample
Testa N Median IQR Range
MMSE 621 20 8 0–30
NART-IQ 351 107 15 0–128
Hopkins 596 9 6 0–32
Animals 599 7 5 0–24
FAS 599 20 18 0–67
PAL 456 4 3 0–17
DMTS 443 11 4 0–19
IADL 546 16 10 0–30
PSMS 543 7 3 0–23
NPI (patient) 551 11 14 0–67
NPI (carer) 550 5 9 0–56
SIMD rank 613 4306 3944 51–6504
aMMSE, Mini-mental state examination;NART-IQ, Estimated IQ using
the national adult reading test; Hopkins, Hopkins verbal learning test;
Animals, Category (Semantic) Fluency—naming animals; FAS, Lexical
verbal !uency using the letters F, A and S; PAL, Paired-associate
learning from CANTAB; DMTS, Delayed match to sample from
CANTAB; IADL, Instrumental activities of daily living scale; PSMS,
Personal self-maintenance scale; NPI, Neuropsychiatric inventory;
SIMD, Scottish index of multiple deprivation.
Predictors of survival in AD




strongly with each other, as did IADL and PSMS
scores. NPI scores for the patient and the carer corre-
lated signi!cantly with each other and with the three
factors, but these factors did not correlate with each
other.
Effect estimates did not vary with survival time used
(longest, middle or shortest) and so the middle sur-
vival was used.
Median survival was 65months [interquartile range
(IQR) 69]. Women survived signi!cantly longer than
men (71months, IQR not calculable, versus
52months, IQR 63; Log Rank p= 0.001) as did those
treated with donepezil rather than rivastigmine
(71months, IQR 74, versus 54months, IQR 67; Log
Rank p= 0.021).
There were signi!cant differences in survival between
decade age groups (Log Rank p< 0.001). Median sur-
vival was 91months for those aged from 50–59 (IQR
not calculable), 85months for those aged from 60–69
(IQR not calculable), 66months for those aged from
70–79 (IQR 65), 53months for those aged from 80–89
(IQR 61) and 33months for those aged 90 or over
(IQR 55).
Results of Cox regression models for each variable are
shown in Table 2. Poorer performance on all cognitive
tests—apart fromDMTS which showed a non-signi!cant
trend—was signi!cantly associated with worse survival.
Higher NPI scores for the patient and carer were asso-
ciated with poorer survival. Of the NPI factors, only
the psychotic factor was signi!cantly associated with
worse survival, but the hazard ratio for the mood
factor was also elevated. Choice of cholinesterase
inhibitor did not signi!cantly affect survival, but
greater deprivation was signi!cantly associated with
worse survival.
Table 3 shows the results of the multivariate Cox
regression models. Age had a consistently signi!cant
effect on survival with a hazard ratio of 1.33–1.42 in
all models per standard deviation increase. Gender
was signi!cantly associated with survival but became
non-signi!cant with an attenuated effect in the
more-adjusted models.
Both MMSE and NART-IQ were signi!cantly associ-
ated with survival but only MMSE remained signi!cant
when both were included in the model. Entering the
standard bedside battery of the MMSE and tests of
frontal function (Animals and FAS), as recommended
by the Mental Welfare Commission for Scotland
(2007) for the assessment of dementia, resulted in both
MMSE and Animals being signi!cant covariates—that
is, higher cognitive function and, speci!cally, better
frontal lobe function, were associated with better sur-
vival. PAL remained a signi!cant predictor of survival
in a model with PAL and DMTS entered into it. Enter-
ing the three signi!cant cognitive tests (MMSE, Animals
and PAL) or indeed all the cognitive tests conducted
identi!ed PAL as a consistently signi!cant covariate,
that is, a higher PAL score was associated with better
survival.
Of the measures of ADLs, IADL was signi!cantly
associated with survival but became non-signi!cant
when the patient’s NPI score was included in a model.
The patient’s NPI score was signi!cantly associated
with survival but the carer’s NPI score was not. Dep-
rivation, measured by SIMD, was a signi!cant predic-
tor of survival in a univariate model but not in any
multivariate model. Examining individual NPI factors
(mood, psychotic and frontal) identi!ed the psychotic
factor as the only signi!cant covariate. In a fully-
adjusted model, the PAL and NPI psychotic factor
remained signi!cant predictors of survival.
The sensitivity analyses did not affect the results.
There was little evidence of age by gender interaction
following formal testing. Re-running all models using
Table 2 Age- and gender-adjusted univariate hazard ratios for the
relation between study participant characteristics and mortality
Modela Deaths N HRc 95% CI P
MMSE 471 621 1.32 1.21, 1.44 <0.001
NART-IQ 264 351 1.13 1.01, 1.28 0.038
Hopkins 449 596 1.31 1.19, 1.45 <0.001
Animals 454 599 1.30 1.18, 1.44 <0.001
FAS 454 599 1.26 1.14, 1.39 <0.001
PAL 339 456 1.34 1.19, 1.50 <0.001
DMTS 328 443 1.11 1.00, 1.23 0.062
IADL 422 546 1.17 1.06, 1.30 0.002
PSMS 421 543 1.17 1.06, 1.28 0.002
NPI (patient) 430 551 1.20 1.09, 1.32 <0.001
NPI (carer) 428 550 1.12 1.03, 1.23 0.013
NPImood
factor
225 358 1.07 0.93, 1.22 0.38
NPI psychotic
factor
225 358 1.18 1.04, 1.34 0.010
NPI frontal
factor
225 358 0.99 0.86, 1.13 0.84
Drugb 502 653 1.09 0.90, 1.32 0.39
SIMD rank 472 613 1.11 1.01, 1.21 0.028
aMMSE, Mini-mental state examination; NART-IQ, Estimated IQ using
the national adult reading test; Hopkins, Hopkins verbal learning test;
Animals, Category (Semantic) Fluency—naming animals; FAS, Lexical
verbal !uency using the letters F, A and S; PAL, Paired-associate learning
from CANTAB; DMTS, Delayed match to sample from CANTAB;
IADL, Instrumental activities of daily living scale; PSMS, Personal
self-maintenance scale; NPI, Neuropsychiatric inventory; SIMD, Scottish
index of multiple deprivation.
bCategorical variable: whether patient received donepezil (reference) or
rivastigmine.
cHazard ratios, computed usingCox regression analysis, are for one standard
deviation disadvantage, apart from drug given.
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Table 3 Hazard ratios for the relation of study participant characteristics with mortality (analyses are stepwise conditional entry with age and gender
forced into the models as established risk factors for survival in dementia)
Modela Deaths N p HRb (95% CI)
Variables included in the model but
statistically non-significant (p>0.05)
Age 502 653 <0.001 1.35 (1.23, 1.48) –
Male gender <0.001 1.44 (1.19, 1.73)
Age 471 621 <0.001 1.37 (1.24, 1.51) –
Male gender <0.001 1.43 (1.18, 1.74)
MMSE <0.001 1.32 (1.21, 1.44)
Age 264 351 <0.001 1.42 (1.24, 1.63) –
Male gender 0.059 1.29 (0.99, 1.68)
NART-IQ 0.038 1.13 (1.01, 1.28)
Age 263 350 <0.001 1.38 (1.20, 1.58) NART-IQ (p=0.39)
Male gender 0.098 1.25 (0.96, 1.63)
MMSE <0.001 1.32 (1.17, 1.48)
Age 453 598 <0.001 1.33 (1.21, 1.48) –
Male gender <0.001 1.42 (1.17, 1.74)
MMSE 0.008 1.17 (1.04, 1.32)
Animals 0.004 1.19 (1.06, 1.35)
Age 453 598 <0.001 1.36 (1.23, 1.50) –
Male gender <0.001 1.46 (1.19, 1.78)
MMSE 0.002 1.21 (1.07, 1.36)
FAS 0.042 1.13 (1.00, 1.27)
Age 450 592 <0.001 1.32 (1.20, 1.46) FAS (p=0.30)
Male gender <0.001 1.45 (1.19, 1.77)
MMSE 0.005 1.18 (1.05, 1.33)
Animals 0.004 1.19 (1.06, 1.34)
Age 308 419 <0.001 1.33 (1.18, 1.51) DMTS (p=0.23)
Male gender 0.024 1.32 (1.04, 1.69)
PAL <0.001 1.36 (1.20, 1.53)
Age 335 451 <0.001 1.35 (1.20, 1.52) MMSE (p=0.11) Animals (p=0.055)
Male gender 0.014 1.34 (1.06, 1.69)
PAL <0.001 1.34 (1.19, 1.50)
Age 338 455 <0.001 1.33 (1.18, 1.49) MMSE (p=0.056)
Male gender 0.013 1.34 (1.06, 1.69)
PAL <0.001 1.34 (1.20, 1.51)
Age 205 278 <0.001 1.39 (1.19, 1.62) MMSE (p=0.12), NART-IQ (p=0.69),
Animals (p=0.12), FAS (p=0.18),
Hopkins (p=0.11), DMTS (p=0.60)
Male gender 0.28 1.18 (0.87, 1.60)
PAL <0.001 1.35 (1.17, 1.57)
Age 421 543 <0.001 1.39 (1.25, 1.55) PSMS (p=0.26)
Male gender <0.001 1.51 (1.23, 1.86)
IADL <0.001 1.18 (1.07, 1.30)
Age 428 549 <0.001 1.42 (1.28, 1.58) NPI (carer) (p=0.50)
Male gender 0.001 1.42 (1.16, 1.74)
NPI (patient) <0.001 1.20 (1.09, 1.32)
Age 472 613 <0.001 1.39 (1.26, 1.53) –
Male gender <0.001 1.43 (1.18, 1.74)
SIMD 0.028 1.11 (1.01, 1.21)
(Continues)
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only cases with no missing data (n= 236) gave similar
results, but the effect of gender was attenuated (age-
adjusted HR male gender 1.17, 95% CI 0.84, 1.62,
p= 0.35). Characteristics of individuals with missing
data and the non-missing dataset are shown in
Table 4.
Table 5 shows the causes of death recorded on the
patient’s death certi!cates classi!ed into categories
adapted from Thomas et al. (1997). There were no dif-
ferences between men and women apart from the
general categories of ‘other disease’ (t=!2.0, df=
333.5, p = 0.05) and ‘senility’ (t=!3.1, df= 603.3,
p = 0.002) but the former is a heterogeneous category
and there were very few instances of men dying with
‘senility’ recorded on their death certi!cate (n= 4,
2.5%). Therefore, cause of death data for men and
women were analysed together. One hundred and
!fty-nine patients (31.7% deceased individuals) had
pneumonia recorded as a cause of death and 36
(7.2%) senility or a similar non-speci!c category.
Table 3. (Continued)
Modela Deaths N p HRb (95% CI)
Variables included in the model but
statistically non-significant (p>0.05)
Age 270 353 <0.001 1.42 (1.23, 1.63) IADL (p=0.83) SIMD (p=0.66)
Male gender 0.038 1.32 (1.02, 1.71)
NPI (patient) 0.003 1.21 (1.07, 1.36)
PAL <0.001 1.35 (1.18, 1.54)
Age 225 295 <0.001 1.37 (1.17, 1.61) NPI mood factor (p=0.42) NPI frontal factor (p=0.83)
Male gender 0.16 1.23 (0.92, 1.63)
NPI psychotic factor 0.010 1.18 (1.04, 1.34)
Age 175 236 0.001 1.39 (1.15, 1.67) Animals (p=0.14) IADL (p=0.88) NPI (patient) (p=0.25)
Male gender 0.39 1.15 (0.83, 1.60)
PAL 0.007 1.25 (1.06, 1.47)
NPI psychotic factor 0.012 1.21 (1.04, 1.40)
aMMSE, Mini-mental state examination; NART-IQ, Estimated IQ using the national adult reading test; Hopkins, Hopkins verbal learning test; Animals,
Category (Semantic) Fluency—naming animals; FAS, Lexical verbal !uency using the letters F, A and S; PAL, Paired-associate learning from CAN-
TAB; DMTS, Delayed match to sample from CANTAB; IADL, Instrumental activities of daily living scale; PSMS, Personal self-maintenance scale;
NPI, Neuropsychiatric inventory; SIMD, Scottish index of multiple deprivation.
bHazard ratios, computed using Cox regression analysis, are for one standard deviation disadvantage, apart from gender.
Table 4 Comparison of the characteristics of patients with complete data and those with any missing data
Variablea No missing data (N=236) Missing data (N=417) p
Age (mean, sd) 78.0 (6.6) 76.6 (8.1) 0.020
Female (%) 70.3 70.3 0.98
Donepezil use (%) 64.8 66.2 0.73
MMSE (mean, sd) 20.6 (4.7) 18.5 (6.3) <0.001
NART-IQ (mean, sd) 107.0 (10.2) 99.7 (28.4) 0.009
Hopkins (mean, sd) 10.2 (5.0) 8.7 (4.7) <0.001
Animals (mean, sd) 8.8 (4.4) 7.2 (4.1) <0.001
FAS (mean, sd) 24.7 (13.7) 20.4 (12.4) <0.001
PAL (mean, sd) 4.5 (1.8) 4.1 (1.8) 0.016
DMTS (mean, sd) 11.4 (2.6) 10.8 (3.5) 0.022
IADL (mean, sd) 14.8 (6.2) 16.6 (6.5) 0.001
PSMS (mean, sd) 7.4 (2.7) 8.3 (3.3) 0.001
NPI (patient) (mean, sd) 12.6 (11.6) 14.0 (11.3) 0.156
NPI (carer) (mean, sd) 6.1 (6.6) 7.4 (7.4) 0.032
NPI mood factor (mean, sd) !0.2 (0.98) 0.11 (1.10) 0.38
NPI psychotic factor (mean, sd) 0.01 (1.02) 0.00 (0.97) 0.96
NPI frontal factor (mean, sd) 0.02 (1.07) !0.05 (0.70) 0.65
SIMD Rank (mean, sd) 4074.1 (1964.2) 3980.5 (2007.2) 0.57
aMMSE, Mini-Mental State Examination; NART-IQ, Estimated IQ using the National Adult Reading Test; Hopkins, Hopkins Verbal Learning Test;
Animals, Category (Semantic) Fluency—naming animals; FAS, Lexical Verbal Fluency using the letters F, A & S; PAL, Paired Associate Learning from
CANTAB;DMTS, DelayedMatch to Sample fromCANTAB; IADL, Instrumental Activities ofDaily Living scale; PSMS, Personal Self-maintenance scale;
NPI, Neuropsychiatric Inventory; SIMD, Scottish Index of Multiple Deprivation.
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One hundred and eleven patients (22.2%) had cardiac
disease and 45 (9.0%) had other vascular disease
recorded on their death certi!cates.
Rates of all recorded categories of causes of death
are higher than the rates for all deaths in 2009 in
Lothian apart from neoplasms (rates for dementia,
‘other vascular disease’ and ‘senility’ were not avai-
lable from data from the General Register Of!ce for
Scotland 2009; similarly, it was not possible to calcu-
late a meaningful category of ‘other disease’ from
available data). Hospital discharge data (Scottish
Morbidity Record; SMR 01) estimate the crude preva-
lence of coronary heart disease in those aged over
75 to be 16.1% in Lothian (22.3% M, 12.3% F; ISD
Scotland 2011) suggesting a slightly higher rate of
cardiovascular disease in the women in this cohort
with probable AD than the general female population.
Comparing individuals who died with cerebrovascu-
lar disease mentioned on their death certi!cate (n=87,
17.3%) to those without revealed no signi!cant differ-
ences in mean overall NPI scores, factor scores or
relevant individual items (agitation, aggression, hallu-
cinations or delusions) for which antipsychotics might
be prescribed. This suggests that antipsychotic-related
mortality has not confounded the results.
Discussion
The main !nding of this study was that, in addition to
increasing age and male gender, a lower score on PAL
and the presence of psychotic symptoms at baseline
were associated with signi!cantly worse survival. Sur-
vival was consistently approximately 33%–42% worse
per standard deviation increase in age at baseline in
all models. Women survived longer in this study, as
has been often shown in dementia (e.g. Stern, et al.
1997; Doody, et al. 2005; Sinforiani, et al. 2010 but
not Brookmeyer et al. 2002), but the effect of gender
became non-signi!cant in models including more
variables. Gambassi et al. (1999) have suggested that
their observed gender-differences in mortality might
result from different levels of comorbidity, but few
gender-differences in causes of death were observed.
Predictors of survival
In this highly selected, tertiary-referral clinic sample,
median overall survival was 65months (5.4 years)
and median survival by age-group was: 50–59—
91months (7.6 years), 60–69—85months (7.1 years),
70–79—66months (5.5 years), 80–89—53months
(4.4 years) and over 89—33months (2.8 years).
Overall survival in this sample was slightly longer
than the 4.9 years reported by Doody et al. (2005)—
despite the wide recruitment strategy used in that
study—and much longer than the 3.1 years reported
from the Canadian Study of Health and Aging
(Wolfson, et al. 2001), even though they estimated
survival from onset of symptoms. Tsai et al. (2007)
found a mean survival of 4.5 years in their memory
clinic sample in China, though their AD death rate
was only 28.9% compared with 77% in the current
sample.
Rait et al. (2010) reported a comparable median
survival for 60–69 year olds of 6.7 years (versus 7.1 years
in this study) despite using a primary care sample rather





Cause na %b % Lothian deaths (2009)c na %b % Lothian deaths (2009)c
Dementia 116 72.5 – 243 71.1 –
Pneumonia 54 33.8 2.8 105 30.1 4.0
Cardiac disease 35 21.9 20.9 76 22.2 15.9
Cerebrovascular disease 31 19.4 7.4 73 21.3 11.0
Neoplasms 21 13.1 31.7 37 10.8 27.6
Other vascular disease 15 9.4 – 30 8.8 –
‘Senility’ or other general term 4 2.5 – 32 9.4 –
Falls 7 4.4 1.0 19 5.6 1.8
Diabetes 7 4.4 0.9 15 4.4 1.1
Hip fracture 4 2.5 – 18 5.3 –
Other disease 58 36.3 – 102 29.8 –
aNumber of deceased individuals from present sample with each cause mentioned on their death certi!cate.
bPercentages of causes of death for all deceased individuals add up to more than 100 because multiple causes were recorded for each individual.
cLothian data are for all 2009 deaths from General Register Of!ce for Scotland (2009)—data only available for routinely reported categories.
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than a tertiary-referral sample. However, excluding
untreated patients from our analysis would be expected
to bias the results towards prolonged survival. Further-
more, treatment itself is unlikely to be associated with
poorer survival.
In the present study baseline cognitive function,
measured by MMSE, categorical verbal !uency
(Animals) and PAL, predicted survival in this clinic
sample of people with AD. However, in a model
containing all the cognitive tests, PAL was the only
signi"cant predictor of survival. Prospective (Tsai
et al. 2007; Andersen et al. 2010; Hötte et al. 2010)
and retrospective studies (Landi et al. 1999) have
found that baseline cognitive function—either mea-
sured by MMSE or severity of dementia—was signif-
icantly associated with increased mortality. However,
Reisberg et al. (1996) found that mortality was not
related to baseline dementia severity.
National Adult Reading Test score has been shown
by McGurn et al. (2004), using a sample from this
treatment centre, to be a reliable measure of pre-
morbid full scale IQ in patients with dementia and,
therefore, serves as a putative index of cognitive re-
serve (Whalley, et al. 2004; Richards and Deary
2005; Stern 2006; Stern 2009). NART-IQ was signi"-
cantly associated with survival in a model including
age and gender—in this study, individuals with
lower estimated premorbid IQ declined more rapidly
after diagnosis in contrast to the cognitive reserve
hypothesis (Stern et al. 1999; Scarmeas et al. 2006).
However, NART-IQ did not remain signi"cant when
MMSE was included in the model.
Both IADL and the patient’s NPI score predicted
survival in this sample. However, IADL became
non-signi"cant when further variables were included,
and the NPI psychotic factor was the only element
that signi"cantly predicted survival. Newcomer et al.
(2003) found that requiring maximum help in
ADLs was associated with worse survival; this effect
increased with the numbers of activities requiring
assistance. Agüero-Torres et al. (1998) found that
those who functioned worse declined faster. Miller
et al. (2011), in the CATIE-AD trial, found that
preserved ADLs were protective for nursing home
admission, though they did not report predictors of
survival.
Tun et al. (2007) found that survival was sig-
ni"cantly lower in AD patients with more BPSD.
Sinforiani et al. (2010) also found that higher NPI
score at baseline was associated with earlier loss of
autonomy. Scarmeas et al. (2005) reported that
delusions and hallucinations were associated with
faster decline, both in cognition and function, and
that hallucinations were associated with increased
mortality.
Causes of death
Bronchopneumonia is commonly reported in people
dying with dementia (Morgan and Clarke 1995), up
to 70.9% in presenile AD (Thomas et al. 1997). Table 5
shows a lower rate of pneumonia at death suggesting
that other age-related causes of death might be more
important in a late-onset dementia sample compared
with patients with early-onset disease.
High rates of cerebrovascular disease and diabetes
at death con"rm the importance of cardiovascular
risk factors, particularly diabetes, in the natural
history of AD (Knopman, et al. 2001; Solfrizzi, et al.
2004; Luchsinger, et al. 2005; Whitmer, et al. 2005).
The high rate of falls suggests that impaired mobility
may be an important factor in the later stages of the
disease. Indeed, Buchner and Larson (1987) found a
very high fracture rate (15%) in a sample of patients
with AD.
Limitations
The assessment battery used in this clinic is likely to be
more extensive than that used elsewhere in the UK,
though the treatment protocol will have been similar.
Lothian has less of an ethnic mix than average in the
UK but it provides a stable population, with migration
particularly low in this age group.
Because the data were collected for a service evalu-
ation—and not for research purposes—they do pres-
ent limitations, and the date of assessment had to be
estimated from the patient’s date of birth and their
age when assessed, as described above. However, there
were no differences in effect estimates when the
longest or shortest possible survival times were used,
so a midpoint date of assessment was used to calculate
survival.
Sensitivity analyses examining the effects of assign-
ing worse survival to younger individuals, those with
higher PAL scores and fewer psychotic symptoms did
not alter the results. Furthermore, there was no evi-
dence of age by gender interaction.
Details of prescribed medication were not available,
but increased mortality related to antipsychotic medi-
cation (Schneider et al. 2005; Wang et al. 2005), as
mentioned above, does not seem to have confounded
the results: individuals with higher NPI scores—for
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whom these medications might be prescribed—did
not have an excess of cerebrovascular disease.
Cardiovascular disease and other risk factors, such
as smoking, obesity and individual socio-economic
status (as opposed to the area-based measure used
here) are extremely important in dementia survival.
The absence of these variables is a limitation of this
study but because the clinic served the whole region
of Lothian, there is likely to have been a wide spread
of these risk factors, as shown by the range of SIMD
ranks, and so confounding can be assumed to be
minimal.
Although the sample is speci!c for the patients with
treated probable AD, it has, by de!nition, excluded the
patients with other dementias and the patients with
untreated AD. The implications for survival of using
a treated sample have been discussed above. In addi-
tion, it should be mentioned that this study does not
allow us to comment on severe dementia because
few patients had a baseline MMSE of lower than 12
(n= 54, 12.9%), in line with trial data and guidelines
at the time.
Recording of causes of death on death certi!cates is
widely acknowledged to be less than completely accu-
rate, particularly for dementia (Martyn and Pippard
1988; Morgan and Clarke 1995). This is con!rmed
in this study because only 359 (71.5% of deceased)
patients had dementia entered onto their death certif-
icate. It is likely that other diseases are also under-
reported, perhaps not to the same extent, but this is
impossible to estimate.
The comparison data are based on all deaths—
because these were the only data available—but
79.5% deaths in Scotland in 2009 were older than
65 years (General Register Of!ce for Scotland
2009) and the majority of the outcomes are age-
related diseases. Proportions of deaths of individ-
uals aged over 65 years were similar for all areas
covered by the Lothian Memory Treatment Centre.
Conclusion
In addition to the anticipated impact of age and gen-
der, the presence of psychotic symptoms and poor
performance on PAL at baseline are also indicators
of poor prognosis.
These clinic-based data indicate that at diagnosis,
clinicians should not be optimistic or pessimistic
about prognosis according to most measures of cur-
rent cognitive status, pre-morbid mental ability, or
current functional abilities, or the presence of other
BPSDs. Age is a useful predictor of survival, with those
over 90 years surviving less than 3 years on average.
Common causes of death in people with AD were car-
diovascular disease (in women) and falls: these repre-
sent opportunities at diagnosis for prevention to
improve survival.
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Background Geographical variation in dementia prevalence and incidence may
indicate important socio-environmental contributions to dementia
aetiology. However, previous comparisons have been hampered by
combining studies with different methodologies. This review sys-
tematically collates and synthesizes studies examining geographical
variation in the prevalence and incidence of dementia based on
comparisons of studies using identical methodologies.
Methods Papers were identified by a comprehensive electronic search of rele-
vant databases, scrutinising the reference sections of identified pub-
lications, contacting experts in the field and re-examining papers
already known to us. Identified articles were independently re-
viewed against inclusion/exclusion criteria and considered according
to geographical scale. Rural/urban comparisons were meta-analysed.
Results Twelve thousand five hundred and eighty records were reviewed
and 51 articles were included. Dementia prevalence and incidence
varies at a number of scales from the national down to small areas,
including some evidence of an effect of rural living [prevalence
odds ratio (OR)! 1.11, 90% confidence interval (CI) 0.79–1.57;
incidence OR! 1.20, 90% CI 0.84–1.71]. However, this association
of rurality was stronger for Alzheimer disease, particularly when
early life rural living was captured (prevalence OR! 2.22, 90% CI
1.19–4.16; incidence OR! 1.64, 90% CI 1.08–2.50).
Conclusions There is evidence of geographical variation in rates of dementia in
affluent countries at a variety of geographical scales. Rural living is
associated with an increased risk of Alzheimer disease, and there is
a suggestion that early life rural living further increases this risk.
However, the fact that few studies have been conducted in
resource-poor countries limits conclusions.
Keywords Dementia, Alzheimer disease, epidemiology, geography, disease
clustering
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Tobler’s first law of geography states that the relation-
ship between entities is stronger when they are close
than when they are distant.1 In epidemiology, this is
equally true for disease occurrence: clustered areas of
low or high incidence may implicate environmental
exposures associated with the disease, and this may
have important public health consequences.
Leukaemia demonstrates geographical clustering that
may be related to proximity to nuclear facilities.2,3
Similarly, the worldwide variation in multiple scler-
osis rates suggests a complex interplay of genetic and
environmental factors, such as climate, diet, geomag-
netism, toxins and infection.4–6 Clustering in both
space7,8 and spacetime9 in schizophrenia has been
described. Although systematic reviews of geograph-
ical variation in dementia exist,10–12 previous aggrega-
tions of the evidence have relied on the ad hoc
comparison of dementia occurrence across studies
focusing on contrasting geographical locations (e.g.
different countries or urban and rural areas).
However, data from a single study in one geograph-
ical location cannot be directly compared with those
of another single centre study from another location
because methodological differences between the stu-
dies; for example, differing diagnostic criteria or the
way they are operationalized, may produce artefactual
differences in prevalence or incidence. Accordingly,
we provide an update of this evidence together with
meta-analysis examining geographical variation in the




We adopted a four-pronged approach to identifying rele-
vant studies. First, we conducted an electronic search of
relevant databases. Secondly, we scrutinized the refer-
ence sections of identified publications. Thirdly, we con-
tacted experts in the field. Fourthly, we re-examined
papers already known to us. Searches were conducted
by an information scientist (C.F.). Table 1 shows
databases utilized with dates. Comprehensive search cri-
teriawere developed iteratively. The full electronic search
strategies for all databases used, including limits applied,
are reported in the Supplementary Appendix A1. Results
of the literature search were independently screened in
parallel by two reviewers (T.R. and G.H.). Abstracts of
relevant titles were reviewed and the full text of each
highlighted article was obtained.
Eligibility criteria
Inclusion criteria were as follows: cross-sectional and
longitudinal studies of any length offering a compari-
son of dementia prevalence or incidence between two
or more different sites, at any geographical scale.
Grey literature and theses were included. We did
not limit the search by language (as long as there
was an English language abstract) with the intention
of having relevant papers translated. We also included
papers in languages other than English if other
reports from the same study had been published in
English to allow adequate assessment of the method-
ology, and this further report contained relevant data.
Articles could consider all causes of dementia apart
from those secondary to external causes or where de-
mentia is a later secondary feature of the disorder,
e.g. alcohol or traumatic brain injury, Parkinson’s dis-
ease, Huntington’s disease and Creutzfeld Jakob
disease, either sporadic or variant.
Exclusion criteria were as follows: papers comparing
studies using external comparison groups, which were
conducted independently or which used different meth-
odologies (for example, the European Community
Concerted Action on the Epidemiology and Prevention
of Dementia/European Collaboration on Dementia
papers13–16 or other ‘quantitative integrations of the lit-
erature’10), studies with no spatial variable (e.g. compar-
ing different ethnic groups or investigating aluminiumor
silicate concentrations in water) and references with no
abstract and a vague title (e.g. ‘epidemiology of demen-
tia’). Studies focusing purely on young onset dementia
were excluded to reduce heterogeneity in the review.






ASSIA (Applied Social Science
Index)
1987 8 April 2010
Embase 1974 8 April 2010
FRANCIS 1984 8–9 April 2010
GEOBASE 1980 8 April 2010
Global Health 1973 9 April 2010
LILACS 1982 9 April 2010
Medline 1950 8 April 2010
PsycINFO 1806 8 April 2010
CINAHL 1981 8 April 2010
COPAC 1100 14 April 2010




– 14 April 2010
Australian Digital Theses (ADT)
Program
1998 14 April 2010
Index to Theses – 14 April 2010
ProQuest Dissertations and
Theses
1861 15 April 2010
Theses Canada Portal 1965 15 April 2010
Conference Papers Index – 15 April 2010
PapersFirst 1993 15 April 2010
ProceedingsFirst 1993 15 April 2010
GEOGRAPHICAL VARIATION IN DEMENTIA 1013
 at U










A large number of papers describe the clusters of
amyotrophic lateral sclerosis/parkinsonism–dementia
complex in the Pacific basin. This cluster was
included because the condition is prominently char-
acterized by dementia. Due to the wealth of literature
describing these isolated clusters, a representative
paper was selected for inclusion.
Data collection
The principal summary measure was the prevalence or
incidence of dementia in the two (or more) areas stu-
died. Other data collected were the scale of comparison
or areas that were compared, methods (including diag-
nostic criteria) and measures used, details and number
of participants, including ages. The studies were also
assessed for quality of design and methodology from A
(best) to E (worst), including a consideration of bias.
This measure of quality took into account quality and
limitations of case-finding procedures, diagnostic
criteria used, standardization across sites and com-
pleteness of follow-up in longitudinal studies.
Estimates of error were not reported by all authors, lim-
iting the precision of comparisons of reported prevalence
or incidence rates. Where possible, reported P-values
were converted to 95% confidence intervals (CIs).17
Meta-analysis
Numbers of cases and non-cases in the studies compar-
ing prevalence or incidence of dementia in rural and
urban areas were used to compute odds ratios (ORs)
with accompanying 90% CIs, in line with statistical guid-
ance.18 Urban areas formed the referent in all models.
Where raw numbers were not reported, ORs and 95%
CIs were converted to log ORs and log variances. These
study-specific estimates of prevalence and incidence
were meta-analysed, using random-effects models be-
cause there was a large amount of heterogeneity (preva-
lence studies: I2! 90.8%; incidence studies: I2! 81.2%).
Authors of studies reporting insufficient data19–21 were
contacted, apart from Leighton et al.22 for whom contact
details were unavailable.
Sensitivity analyses
One prevalence study classified participants according to
more than one set of diagnostic criteria.23 In the main
analyses, the results using Diagnostic and Statistical
Manual of Mental Disorders, fourth revision (DSM-IV)
criteria were used. We also examined the effect of alter-
ing the diagnostic criteria used and the effect of exclud-
ing the study completely from themodels.We conducted
a further sensitivity analysis stratifying the prevalence
and incidence meta-analyses by study quality.
Statistical analyses were conducted using R version
2.15.024 and the metafor package.25 Figures 3 and 4
were drawn with the R package Rmeta.26 The report-
ing of this systematic review conforms to the
Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) statement.27
Results
A total of 12 580 records were screened, and the two
reviewers (T.R. and G.H.) produced shortlists of 164
and 173 papers, respectively, that potentially matched
inclusion criteria. Of 163 papers examined, 112 stu-
dies were excluded (reasons for exclusion are outlined
in Figure 3, which shows the screening process), leav-
ing 51 articles (from 35 unique studies), which are
summarized in Tables 2–6.
The studies included were conducted across the world,
thoughpredominantly in high-income countries (Europe,
Canada and the USA). The studies ranged in size from
32128 to the entire population of the USA.29 Methodolo-
gies included multiple-phase population surveys
(n! 1319,21,30–50), one-phase surveys (n! 1022,23,28,51–59),
using death certificate data (n! 820,29,49,60–65,88) and case
registers (n! 366–72). Eight studies included a longitu-
dinal design allowing dementia incidence to be
ascertained.19,31,34–35,38–41,43,58,59
Diagnostic criteria used included the International
Classification of Diseases (ICD), 9th revision73
(n! 520,53,59,63,68–70) or ICD-1074 (n! 829,35–37,38,42,43,
46,47,50,60,62,65), DSM-III75 or DSM-III-R76
(n! 830,32–36,39,42–45,48,49,52) or DSM-IV77
(n! 519,23,46,47,50,57,58). Three studies did not state the
diagnostic criteria they used.22,61,64,88 Tests used included
the Mini-Mental State Examination78 (MMSE) in vari-
ous languages (n! 919,21,30,31,37,38,40,41,46,47,49–51), the
modified MMSE79,80 (3MS; the Canadian Study of
Health & Aging32–34,39), the Community Screening
Instrument for Dementia81 (CSID; the
Ibadan–Indianapolis study35,36,42,43), the cognitive part
of the Cambridge Examination for Mental Disorders of
the Elderly82 (CAMCOG; n! 231,40,41,50), the Compre-
hensive Assessment and Referral Evaluation (CARE) or
short-CARE interview83 (n! 228,54) and the Mental
Status Questionnaire84 (MSQ) or Short Portable MSQ85
(n! 228,59). Three studies31,40,41,52,55,56 used the Geriatric
Mental Schedule (GMS) and the Automated Geriatric
Examination for Computer Assisted Taxonomy86,87
(AGECAT). Thirteen studies included a clinical assess-
ment of participants.19,21,30,32–39,42–49,50,58,66,67,71
The papers included in the review were divided into
groups reflecting the scale of comparison. Each group
will be considered, in turn, comparing rates between
countries or nationwide surveys, rural and urban
areas, regions, towns or cities and smaller areas.
Country-by-country comparisons or
nationwide surveys
Table 2 summarizes the results of the studies identi-
fied which compared rates of dementia between
countries. There were two main methodologies used
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at this scale: comparing mortality rates (of the whole
population or a sample) between two or more
countries and identifying the country of birth of indi-
viduals in a discrete area in a single country.
Age-adjusted Alzheimer disease (AD) mortality in
1999 was reported as 15.9% in the USA compared
with 21.2% in Puerto Rico.60 Rates for 2004 were
20.9 and 32.4%, respectively. They conjectured that
the increase in dementia rates might be explained
by improved survival.
The ‘Colombo 2000’ project found disease-specific
mortality rates for AD to be higher in Italy (9.8/
10 000) than in Argentina (3.4/10 000), which has a
large Italian immigrant population.64,88 Another study
comparing random samples of the over 60s found that
the proportion scoring less than 20 out of 30 on the
MMSE was 4.5% in Argentina, 9.4% in Chile and 7.2%
in Cuba.51 With a higher cut-off of 22 or less out of
30, the proportions were 8.4% in Argentina, 19.7% in
Chile and 16% in Cuba.
The 10/66 Dementia Research Group focuses particu-
larly on the under-researched (and therefore
resource-poor) areas of the world.23,57 The authors
found a much lower prevalence of dementia by
DSM-IV than by 10/66 consensus criteria in India
(rural and urban) and Peru (rural only) (Figure 2).
Dementia prevalence was found to vary between
countries, although the directly standardized
prevalence rates differed with the diagnostic criteria
used; compared with other sites, prevalence of de-
mentia was higher in Cuba (10/66 criteria: 12.6%,
95% CI 10.4–14.9; DSM-IV: 6.3%, 95% CI 5.0–7.7)
and the Dominican Republic (10/66 criteria: 9.8%,
95% CI 8.1–11.1; DSM-IV: 4.2%, 95% CI 3.3–5.1)
and lower in rural China (10/66 criteria: 4.8%, 95%
CI 3.1–6.4), rural Peru (DSM-IV: 0.4%, 95% CI 0.0–
1.0) and both rural (DSM-IV: 0.3%, 95% CI 0.1–0.5)
and urban (DSM-IV: 0.9%, 95% CI 0.3–1.6) India.
The remaining studies used the second method-
ology mentioned earlier—identifying the country
of birth of individuals in a single area, thus provid-
ing insight into the effect of place of birth on the
risk of developing dementia. The Islington study
interviewed house to house and grouped the over
65s by country of birth.54 They found no relation
between migration per se and dementia. However,
the relative risk (RR) for developing dementia did
vary by place of birth, being lower in the Irish
population (RR: 0.36, 95% CI 0.15–0.87) and
higher in the case of people born in Africa or the
Caribbean (RR: 1.72, 95% CI 1.06–2.81) when com-
pared with British-born residents. Another
London-based study found a higher dementia
prevalence in African–Caribbean-born residents of
Haringey compared with the White UK-born popu-
lation (OR! 3.07, 95% CI 1.28–7.32).50




12 580 records after
duplicates removed
12 580 records screened 12 417 records excluded
163 full text articles
assessed for eligibility
112 articles excluded:
38 no spatial comparison
29 no within!study comparison
16 not prevalence/incidence
12 no data reported
9 duplicated other papers








Figure 1 PRISMA diagram showing selection of studies for inclusion in systematic review of geographical clustering of
dementia prevalence and incidence
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Cuba Peru U Venezuela Mexico R China R India R
DR Peru R Mexico U China U India U
10/66 Criteria
DSM IV Criteria
Figure 2 Comparison of standardized dementia prevalence (95% CI) with different diagnostic criteria. Constructed from
10/66 Dementia Research Group data.23 DR!Dominican Republic, U!urban, R! rural
Study [reference]
Ogunniyi et al (2000)  [ 42 ]
Ogunniyi et al (2000)  [ 42 ]
Lin et al (1998)  [ 37 ]
Matthews et al (2005)  [ 40 ]
Zhang et al (2006)  [ 47 ]
Rodriguez et al (2008)  [ 23 ]
Rodriguez et al (2008)  [ 23 ]
Rodriguez et al (2008)  [ 23 ]
Rodriguez et al (2008)  [ 23 ]
Jean et al (1996)  [ 67 ]
Yip et al (1997)  [ 49 ]
Arslantas et al (2009)  [ 21 ]











































































0 1 2 3 4 5 6
Odds ratio
Figure 3 Meta-analysis with forest plot of urban/rural differences in dementia prevalence (using DSM-IV criteria for
Ref. 23). Rural": dementia cases in rural areas, Rural#: non-dementia cases in rural areas, Urban": dementia cases in
urban areas and Urban#: non-dementia cases in urban areas. Articles without case numbers reported ORs and 95% CIs
rather than raw numbers. Urban areas form the referent
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Table 3 outlines publications comparing rates of de-
mentia in rural and urban areas. The rural/urban
comparisons were quantitatively examined by
meta-analysis where possible with the remaining stu-
dies being summarized narratively.
Papers that reported (or provided) sufficient preva-
lence21,23,30,37,40,42,47,49,67 or incidence19,34,40,43 data
were meta-analysed using random-effects models,
and results are shown in Figures 3 and 4, respectively.
Urban areas form the reference group throughout.
Out of the authors contacted, two replied providing
data for inclusion in the meta-analysis.19,21 Two art-
icles were excluded due to reporting insufficient
data.20,22 The latest report from the 10/66 Dementia
Research Group was excluded because it did not give
sufficient data for inclusion despite reporting a
slightly later stage of the study.57
There was evidence of an association between rur-
ality and prevalence of AD37,42,47,67 (OR! 1.50, 90%
CI 1.33–1.69) but much less so for vascular demen-
tia30,37,47 (OR! 1.09, 90% CI 0.65–1.83). Evidence was
weaker for an association between rurality and
non-specific dementia prevalence21,23,30,37,40,49
(OR! 0.91, 90% CI 0.57–1.45). Pooling all prevalence
studies regardless of diagnostic sub-
type21,23,30,37,40,42,47,49,67 resulted in an intermediate
risk of dementia (OR! 1.11, 90% CI 0.79–1.57).
Only one prevalence study classified participants ac-
cording to more than one set of diagnostic criteria.23
Altering the criteria used had a substantial effect on
the association between non-specific dementia and
rurality: using DSM-IV criteria (OR! 0.91, 90% CI
0.57–1.45), using 10/66 consensus criteria
(OR! 1.14, 90% CI 0.80–1.61) and excluding the
four comparisons reported in this study (OR! 1.32,
90% CI 0.73–2.39). Combining all prevalence
studies regardless of diagnostic subtype showed
a similar pattern: DSM-IV (OR! 1.11, 90% CI
0.79–1.57); 10/66 criteria (OR! 1.26, 90% CI 0.97–
1.65); and excluding the study (OR! 1.46, 90% CI
1.02–2.09).
Stratifying prevalence studies by quality reduced the
association between rurality and dementia (studies
rated D or better:21,23,37,40,42,47,49,67 OR! 1.16, 90%
CI 0.80–1.68, C or better:23,37,40,42,47,49,67 OR! 1.03,
90% CI 0.80–1.32 and B or better:23,37,40,42,47
OR! 0.95, 90% CI 0.69–1.29) apart from the two com-
parisons from the one study rated A for quality,42
which captured early life rural living in which there
was an increased association between rurality and AD
(OR! 2.22, 90% CI 1.19–4.16).
There was evidence of an association between rur-
ality and dementia incidence19,34,40,43 (OR! 1.20, 90%
CI 0.84–1.71), stronger for AD43 (OR! 1.64, 90% CI
1.08–2.50) than for non-specific dementia19,40
(OR! 0.81, 90% CI 0.61–1.09). Restricting the
meta-analysis to incidence studies rated A for qual-
ity19,43 (no incidence study was rated lower than B)
had little effect on the association with rurality
(OR! 1.17, 90% CI 0.66–2.06).
There was no evidence of publication bias on formal
testing (regression test for funnel plot asymmetry:
prevalence studies z!"1.34, P! 0.18; incidence stu-
dies z! 1.51, P! 0.13).19,43
Among the studies reporting insufficient data for
meta-analysis, a study examining all Japanese death
certificates from 1979 to 1990 found that the AD mor-
tality was similar for rural and urban areas,20 and a
study in Nigeria found that prevalence of ‘chronic
brain syndrome’ did not vary between Yoruba villages
and a nearby town in men (6%) but did in women
(5% vs 9%).22
Regional comparisons
‘Region’ here refers to an area within a country larger
than a town or city. Table 4 summarizes the results of
studies identified, which compared rates of dementia
between regions.
The Canadian Study of Health & Aging reported a
similar prevalence of dementia across Canada but
suggested that the relative prevalence of dementia
subtypes varied across regions.32–34 Particularly low
prevalence of dementia in Ontario men was explained
by discrepancies in the use of diagnostic criteria.32
Another Canadian study concluded that dementia
prevalence varies little across regions.39 They did
note differences between community and institutional
samples and noted that dementia prevalence was
higher in areas of lower socio-economic status. In
rural Manitoba, Canada, the prevalence of dementia
among the Cree was found to be the same as a non-
native sample in Winnipeg, but there was just one
case of AD identified in the Cree (0.5%) compared
with 20 in the Winnipeg sample (8.3%; age-adjusted
rate: 3.5%, 95% CI 2.1–4.8; P<0.001).48
A comparison of all dementia deaths in 1999/2000
and 2005/06 across the USA at the county level
showed a pattern of marked variation in dementia
and AD mortality different to that of cardiovascular
disease and stroke.65 Three ‘co-operative longitudinal
studies’ in the USA reported 6-year incidence rates of
29.8% in East Boston, 25.0% in New Haven and 20.4%
in Iowa.59 Using stricter criteria reduced the variation
between sites (East Boston 15.4%, New Haven 14.3%
and Iowa 11.3%). Prevalence of AD in South Carolina
showed ‘notable variation’ at a county level.68–70
However, it was unclear whether the location was
where the individual was born or where they were
lived as an adult. Clustering of AD deaths in the
north-west and south-east of the USA, with a 4-fold
difference in rates between the highest and lowest was
identified over the period of 1999–2004.29 A study in
Puerto Rico noted variation in mortality rates with
dementia in the eight regions of the island.60
The amyotrophic lateral sclerosis/parkinsonism–
dementia complex clusters in the Chamorro popula-
tion of Guam (one of the Mariana Islands in the
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western Pacific Ocean) and elsewhere have been ex-
tensively studied.89 A representative study on Guam
identified an incidence gradient, with higher preva-
lence in southern and central Guam and lower preva-
lence in northern and western Guam.72,90 More recent
reports have not focused directly on the geographical
spread of cases.91 There have been suggestions that
this cluster could be related to the consumption of a
palm, Cycas micronesica, but this has not been defini-
tively proven.92 Similar clusters have been described
on the Kii peninsula of Japan—with prevalence in
two villages approximately one hundred times that in
the rest of the country93—and in West New Guinea.94
Examination of Australian death certificates re-
vealed a much higher prevalence of dementia at
death in Tasmania and ‘senility’ in South Australia
than the rest of the country.63 Dementia prevalence
at death was predominantly related to place of death,
but those who were born and died in Tasmania had
the highest rate of all. In Tasmania, 43% of dementia
death certificates were linked to a single practitioner.
A Japanese study found that AD mortality varied
across the country, with Miyazaki prefecture approxi-
mately double and Okinawa approximately half the
overall national rate.20 Across four areas of China, a
north–south gradient in dementia prevalence, particu-
larly for vascular dementia, and a less pronounced
east–west gradient were identified.46,47
The Medical Research Council Cognitive Function
and Ageing study concluded that there was no evi-
dence of variation in incidence or prevalence of de-
mentia in England and Wales.31,40,41 The incidence of
dementia in a working class urban area of Spain was
double that in both the agricultural and professional
class urban areas.19 A Finnish study found a higher
prevalence of AD in the north and east of the country
than elsewhere.44,45
Town/city comparisons
Table 5 outlines the articles comparing rates of de-
mentia between towns and cities.
The Ibadan–Indianapolis study identified a higher
age-adjusted prevalence of dementia in Indianapolis,
USA (4.82%) compared with Ibadan, Nigeria
(2.29%; AD: 3.69% vs 1.41%).36,42 At follow-up, age-
standardized annual dementia incidence rates were
higher in Indianapolis (3.24%, 95% CI 2.11–4.38;
Ibadan: 1.35%, 95% CI 1.13–1.56), as were age-
standardized annual AD incidence rates
(Indianapolis: 2.52%, 95% CI 1.40–3.64; Ibadan:
1.15%, 95% CI 0.96–1.35).35,43
The rates of dementia in the institutionalized elderly
population with moderate or severe dementia in New
York and London were found to be similar.28 A later
study found that rates of organic illness were higher
in New York for both men (5.7%; London 2.2%) and
women (10.1%; London 5.4%).52
In Okinawa, there was some evidence of variation in
rates of dementia between Sashiki village and Ikema
island, but these were not formally compared and
used as an idiosyncratic case classification.53
No difference in dementia prevalence was found
between Zaragoza, Spain and Liverpool.55,56
Furthermore, they identified no sex or age differences.
The 3C study found no differences in the distribution
of cognitive test scores in three cities across France.58
Small area comparisons
Large-scale (or small area) comparisons are poten-
tially the most informative with regard to identifying
socio-environmental risk factors for dementia. Table 6
outlines the papers making such comparisons.
Death certificates for the over 70s were examined in
Newfoundland, Canada and two areas had substan-
tially higher dementia mortality rates.61 An excess of
individuals born on the north shore of Bonavista Bay
dying from dementia were identified (14.3%; south
shore: 2.9%). This was not related to differential sur-
vival or sex distribution but may have been affected
by kinship and migration. Projet IMAGE found no
real variation in standardized prevalence rates of de-
mentia in an area of Québec, Canada, despite a trend
in two areas.66,67,71 A Swiss study identified a dose–
response relationship between the length of time




All published studies indicate that the prevalence and,
in one case, incidence of dementia varied between
countries, but the precision of estimates was not
always clear. Comparing rural and urban areas,
there was evidence for an association between rurality
and prevalence and incidence of AD. The association
with AD prevalence was increased in studies that cap-
tured early life rural living. There was less evidence
for an association with prevalence or incidence of a
general category of dementia. At a regional level, the
findings were mixed with some,31–34,40,41 but not all,19
of the better quality studies suggesting that there is
little evidence of variation in dementia prevalence or
incidence. However, very few studies report data sup-
porting their findings, limiting the certainty of
conclusions.
There were fewer large-scale studies and therefore
conclusions must be tentative. However, the best
quality studies did find variation in dementia inci-
dence between towns/cities.35,36,42,43 The 3C study58
did not but reported the distribution of cognitive
test scores rather than actual diagnoses of dementia.
At the most informative (i.e. largest) scale, there were
fewest studies. However, all except for Projet
IMAGE66,67,71 found evidence of variation in dementia
prevalence. There were no studies of dementia inci-
dence at this scale.
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To summarize, there is evidence, at all scales, of
geographical variation in the prevalence or incidence
of dementia and, specifically, a higher risk of AD in
rural areas. At first glance, the different patterns seen
at different scales seem contradictory and confusing.
However, this is a common finding with geographical
data, the modifiable areal unit problem where, ‘if the
spatial units in a particular study were specified dif-
ferently, we might observe very different patterns and
relationships’.95 Unfortunately, none of the included
studies collected their data or conducted their
analyses at more than one scale, which might
shed some light on this ubiquitous problem of spatial
data.
The definition of rurality
There was substantial heterogeneity in the studies
comparing rural and urban areas. This is likely to be
due, at least in part, to the notoriously difficult def-
inition of ‘rurality’. A Japanese study defined an ad-
ministrative unit as ‘rural’ if the population numbered
30 000 or fewer.20 In Sicily, the isolation of rural
Troina (where the ‘economy is almost completely
based on farming and grazing’) is contrasted with
the urban area ‘connected by rail, sea, a regional
road, and a motorway . . . [where] the economy is
more diversified’.30 The 10/66 Dementia Research
Group defined rural areas ‘by low population density,
and traditional agrarian lifestyle’.96 Projet IMAGE
defined a rural area as containing villages rather
than cities.97,98 Nevertheless, it is surprising how
many studies do not explicitly define rurality—e.g.
neither Liu et al.38 nor investigators in the Canadian
Study of Health and Aging32,34,99 provided a definition
of rurality. This is easier to understand when compar-
ing extremes, for example a large city and distant
villages, when the difference is obvious. However, it
becomes more difficult to make subtle distinctions.
Indeed, a perfect definition may remain elusive, and
the epidemiological importance may not lie in the
contrast but, rather, in the optimum population dens-
ity (as has been demonstrated for cardiovascular dis-
ease and stroke in men100) and access to health
services and factors conducive to a healthy lifestyle.
Young onset dementia
Although studies purely examining young onset de-
mentia were excluded from this review, there are a
number of relevant studies that echo the findings in
late onset dementia. A study in Israel—using country
of birth as the spatial variable—found age- and
sex-adjusted incidence rates for European–
American-born individuals to be double that of
African–Asian-born people.101 At a larger scale, a
study in Edinburgh identified all 55 unrelated cases
of young onset AD admitted to hospital and
noted high prevalence in two geographical areas.102
A subsequent study of young onset dementia across
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distribution of cases and found non-random distribu-
tion of cases of young onset AD but not vascular
dementia.103–106 This pattern was partly, but not en-
tirely, explained by kinship, suggesting that socio-
environmental factors may also play a role in the
aetiology of young onset dementia.104
Limitations of the review and risk of bias
within and across studies
The methodology of this review was systematic and
robust and the wide, professionally conducted search,
and two independent reviewers are likely to have
identified all the available literature.
There is the possibility that variation in dementia
prevalence or incidence might be the result of
chance, but this review includes a large number of
studies, many of them methodologically robust,
which have found variation, suggesting that chance
is unlikely to be behind all of them. Furthermore,
all the studies included in the review offer
within-study comparisons minimizing the possibility
that identified variations in prevalence or incidence
are the result of methodological differences between
studies.
The first and most profound limitation to and source
of bias in this review is the lack of attention paid to
epidemiological studies of dementia in large areas of
the world,107 a point noted and beginning to be reme-
died by bodies such as the 10/66 Dementia Research
Group,23,57 also recently highlighted in relation to stu-
dies in Eastern and Middle European countries.16
This is particularly important because it is predicted
that increases in dementia prevalence will be larger
in the developing world than elsewhere.107,108
Until there are good quality epidemiological studies
across the world, no conclusions regarding the
global variation of dementia can be any less than
conjectural.
There are significant methodological difficulties
involved when comparing epidemiological studies,
such as the method and thoroughness of case find-
ing,10 whether the entire population or a sample will
be studied109 and the choice of study setting itself.
These difficulties are compounded in studies of de-
mentia by consideration of different diagnostic criteria
and whether to include mild cases,10 let alone indi-
viduals with ‘mild cognitive impairment’. Further
biases, such as differential survival and consequent
differing age structures of populations, variation in
diagnosis rates and reporting of dementia,63,110
screening non-participation and validation,111 access
to health care and levels of health and education
make conducting and interpreting such studies—
even when they are methodologically identical—ex-
tremely difficult.11 These challenges are likely to
have produced some bias in the studies and are re-
flected in the variation in quality ratings for the stu-
dies. One interesting finding from two studies51,59 is
that geographical variation reduces with stricter
diagnostic criteria, confirming Jorm’s assertion that
the inclusion or exclusion of milder cases can have
an important effect on the findings of quantitative
studies of dementia.10
Considering diagnostic criteria in more detail, no
studies investigated definitive neuropathological diag-
noses, and therefore, differential rates of dementia
subtypes must be considered no more certain than
‘probable’, in line with diagnostic criteria.112–116
Therefore, the possibility remains that the clinical
diagnoses reported in these studies may not perfectly
reflect neuropathology, as has been shown previ-
ously.117,118 The common neuropathological finding
of mixed pathologies further complicates matters.
This suggests that conclusions regarding specific de-
mentia subtypes should be considered tentative.
A large number of studies rely on case registers or
death certificate data. These methodologies are highly
susceptible to bias in that the diagnosis has to be
correctly made, recorded and transcribed into the ap-
propriate record. Estimated rates of accurate dementia
reporting on death certificates are 25–58%,110,119 but
more recent studies suggest that this is improving, for
example, in a cohort of 502 deceased individuals with
probable AD, 359 (71.5%) had dementia correctly re-
corded as a cause of death.120 Furthermore, there is a
potential spatial confounder in that clinical service
provision or quality may vary with geography, result-
ing in variation of dementia prevalence as in one
study where 43% of the cases in a cluster could be
linked back to just one clinician, who presumably had
a particular interest in dementia.63
Screening studies are more robust, particularly
two-stage screening designs and especially when the
whole population is screened rather than a sample.
However, there is still a danger of selection bias creep-
ing in.111 The best quality studies included were
the Neurologic Disorders in Central Spain Study19
and, despite numerous methodological challenges—
including estimating the ages of some of the
Yoruba interviewed—the Ibadan–Indianapolis
study.35,36,42,43 Both studies showed variation in
dementia incidence and the latter showed variation
in AD prevalence.
The cultural validity of the tests and the rating
scales, even if translated, is often unclear.
Furthermore, cultural factors related to ageing and
functional decline are also highly relevant to variation
and a source of bias. Different cultures react to and
accommodate ageing in different ways and will treat
symptoms of cognitive and functional decline differ-
ently. We must not ignore the implicit value-laden
nature of many, if not all, diagnoses,121 even demen-
tia—for example, what level of functioning can be
expected at what age—and the variation of these
values in different countries and different cultures.
In fact, from a global perspective, the individual
with dementia may not be a fixed kind of person
but what Hacking describes as a ‘moving target’.122
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Further potential confounders include differential
survival or migration—for example, if individuals at
a higher risk of developing dementia in an area die or
move away, those remaining will have an artefac-
tually low prevalence of dementia. Both migration61
and differential survival35,36,42,43,61 were considered by
a small number of the studies. The methodology most
susceptible to bias by migration is comparing country
of birth of individuals living in a discrete geographical
area. The finding that risk of dementia is increased in
people born in Africa or the Caribbean50,54 is not
matched by increased rates of dementia in these
countries that suggests migration may have con-
founded the studies using this methodology.
Similarly, genetic relatedness is a factor that must
be taken into account and was estimated by some
of the studies included.61,103,104,123
The spatial variable must also be recorded from a
sufficiently early point in life to avoid reverse causal-
ity, for example mapping the location of death of
people with dementia may merely identify the loca-
tions of care homes or hospitals with long-stay
beds.110
The relative dearth of larger scale comparisons—for
example regions, towns or postal districts—limits the
precise assessment of any variation that might be
found and thus the conclusions that can be drawn
about possible socio-environmental exposures.
This review explicitly excluded papers comparing
studies conducted independently or with different
methodologies. Therefore, there are potentially further
studies looking at rates of dementia in rural areas, but
the methodological difficulties in combining these
with separate studies preclude such a comparison.
This criterion is unlikely to have introduced substan-
tial bias but clearly reduces the data available sub-
stantially with a consequent impact on CIs for effect
estimates.
Implications
Apart from implications for health service provision,
the real interest in identifying variation in the preva-
lence and incidence of a disease is in identifying po-
tentially modifiable risk factors. Many socio-
environmental risk factors are likely to have their
effect on dementia risk early in life,124–126 though
not all studies confirm this association.127 Some of
the studies included in the current review examined
early life effects, for example place of birth61 or living
in a rural area in childhood,42,43 but the majority
measured their exposures at the time of the study.
The rural/urban meta-analysis suggested that, al-
though rural living may be associated with increased
rates of AD, early life rural living may have an even
greater effect. There are two possible implications of
this finding: that exposure in early life has a greater
effect or that duration of exposure determines the
risk. Further research is required to clarify this
finding.
However, any consideration of geographical vari-
ation of dementia must also include geographical
variation of related conditions and risk factors.
Cardiovascular and cerebrovascular diseases have
been shown to vary in incidence across Scotland,
and this variation is partly related to smoking (in
both sexes), population density, deprivation, blood
pressure and body mass index (in men).100
Temporal trends are also important. The possibility
that changes in dementia incidence over time, and
some geographical variation, might be related to im-
proved survival following stroke has been raised.128,129
Detailed examination of secular trends in dementia,
related conditions and risk factors is required.130
Given the early effects of some risk factors and the
presence of pathological changes of AD decades before
the clinical onset of dementia,131 any attempts at pre-
vention will need to begin sufficiently early in life.
Study [reference]
Ogunniyi et al (2006)  [ 43 ]
Ogunniyi et al (2006)  [ 43 ]
Bermejo!Pareja et al (2008)  [ 19 ]
Hebert et al (2000)  [ 34 ]
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Figure 4 Meta-analysis with forest plot of urban/rural differences in dementia incidence. Rural!: dementia cases in rural
areas, Rural": non-dementia cases in rural areas, Urban!: dementia cases in urban areas and Urban": non-dementia cases
in urban areas. Articles without case numbers reported ORs and 95% CIs rather than raw numbers. Urban areas form the
referent
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A number of systematic reviews have shown that
modifying risk factors in late life, for example low-
ering blood pressure132 or treatment with statins,133
are ineffective in preventing dementia, consistent
with the evidence that many risk factors for dementia
have their effects in mid-life or earlier.134–137
This need for sufficiently early intervention is re-
flected in the ideal methodology of dementia epidemi-
ology studies and the importance of measuring risk
factors—including location—at the most appropriate
time point. Identification of any putative risk factors,
at any geographical scale, requires their measurement
to be at a sufficiently early stage for the findings to be
clinically meaningful.
Conclusions
Though the extant evidence is far from consistent and
varies in quality, prevalence and incidence of demen-
tia do vary, at a number of scales and between
countries, regions, towns and cities and small areas.
There is weak evidence for variation in dementia in-
cidence or prevalence between rural and urban areas
but stronger evidence for AD. Furthermore, early
exposure to rural living may have an increased
effect on the association between rurality and AD.
Further work to provide higher quality evidence of
geographical and temporal variation is required, and
comparisons could usefully be made with the geo-
graphical distributions of related conditions, such as
stroke and cardiovascular disease. The next question
is whether the causes of this observed variation can
be identified, and, if so, could they highlight modifi-
able socio-environmental risk factors, thus making
dementia a preventable disease?
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KEY MESSAGES
! Identifying geographical variation in dementia prevalence and incidence could lead to the identifi-
cation of potentially modifiable risk—or protective—factors.
! This review identifies evidence, based on within-study comparisons, at a variety of scales of geo-
graphical variation of dementia.
! Furthermore, there is evidence from meta-analysis of an association between rural living and AD,
particularly for early life rural living.
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APPENDIX: Search Terms 
Medline search  
 (Geograph* or cluster* or Afghanistan or Albania or Algeria or Angola or Antarctica or 
Argentina or Armenia or Australia or Austria or Azerbaijan or Bahamas or Bahrain or 
Bangladesh or Barbados or Belarus or Belgium or Belize or Benin or Bermuda or 
Bolivia or Bosnia or Botswana or Brazil or Brunei or Bulgaria or Burkina fasso or 
Burma or Burundi or Cambodia or Cameroon or Canada or Central African republic or 
Chad or Chile or China or Colombia or Congo or Costa Rica or Cote divoire or Croatia 
or Cuba or Cyprus or Czech republic or Denmark or Dominica or Dominican republic 
or Ecuador or Egypt or El Salvador or England or Equatorial guinea or Eritrea or 
Estonia or Ethiopia or Finland or France or Georgia or Germany or Ghana or Greece 
or Greenland or Guinea or Hong kong or Hungary or Iceland or India or Indonesia or 
Iran or Iraq or Ireland or Israel or Italy or Jamaica or Japan or Jordan or Kazakhstan or 
Kenya or Korea or Kuwait or Kyrgyzstan or Laos or Latvia or Lebanon or Lesotho or 
Libya or Lithuania or Malawi or Malaysia or Mali or Mexico or Mongolia or Morocco or 
Mozambique or Namibia or Nepal or Netherlands or New Zealand or Nicaragua or 
Niger or Nigeria or Norway or Pakistan or Papua new Guinea or Paraguay or Peru or 
Philippines or Poland or Portugal or Puerto Rico or Romania or Russia or Rwanda or 
Saudi Arabia or Scotland or Senegal or Serbia or Sierra Leone or Singapore or Slovakia 
or Slovenia or Somalia or South Africa or Spain or Sri lanka or Sudan or Swaziland or 
Sweden or Switzerland or Syria or Taiwan or Tajikistan or Tanzania or Thailand or 
Togo or Trinidad or Tunisia or Tunisia or Turkey or Turkmenistan or Uganda or 
Ukraine or United Arab Emirates or United kingdom or United states or Uruguay or 




(Geograph* or cluster* or Afghanistan or Albania or Algeria or Angola or Antarctica or 
Argentina or Armenia or Australia or Austria or Azerbaijan or Bahamas or Bahrain or 
Bangladesh or Barbados or Belarus or Belgium or Belize or Benin or Bermuda or 
Bolivia or Bosnia or Botswana or Brazil or Brunei or Bulgaria or Burkina fasso or 
Burma or Burundi or Cambodia or Cameroon or Canada or Central African republic or 




or Cuba or Cyprus or Czech republic or Denmark or Dominica or Dominican republic 
or Ecuador or Egypt or El Salvador or England or Equatorial guinea or Eritrea or 
Estonia or Ethiopia or Finland or France or Georgia or Germany or Ghana or Greece 
or Greenland or Guinea or Hong kong or Hungary or Iceland or India or Indonesia or 
Iran or Iraq or Ireland or Israel or Italy or Jamaica or Japan or Jordan or Kazakhstan or 
Kenya or Korea or Kuwait or Kyrgyzstan or Laos or Latvia or Lebanon or Lesotho or 
Libya or Lithuania or Malawi or Malaysia or Mali or Mexico or Mongolia or Morocco or 
Mozambique or Namibia or Nepal or Netherlands or New Zealand or Nicaragua or 
Niger or Nigeria or Norway or Pakistan or Papua new Guinea or Paraguay or Peru or 
Philippines or Poland or Portugal or Puerto Rico or Romania or Russia or Rwanda or 
Saudi Arabia or Scotland or Senegal or Serbia or Sierra Leone or Singapore or Slovakia 
or Slovenia or Somalia or South Africa or Spain or Sri lanka or Sudan or Swaziland or 
Sweden or Switzerland or Syria or Taiwan or Tajikistan or Tanzania or Thailand or 
Togo or Trinidad or Tunisia or Tunisia or Turkey or Turkmenistan or Uganda or 
Ukraine or United Arab Emirates or United kingdom or United states or Uruguay or 




(Geograph* or cluster* or Afghanistan or Albania or Algeria or Angola or Antarctica or 
Argentina or Armenia or Australia or Austria or Azerbaijan or Bahamas or Bahrain or 
Bangladesh or Barbados or Belarus or Belgium or Belize or Benin or Bermuda or 
Bolivia or Bosnia or Botswana or Brazil or Brunei or Bulgaria or Burkina fasso or 
Burma or Burundi or Cambodia or Cameroon or Canada or Central African republic or 
Chad or Chile or China or Colombia or Congo or Costa Rica or Cote divoire or Croatia 
or Cuba or Cyprus or Czech republic or Denmark or Dominica or Dominican republic 
or Ecuador or Egypt or El Salvador or England or Equatorial guinea or Eritrea or 
Estonia or Ethiopia or Finland or France or Georgia or Germany or Ghana or Greece 
or Greenland or Guinea or Hong kong or Hungary or Iceland or India or Indonesia or 
Iran or Iraq or Ireland or Israel or Italy or Jamaica or Japan or Jordan or Kazakhstan or 
Kenya or Korea or Kuwait or Kyrgyzstan or Laos or Latvia or Lebanon or Lesotho or 
Libya or Lithuania or Malawi or Malaysia or Mali or Mexico or Mongolia or Morocco or 




Niger or Nigeria or Norway or Pakistan or Papua new Guinea or Paraguay or Peru or 
Philippines or Poland or Portugal or Puerto Rico or Romania or Russia or Rwanda or 
Saudi Arabia or Scotland or Senegal or Serbia or Sierra Leone or Singapore or Slovakia 
or Slovenia or Somalia or South Africa or Spain or Sri lanka or Sudan or Swaziland or 
Sweden or Switzerland or Syria or Taiwan or Tajikistan or Tanzania or Thailand or 
Togo or Trinidad or Tunisia or Tunisia or Turkey or Turkmenistan or Uganda or 
Ukraine or United Arab Emirates or United kingdom or United states or Uruguay or 




(Geograph* or cluster* or Afghanistan or Albania or Algeria or Angola or Antarctica or 
Argentina or Armenia or Australia or Austria or Azerbaijan or Bahamas or Bahrain or 
Bangladesh or Barbados or Belarus or Belgium or Belize or Benin or Bermuda or 
Bolivia or Bosnia or Botswana or Brazil or Brunei or Bulgaria or Burkina fasso or 
Burma or Burundi or Cambodia or Cameroon or Canada or Central African republic or 
Chad or Chile or China or Colombia or Congo or Costa Rica or Cote divoire or Croatia 
or Cuba or Cyprus or Czech republic or Denmark or Dominica or Dominican republic 
or Ecuador or Egypt or El Salvador or England or Equatorial guinea or Eritrea or 
Estonia or Ethiopia or Finland or France or Georgia or Germany or Ghana or Greece 
or Greenland or Guinea or Hong kong or Hungary or Iceland or India or Indonesia or 
Iran or Iraq or Ireland or Israel or Italy or Jamaica or Japan or Jordan or Kazakhstan or 
Kenya or Korea or Kuwait or Kyrgyzstan or Laos or Latvia or Lebanon or Lesotho or 
Libya or Lithuania or Malawi or Malaysia or Mali or Mexico or Mongolia or Morocco or 
Mozambique or Namibia or Nepal or Netherlands or New Zealand or Nicaragua or 
Niger or Nigeria or Norway or Pakistan or Papua new Guinea or Paraguay or Peru or 
Philippines or Poland or Portugal or Puerto Rico or Romania or Russia or Rwanda or 
Saudi Arabia or Scotland or Senegal or Serbia or Sierra Leone or Singapore or Slovakia 
or Slovenia or Somalia or South Africa or Spain or Sri lanka or Sudan or Swaziland or 
Sweden or Switzerland or Syria or Taiwan or Tajikistan or Tanzania or Thailand or 
Togo or Trinidad or Tunisia or Tunisia or Turkey or Turkmenistan or Uganda or 
Ukraine or United Arab Emirates or United kingdom or United states or Uruguay or 





This search was then combined using ‘AND’ with 
 
(Dementia or Alzheimer* or Alzheimer Disease or Aphasia, Primary Progressive or 
Primary Progressive Nonfluent Aphasia or Creutzfeldt-Jakob Syndrome or Dementia, 
Vascular or CADASIL or Dementia, Multi-Infarct or Diffuse Neurofibrillary Tangles 
with Calcification or Frontotemporal Lobar Degeneration or Frontotemporal Dementia 





(Prevalence or incidence or distribut* or epidem*).af. 
 
limited to English Language and humans 
 
This search strategy was used across all the larger bibliographic databases.  
 
Simple search 
For smaller databases a simpler search was used as follows 
 




Dementia or Alzheimer* or Alzheimer Disease or Aphasia, Primary Progressive or 
Primary Progressive Nonfluent Aphasia or Creutzfeldt-Jakob Syndrome or Dementia, 
Vascular or CADASIL or Dementia, Multi-Infarct or Diffuse Neurofibrillary Tangles 
with Calcification or Frontotemporal Lobar Degeneration or Frontotemporal Dementia 
or Primary Progressive Nonfluent Aphasia or Lewy Body Disease or Pick Disease of the 
Brain 
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a b s t r a c t
Objective: Individual cardiovascular disease (CVD) risk factors are associated with dementia. For the !rst
time, we investigated whether the Framingham CVD risk scoreewhich comprises these multiple risk
factorsewas also associated with future dementia risk.
Methods: Individual participant meta-analysis of two large, general population cohort studies
(N ! 11,887). For the purposes of comparison of the dementia results, we also examined the association
between the Framingham CVD risk score and CVD-related death.
Results: Framingham CVD risk score was associated with dementia death (hazard ratio per 10%
increased risk, 95% con!dence interval: 4.00, 2.44e6.56). Adjusting for age eliminated this association
(1.04, 0.53e2.01); similarly, age explained 88% of the ability of the Framingham CVD risk score to predict
CVD death.
Conclusions: The Framingham CVD risk score was no more strongly associated with future dementia than
age. It therefore offers no added value in predicting dementia.
! 2013 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Cardiovascular disease (CVD) and dementia represent a major
disease burden worldwide. These conditions share a series of risk
factors (hypertension, smoking, obesity, diabetes, and dyslipide-
mia) [1]. CVD itself, particularly multiple strokes, also appears to
elevate dementia risk [2]. The Framingham Cardiovascular Disease
Risk Score [3], which comprises these risk factors, is a standard tool
for assessing future risk of CVD in people who are apparently
healthy. This raises the possibility that this risk score might also be
useful in identifying people at increased risk of developing de-
mentia. Since the Framingham CVD risk score is already commonly
used in clinical practice, the implications of such an observation
would be considerable.
While the Framingham CVD risk score has been shown to pre-
dict cognitive decline [4], an aspect of dementia, to the best of our
knowledge, there are no prospective studies examining the links
between the Framingham CVD risk score and future dementia [5].
Accordingly, we meta-analysed individual-participant data from
two large English population-based cohort studies.
2. Methods
Participants were taken from the Health Survey for England [6],
a series of annual, on-going, independent, general population-
based cross-sectional studies that are representative of
household-dwelling individuals in England in most years. Partici-
pants gave informed consent and ethical approval was obtained
from the London Research Ethics Council.
The scienti!c focus of each survey changes year to year; risk
factor data for calculating the Framingham CVD risk score [3] (age,
sex, HDL-cholesterol, total cholesterol, systolic blood pressure,
smoking, and diabetes) were available for surveys conducted in
1998 and 2003. Mortality follow-up of study members in these
* Corresponding author. Alzheimer Scotland Dementia Research Centre, Univer-
sity of Edinburgh, 7 George Square, Edinburgh EH8 9JZ, UK. Tel.: "44 (0)131 650
4341; fax: "44 (0)131 242 6370.
E-mail address: tom.russ@nhs.net (T.C. Russ).
Contents lists available at SciVerse ScienceDirect
Atherosclerosis
journal homepage: www.elsevier .com/locate/atherosclerosis
0021-9150/$ e see front matter ! 2013 Elsevier Ireland Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.atherosclerosis.2013.02.020




studies continued until death or 15th February 2008, whichever
came !rst. Dementia- and CVD-related deaths [3] were identi!ed
from any mention on death certi!cates of the following codes:
dementiaeICD-9 codes 290.0e290.4 (senile dementia, uncompli-
cated; presenile dementia; senile dementia with delusional or
depressive features; senile dementia with delirium; or vascular
dementia), 294.9 (unspeci!ed persistent mental disorders due to
conditions classi!ed elsewhere), 331.0e331.2 (Alzheimer’s disease;
frontotemporal dementia; or senile degeneration of the brain), and
331.9 (cerebral degeneration, unspeci!ed) and ICD-10 codes F01,
F03, F09, G30, and G31; CVDeICD-9 codes 410e414 (ischaemic
heart disease), 428 (heart failure), 430e438 (cerebrovascular dis-
ease), 440 (atherosclerosis), and 443e445 (other peripheral
vascular disease; arterial embolism and thrombosis; or athe-
roembolism) and ICD-10 codes I20-I25, I50, I60eI69, I70, I73, and
I74 (characteristics of the two surveys are shown in Table 1).
Using similar methodology to previous studies [7], we used Cox
proportional hazards models to compute study-speci!c effect es-
timates with accompanying standard errors which we pooled in a
random effects meta-analysis. We report unadjusted hazard ratios
(HR) with accompanying 95% con!dence intervals (CI) per 10% in-
crease (disadvantage) in the Framingham CVD risk score in relation
to dementia-related deaths following the convention in testing
multifactorial predictive algorithms [8]. Models were also adjusted
for age and sex. We also ran models examining the association
between the Framingham CVD risk score and CVD-related death to
compare the predictive utility of the score for dementia with its
original purpose.
In addition, we conducted a number of supplementary analyses:
including only individuals aged <75 years since the Framingham
CVD risk score is recommended for use in this age-group; using the
Framingham CVD risk score having substituted BMI for HDL- and
total cholesterol [3]; and dropping any dementia-related deaths
during the !rst two years of follow-up in order to assess reverse
causality. In a further sensitivity analysis, missing values for cova-
riates were imputed with PASW statistics version 18.0 using !ve
imputations. All other statistical analyses were conducted using R
version 2.15.0.
3. Results
From an initial sample of 21,945 participants, 1997 did not
consent to record linkage and 6071 had missing data. Additionally,
we excluded 1990 with evidence of CVD at baseline. These exclu-
sions resulted in an analytic sample of 11,887 (mean [SD] age 54.0
[13.2] years, range ! 35e95). Individuals with missing data
(N ! 6056) were slightly older (55.2 [SD ! 14.4] vs 54.0 [13.2],
p< 0.001) and somewhat more likely to be female (58.9% female vs
54.4%, p < 0.001), the statistically signi!cant differences arising
from a large sample size rather than any sizeable absolute
differences.
Of the 875 deaths during amean (SD) follow up of 7.1 (2.6) years,
54 were dementia-related (13 Alzheimer disease, two vascular
dementia, and 39 dementia sub-type not speci!ed). Fig. 1 shows
the relation of the Framingham CVD risk score with deaths from
dementia and CVD. Higher Framingham CVD risk score was asso-
ciated with increased risk of dementia death: each 10% increase
(disadvantage) was associated with a 4.00-fold (95% CI 2.44e6.56)
increase in the risk of dementia death (ptrend< 0.001). Adjusting for
sex increased the magnitude of the association (HR 5.08; 3.50e
7.37; ptrend < 0.001). Age is a part of the Framingham CVD risk
score algorithm, but because dementia is age-related (HR per year
increase: 1.21; 1.17e1.24) we additionally controlled for age in these
analyses whereupon the association between the Framingham CVD
risk score and dementia was eliminated (age-adjusted HR 1.04;
0.53e2.01; ptrend ! 0.91).
Using CVD-related death as the outcome of interest also
showed a substantial attenuation of the relationship after age-
adjustment although, unlike dementia, there was still evidence
of increased CVD risk. Thus, a higher Framingham CVD risk score
was associated with 3.76-fold (95% CI 2.63e5.39; ptrend < 0.001)
increased risk of CVD death per 10% increase in Framingham CVD
risk score before, and 1.34-fold (0.73e2.45; ptrend ! 0.34) risk after,
age-adjustment.
None of the supplementary analyses, mentioned above, altered
our conclusions. Restricting the models to individuals aged <75
years (N ! 10,828; 12 dementia deaths, 128 CVD deaths) gave an
unadjusted HR for dementia death of 3.96 (95% CI 0.92e16.99,
ptrend ! 0.064) and an age-adjusted HR of 0.96 (0.04e22.2,
ptrend ! 0.98). The unadjusted HR for the association between the
Framingham CVD risk score-BMI and dementia death (N ! 14,148;
53 dementia deaths) was 3.23 (95% CI 1.08e9.71; ptrend < 0.001).
Dropping any deaths during the !rst two years of follow-up (49
dementia deaths) resulted in an unadjusted HR for dementia death
of 2.34 (95% CI 0.46e11.84; ptrend ! 0.30) and an age-adjusted HR of
0.37 (0.01e9.78; ptrend ! 0.55).
Accounting for missing data by multiple imputation did not
appreciably change the results: association between the Framing-
ham CVD risk score and dementia death, unadjusted HR 3.63 (95%
CI 2.78e4.73; ptrend < 0.001), age-adjusted HR 1.13 (0.83e1.53;
ptrend ! 0.45); association between the Framingham CVD risk
score and CVD death, unadjusted HR 3.47 (2.93e4.11;
ptrend < 0.001), age-adjusted HR 1.34 (1.05e1.71; ptrend ! 0.017).
Table 1
Characteristics of the 1998 and 2003 Health Surveys for England.
1998 2003 Total
N (complete data for all variables) 6656 5321 11887
Participants with missing data (%) 2721 (29.0) 3335 (38.9) 6056 (33.8)
Age
mean [SD] 54.0 (13.4) 54.0 (12.9) 54.0 (13.2)
Range 35e95 35e94 35e95
Female (%) 53.9 55.1 54.4
Years of follow-up (mean [SD]) 9.1 (1.6) 4.5 (0.5) 7.1 (2.6)
Number of deaths 713 162 875
Dementia deaths 50 4 54
Cardiovascular disease deaths 252 49 301
Ischaemic heart disease deaths 134 27 161



























Fig. 1. Association of Framingham CVD risk score with dementia and CVD death over a
mean 7.1-year follow-up. Hazard ratios (95% con!dence intervals) are per 10% increase
(disadvantage) in the Framingham CVD risk score in men and women who were free
from dementia and CVD at baseline in the 1998 and 2003 Health Surveys for England
(N ! 11,887).








The aim of the present analyses was to examine whether the
Framingham CVD risk score was useful in predicting future risk of
dementia. In a large population sample of adults who were free
from CVD at study induction, we found an association between
elevated Framingham CVD risk score and an increased risk of de-
mentia death that was greater in magnitude than the relationship
between Framingham CVD risk score and CVD-related death.
However, the Framingham CVD risk scoreedementia relation was
lost when agewas added to themultivariablemodel. While age also
explained 88% of the ability of the Framingham CVD risk score to
predict CVD it did not completely remove the association.
As described, there is evidence of an association between the
Framingham CVD risk score and cognitive decline [4]. To our
knowledge, this is the !rst large-scale prospective population-
based study to examine the association between the Framingham
CVD risk score and dementia, and certainly the !rst to use indi-
vidual participant meta-analysis methodology.
Any mention of dementia on a death certi!cate resulted in a
death being classi!ed as dementia-related. This is appropriate as
dementia may well not be the immediate cause of death but an
important contributory factor. Classifying cause of death according
to death certi!cation is a common methodology in population-
based studies. Under-reporting of dementia on death certi!cates
seems to be improvingda recent memory clinic study found that
71.5% of 502 patients with probable Alzheimer disease had de-
mentia correctly recorded on their death certi!cates [9]. Autopsy
studies con!rm that death certi!cation of CVD is satisfactory for the
purposes of epidemiological research [10].
None of the additional analyses essentially altered the !ndings
of the study. However, dropping dementia-related deaths in the
!rst two years of follow up did reduce the magnitude of the asso-
ciation between the Framingham CVD risk score and dementia
death suggesting that part of the observed association between the
risk score and dementia may relate to participants suffering from
undiagnosed subclinical CVD at baseline. Approximately a third of
participants (33.8%) had data missing for one or more variable
necessary for calculating the Framingham CVD risk score. However,
accounting for missing data by multiple imputation had little effect
on the results and therefore the missing data are unlikely to have
resulted in bias.
While cardiovascular disease risk factors have been linked to
cognitive decline [4] and dementia risk [1], these results suggest
that, importantly, the Framingham CVD risk score was no more
strongly associated with future dementia than age. It therefore
offers no added value in predicting dementia. Therefore, though
CVD risk factors may play a role in dementia aetiology, future
research attention should also focus on non-CVD risk factors and
risk markers for dementia, including changes in Ab42 levels in
cerebrospinal "uid [11], metabolic alterations in PET scans [12], and
possibly also biomarkers related to immune function, endocytosis
and amyloid-b precursor proteins [13e15].
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Psychological Distress as a Risk Factor
for Dementia Death
C urrent estimates suggest that neuropsychiatric dis-orders account for 28% of the global burden ofdisease.1 While depression and anxiety (com-
monly referred to as psychological distress) have been
shown to be a consequence of dementia, the converse is
less clear. The possibility that psychological distress might
be a risk factor for dementia has major public health im-
plications. However longitudinal studies—which are best
placed to examine this relationship—have, with some ex-
ceptions,2,3 been small in scale (affecting study preci-
sion), excluded individuals younger than 65 years (lim-
iting insights into the pre–older age origins of dementia),
or have used clinical samples (reducing generalizability).
Accordingly, we examined the role of psychological dis-
tress as a risk factor for and dementia death by pooling 10
large community-based cohort studies.
Methods. Participants were recruited from the Health Sur-
vey for England,4 an annual general population-based
cross-sectional study (with a longitudinal component)
representative of household-dwelling individuals in En-
gland. Results from 1994 through 2004 were pooled. Par-
ticipants gave informed consent; ethical approval was ob-
tained from the London Research Ethics Council.
Psychological distress was measured during a house-
hold visit using the 12-item General Health Question-
naire (GHQ-12), a widely used measure of psychologi-
cal distress in population studies comprising items rating
anxiety, depression, social dysfunction, and loss of con-
fidence. Higher scores indicate greater distress. We used
a cut off score of 4 or greater to denote psychological dis-
tress as validated against standardized psychiatric inter-
views.5 Dementia was identified from death certifica-
tion and coded according to the International Classification
of Diseases, Ninth Revision (ICD-9) codes 290.0 through
290.4 and 294.9 and International Statistical Classifica-
tion of Diseases, 10th Revision (ICD-10) codes F01, F03,
F09, and G30. Follow-up was until date of death or Feb-
ruary 15, 2008, whichever came first.
We used Cox proportional hazards models to com-
pute hazard ratios with accompanying 95% confidence
intervals for GHQ-12 score in relation to dementia-
related deaths. Study members scoring zero (no appar-
ent distress) denoted the reference group. Models were
adjusted for age, sex, occupational social class (OSC),6
parental OSC, age at leaving full-time education, cur-
rent smoking (yes/no), alcohol consumption (units per
week), and existing cardiovascular disease (CVD) (yes/
no), and diabetes (yes/no). Statistical analyses were con-
ducted using PASW statistics, version 18.0 (SPSS, Chi-
cago, Illinois), and R for Max OS X, version R-2.13.0.
Results. The initial sample included 85 261 adults (in 1996
the GHQ-12 was not used). After removing individuals who
declined linkage to mortality records (n=9325) and those
with missing GHQ-12 data (n=2865), the analytic sample
comprised 73 071 individuals (54.8% women) with a mean
(SD) age of 55.9 (14.3) years (range, 35-102 years). Data
were missing for 1 or more variables in 21% (n=15 355)
of the sample. Individuals with missing data were more
likely to be older, be female, belong to a manual OSC, leave
school later, be a nonsmoker, drink alcohol moderately,
and have CVD and diabetes.
Of the 10 170 deaths during follow-up, 455 had demen-
tia coding. A higher GHQ-12 score was associated with in-
creased risk of dementia death in an age-adjusted model
(GHQ-12 score of 1-3: HR, 1.44 [95% CI, 1.17-1.78];
GHQ-12 score of 4-12: HR, 1.74 [95% CI, 1.36-2.22]; P
value for trend, !.001). Adding all remaining covariates
(sex, OSC, parental OSC, age at leaving full-time educa-
tion, current smoking, alcohol consumption, and existing
CVD and diabetes) led to some attenuation of effect but
statistical significance at conventional levels was retained
(GHQ-12 score of 1-3: HR, 1.27 [95% CI, 1.00-1.61];
GHQ-12 score of 4-12: HR, 1.56 [95% CI, 1.17-2.07]; P
value for trend, .005). In the Figure we relate 7 categories
of GHQ score to dementia death to provide more detailed
insight into the shape of the relationship. There was evi-
dence of a dose-response effect (P value for trend, .001).
Excluding individuals with any missing data (sample
n=57 716;361dementiadeaths)ordementiadeathswithin
5 years (sample n=72 926; 310 dementia deaths)—the lat-
ter to explore reverse causality—did not affect our results.
Comment. We found an association between elevated psy-
chological distress and an increased risk of dementia death
in a large general population sample of apparently dementia-
free adults, which remained after adjustment for age, sex,
OSC, education, alcohol use, smoking, and existing CVD
and diabetes. Cardiovascular risk factors have been linked
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with dementia,7 but the association found in our study re-
mained after controlling for them, thus implicating other
explanations for the gradient seen. One possibility is a toxic
effect of hypercortisolemia in depression on the hippo-
campus.8 Further research is required to investigate whether
appropriate treatment of depression reduces dementia risk.
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COMMENTS AND OPINIONS
More Is Less
I read with great interest the article by Sipahi et al1and the thoughtful accompanying editorial by War-ner Stevenson2 on the impact of QRS duration on
outcomes with resynchronization therapy. I wholeheart-
edly endorse Redberg’s acknowledgment of the merit of
the article.3 However, considering the data showed that
far more costly and invasive procedures were being done
than the evidence justified with far less benefit than an-
ticipated, would not the designation “More Is Less” be
more appropriate, as is true for many treatments and pro-
cedures that fall in the “Less Is More” category?
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QRS Morphology Rather Than QRS Duration
for Predicting CRT Response
S ipahi et al reported in their meta-analysis of 5 car-diac resynchronization therapy (CRT) trials thatQRS duration was an important predictor of re-
sponse to CRT.1 They concluded that patients with a QRS
of 150 milliseconds (ms) or greater had a reduction in





















P for trend, .001
Figure. Age- and sex-adjusted hazard ratios (HRs) with 95% confidence
intervals for psychological distress in relation to the risk of dementia death: the
Health Surveys for England. Reference=zero score on the 12-item General
Health Questionnaire (GHQ-12). Higher score indicates greater distress.
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To quantify the link between lower, subclinically symptomatic,
levels of psychological distress and cause-specific mortality in a large
scale, population based study.
Individual participant meta-analysis of 10 large prospective
cohort studies from the Health Survey for England. Baseline
psychological distress measured by the 12 item General Health
Questionnaire score, and mortality from death certification.
68 222 people from general population samples of adults
aged 35 years and over, free of cardiovascular disease and cancer, and
living in private households in England at study baseline.
Death from all causes (n=8365),
cardiovascular disease including cerebrovascular disease (n=3382), all
cancers (n=2552), and deaths from external causes (n=386). Mean
follow-up was 8.2 years (standard deviation 3.5).
We found a dose-response association between psychological
distress across the full range of severity and an increased risk of mortality
(age and sex adjusted hazard ratio for General Health Questionnaire
scores of 1-3 score 0: 1.20, 95% confidence interval 1.13 to 1.27;
scores 4-6: 1.43, 1.31 to 1.56; and scores 7-12: 1.94, 1.66 to 2.26;
P<0.001 for trend). This association remained after adjustment for
somatic comorbidity plus behavioural and socioeconomic factors. A
similar association was found for cardiovascular disease deaths and
deaths from external causes. Cancer death was only associated with
psychological distress at higher levels.
Psychological distress is associated with increased risk
of mortality from several major causes in a dose-response pattern. Risk
of mortality was raised even at lower levels of distress.
A series of studies have shown an association between
symptoms of depression and anxiety (commonly referred to as
psychological distress) and an elevated risk of premature
mortality,1 2 cardiovascular disease,3-6 and potentially all cancers,7
although these are not universal observations.8 9 Prospective
studies investigating these associations have generally been
small in scale, with only two studies reporting more than 1000
disease events.10 11 Smaller studies lead to unreliable estimates
of risk, do not permit detailed investigation of the effect of
reverse causality, and hamper insights into the association across
the full range of psychological distress severity. Investigation
of the role of reverse causality̶the possibility that the early
stages of disease (for example, chest pain) might cause
psychological distress̶requires large numbers of participants
and events to have a sufficiently large sample after individuals
with existing illness or deaths in the early phases of follow-up
are excluded.
Furthermore, extant studies have been unable to adequately
examine whether a dose-response association exists between
distress and mortality. The increased mortality associated with
mental illness that is sufficiently severe to need admission to a
psychiatric hospital is well described.12 However, if the influence
of psychological distress on mortality is occurring at levels
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lower that hitherto suggested̶in people who would not come
to the attention of mental health practitioners̶this may have
potentially important implications for treatment.
In view of these limitations of existing studies, we undertook
an individual participant meta-analysis of 10 large, community
based cohort studies of the role of psychological distress as a
risk factor for death from all causes, cardiovascular disease,
cancer, and external causes. In contrast to a literature based
meta-analysis, which may have to exclude studies not reporting
their results in an appropriate manner, the possibility of
publication bias is minimised in an individual participant
meta-analysis through close collaboration with data providers.
Furthermore, a literature based meta-analysis cannot provide
precise estimates of associations between risk markers and
disease, reliable information on the shape of a specific risk
factor-disease relation (for example, dose-response threshold),
or a consistent approach to statistical control for plausible
covariates and subgroup analyses.While this approach has been
taken for physiological risk factors for mortality previously,13 14
the present study is the first such meta-analysis of psychological
distress.
Participants were taken from the Health Survey for England,15 16
a representative health examination study sampling people from
the general population living in private households in that
country. From 1994 to 2004, 11 independent, cross sectional
studies with identical methodologies took place on an annual
basis. Consenting studymembers (75 936 (89.1%)) were linked
to National Health Service mortality data up to February 2008.
For this analysis, we used raw data from people aged 35 years
and over from all these study years, with the exception of 1996
when psychological distress was not measured. Ethical approval
was obtained from the London Research Ethics Council.
During a household visit, interviewers collected information
using computer-assisted personal interviewing modules. We
measured psychological distress using the 12 item version of
the General Health Questionnaire (GHQ-12), a widely used
measure of distress in population studies.17 18 The GHQ-12 is
generally considered to be a unidimensional scale of
psychological distress,19 consisting of items capturing symptoms
of anxiety, depression, social dysfunction, and loss of
confidence. Study members respond to whether a symptom is
present by using a four point Likert scale (“not at all”=0, “same
as usual”=0, “more than usual”=1, “muchmore than usual”=1).
A total GHQ-12 score of four or greater leads to people being
defined as psychological distress “cases” and scores 0-3 as
“non-cases”; this definition has been validated against
standardised psychiatric interviews and has been strongly
associated with various psychological disorders such as
depression and anxiety.20 21 Most previous studies used such a
dichotomy and few have examined associations across the full
range of psychological distress. No standard cut-off values exist
for dividing up “cases” identified by a GHQ-12 score threshold.
We therefore chose to divide people into four groups based on
their GHQ-12 score: asymptomatic (score 0), subclinically
symptomatic (score 1-3), symptomatic (score 4-6), and highly
symptomatic (score 7-12).
Causes of death recorded on death certificates were coded using
the international classification of diseases, 9th and 10th revisions
(ICD-9 and ICD-10, respectively).We identified cardiovascular
disease deaths (including ischaemic heart disease,
cerebrovascular disease, peripheral vascular disease and heart
failure) using codes 410-414, 430-438, 440, 443-5, and 428
(ICD-9); and I20-I25, I50, I60-70, I73 and I74 (ICD-10). Cancer
deaths were identified using codes 140-239 (ICD-9) and
C00-D48 (ICD-10). We identified deaths from external causes
using codes 800-999 and E800-E999 (ICD-9) and S00-Y98
(ICD-10). For the main analyses, any mention of a condition
on the death certificate was counted but a subgroup analysis
restricted cases to those where the condition was the underlying
cause of death.
We ascertained that the proportional hazards assumption had
not been violated by inspecting the log(－log(survival)) plot.
We then used Cox proportional hazards models22 to compute
study-specific hazard ratios with accompanying 95% confidence
intervals for the association of GHQ-12 score with mortality
outcomes. Heterogeneity in the effect estimates between studies
was examined using the I2 statistic, which indicates the
proportion of the total variation in the estimates due to
between-studies variation. The I2 varied between 0% and 81.1%,
depending on the mortality outcome and psychological distress
variable used in the analysis. Owing to this heterogeneity, we
pooled the study-specific effect estimates and their standard
errors in random effects meta-analyses. Study members scoring
0 on the GHQ-12 were regarded as being free of psychological
distress and used as the reference group. We compared this
group with the three GHQ-12 score groups (scores 1-3, 4-6, and
7-12), and also reported the hazard ratio per one standard
deviation increment in GHQ-12 score (calculated with sex
specific standard deviations: men 2.41, women 2.75).
Days were the time scale and, for participants with no record
of an event, the data were censored at 15 February 2008.Models
were adjusted for age (years), sex, current occupational social
class (professional, managerial or technical, skilled non-manual,
skilled manual, partly skilled, and unskilled), body mass index,
systolic blood pressure (mm Hg), physical activity (any
moderate to vigorous physical activity in a week), smoking
status (not a current smoker; or <5, 5-10, 10-15, 15-20, and >20
cigarettes per day), alcohol consumption (units per week), and
diabetes at baseline (yes or no). Details on the measurement
protocols and data handling of these covariates can be found
elsewhere.16 23 We calculated the population proportional
attributable risk for each mortality outcome and the four
categories of GHQ-12 score using a standard equation.24
To further examine the association between crude GHQ-12
score and mortality (all cause, cardiovascular disease, cancer,
and external causes), we meta-analysed study specific Cox
proportional hazard models to calculate age and sex adjusted
hazard ratios and 95% confidence intervals for each GHQ-12
score, with score 0 as the reference. In addition, we did a
subgroup analysis to investigate potential reverse causality;
analyses were repeated dropping deaths within the first five
years of follow-up. This analysis did not include deaths from
external causes.
We compared people with data missing for one or more variable
with those with complete data. Covariates were compared with
Student’s test for continuous variables and χ2 tests for
categorical variables. In the sensitivity analysis, we imputed
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missing values for covariates with Predictive Analytics Software
version 18.0,25 using five imputations. All other analyses were
conducted using R version 2.15.026 and the survival andmetafor27
packages. Figures were constructed using the Rmeta28 and gplots
packages. The reporting of this study conforms to the STROBE
statement.29
The initial pooled sample included 85 261 adults. Table 1
shows details of individual studies. We excluded participants
who declined linkage to mortality records (n=9325; web table
1 compares those who consented to record linkage with those
who did not); with missing GHQ-12 data (n=2532); with
baseline cardiovascular disease (n=3492), cancer (n=1511), or
both (n=159); and with no cause of death recorded or for whom
no survival time could be calculated (n=20). The final analytic
sample comprised 68 222 people (37 649 (55.2%) women) with
a mean age of 55.1 years (standard deviation 14.1, range
35-102). The composition of the sample is shown in figure 1 .
Table 2 shows details of the study members’ baseline
characteristics. People with higher GHQ-12 scores generally
had unfavourable levels of covariates and mortality risk, apart
from being slightly younger and having a lower systolic blood
pressure than those with lower GHQ-12 scores. Participants
with the highest GHQ-12 scores were slightly less likely to
drink heavily than those with lower scores.
Of 8365 deaths during a mean follow-up of 8.2 years (standard
deviation 3.5), 3382 death certificates mentioned cardiovascular
disease, 2552 mentioned cancer, and 386 mentioned an external
cause of death. Figure 2 shows the numbers of participants,
total deaths, and the number related to major causes of death.
It also provides the age and sex adjusted hazard ratio for the
relation of increased psychological distress (one standard
deviation increase in GHQ-12 score) with overall mortality,
cardiovascular disease death, cancer death, and death from
external causes for each annual cohort in addition to the totals
and overall effect frommeta-analysis. Overall, we saw increases
of 21% in age and sex adjusted risk of all cause mortality, 22%
in risk of cardiovascular disease death, 9% in risk of cancer
death, and 26% in risk of death from external causes per standard
deviation increase in GHQ-12 score. Individually, all cohorts
showed a similar effect, although the strength of the association
between GHQ-12 score and mortality was somewhat weaker
for 1997 and 2002̶the reason for this is unclear. However,
when we conducted sensitivity analyses by excluding the 1997
and 2002 cohorts from pooled analyses, the hazard ratio was
unchanged. Therefore, we included participants from these
surveys in the main analyses.
We saw a significant association, across the full range of
severity, between psychological distress and all cause mortality.
Table 3 shows the results for the four categories of GHQ-12
score; even the subclinically symptomatic group (score 1-3) had
a 20% increased risk of mortality after adjusting for age and
sex. This association was essentially unchanged after adjusting
for a range of covariates that included occupational social class,
alcohol intake, and smoking. We saw strong evidence of a
dose-response effect (age and sex adjusted hazard ratio per
standard deviation disadvantage in GHQ-12 score 1.21, 95%
confidence interval 1.15 to 1.27; P<0.001 for trend). Figure 3
shows the association between risk of death from all causes and
the full range of psychological distress.
Focusing on cardiovascular disease death in particular showed
a similarly increased risk in association with psychological
distress, again across the full range of severity; subclinically
symptomatic patients were at a 29% increased risk of
cardiovascular disease death (table 3). This association remained
after adjustment for each covariate individually and in a model
incorporating all covariates. The magnitude of the increase in
risk in the fully adjusted model was little attenuated. Again,
there was strong evidence of a dose-response effect (age and
sex adjusted hazard ratio per standard deviation disadvantage
in GHQ-12 score 1.22, 95% confidence interval 1.14 to 1.31;
P<0.001 for trend) across the full range of GHQ-12 scores (fig
3).
Cancer death was not associated with low levels of
psychological distress in the sameway as cardiovascular disease
death (table 3). However, psychological distress in highly
symptomatic patients (GHQ-12 scores 6-12) was associated
with a 41% increased risk of cancer death. Figure 3 confirms
that this association was only present in GHQ-12 scores greater
than six. Nevertheless, we saw a significant dose-response effect
(age and sex adjusted hazard ratio per standard deviation
disadvantage in GHQ-12 score 1.09, 95% confidence interval
1.04 to 1.13; P<0.001 for trend). This association remained after
adjustment for all covariates individually and in the fully
adjustedmodel (hazard ratio per standard deviation disadvantage
in GHQ-12 score 1.05, 0.99 to 1.11, P=0.141).
Death from external causes was also associated with
psychological distress across the full range of scores;
subclinically symptomatic patients were at a 29% increased risk
of death from external causes (table 3). This association
remained on adjustment for covariates individually and remained
unchanged in the fully adjusted model. Once again, we saw
strong evidence of a dose-response effect (age and sex adjusted
hazard ratio per standard deviation disadvantage in GHQ-12
score 1.26, 95% confidence interval 1.14 to 1.40; P<0.001 for
trend) across the full range of GHQ-12 scores (fig 3).
The population proportional attributable risk summarises the
population effect of an exposure taking into account its
prevalence. For the subclinically symptomatic category of
psychological distress, the proportional attributable risk was
3.8% for overall mortality (fully adjusted hazard ratio 1.16),
5.8% for cardiovascular disease mortality (1.25), －1.2% for
cancer mortality (0.95), and 5.4% for deaths from external
causes (1.23).
Data were missing for one or more variables in 39.4% (n=26
860) of the sample. People with missing data were older and
were more likely to be female, be overweight, have lower blood
pressure, be less active, not smoke, drink alcohol within
recommended limits, and have diabetes at baseline. However,
they were nomore likely to belong to a non-manual occupational
social class (web table 2). Therefore, participants with missing
data did not always have unfavourable levels of risk factors.
Accounting for missing data by multiple imputation did not
alter the effect sizes found (table 4 ).
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We excluded deaths occurring within the first five years of
follow-up to examine reverse causality. This subgroup analysis
slightly attenuated the effect size for the association between
psychological distress and all cause mortality (age and sex
adjusted hazard ratio per standard deviation disadvantage in
GHQ-12 score [all data] 1.21, 95% confidence interval 1.15 to
1.27, P<0.001 1.13, 1.10 to 1.17, P<0.001) and cardiovascular
disease death (web table 3). The association with cancer deaths
was further attenuated towards the null by excluding deaths
within the first five years of follow-up (web table 3). Comparing
a narrow case definition (that the condition was the underlying
cause of death) and a broad case definition (that any mention
of the condition on the death certificate was sufficient) had
essentially no effect on the results (web table 4).
The main finding of this study was a dose-response association
between psychological distress and mortality from all causes,
cardiovascular disease, and external causes across the full range
of distress, even in people who would not usually come to the
attention of mental health services. A similar association with
cancer was only seen at higher levels of psychological distress.
These associations remained after adjustment for age, sex,
current occupational social class, body mass index, systolic
blood pressure, physical activity, smoking, alcohol consumption,
and diabetes. The associations with deaths from all causes,
cardiovascular disease, and cancer remained after deaths in the
first five years of follow-up were excluded.
This study is the first to use an individual participant
meta-analysis methodology to examine the association between
a psychological variable and mortality. It used a very large
sample of the general population, and over 8000 participants
died during follow-up. This large sample size provides sufficient
power to allow detailed analyses to be conducted and reverse
causality to be investigated. The cohort participants were well
characterised, allowing relevant contextual variables to be
incorporated into the statistical models, although the possibility
of residual confounding remains.
UsingGHQ-12 score to estimate psychological distress, although
widely used in population based studies,18 is not without
limitations. The scale itself, with non-specific questions about
feelings of unhappiness and confidence, worry, and feelings of
worthlessness, does not provide a clinical diagnosis of anxiety
or depression, even though the 12 items do capture several
diagnostic criteria in ICD-10 or the Diagnostic and Statistical
Manual of Mental Disorders, fourth edition. However, there is
evidence that screening positive on the GHQ-12, defined here
as scores of 4 or more, is associated with anxiety and
depression.20 21 GHQ-12 has been shown to be a valid screening
tool for anxiety and depression diagnosed according to the
Diagnostic and Statistical Manual of Mental Disorders, third
edition (revised).30
Classifying cause of death according to death certification is a
commonmethodology in epidemiological studies. Since causes
of death are based on the certifying doctor’s clinical assessment
and knowledge of the deceased person, they may not always be
perfectly accurate, but it is likely that the broad causes of death
(for example, cardiovascular disease and cancer) used in the
present study were sufficiently valid. The only study in the
United Kingdom comparing death certification, with about 60
autopsy findings,31 found that cardiac disease was correctly
recorded on death certificates in all 21 cases and neoplastic
disease was correctly recorded in 14 of 18 cases. Elsewhere, in
Norway, analyses of 1140 autopsies showed that death
certification of stroke and ischaemic heart disease was
satisfactory for the purposes of epidemiological research.32
Another limitation in the current study was the relatively large
number of participants with data missing for one or more
variables. The differences between those with and without
missing data, detailed above, were all highly significant, apart
from current occupational social class. However, statistical
significance was partly achieved as a result of the large sample
size and the absolute differences are small and unlikely to be
clinically significant. People with missing data were not always
at an increased risk of mortality. Indeed, the sensitivity analysis
using multiple multivariate imputation techniques did not alter
the effect sizes reported; thus, bias resulting from the missing
data was unlikely.
The diminishing magnitude of association between
psychological distress and mortality with increasing duration
of follow-up shown in figure 2 may reflect reverse causality.
That is, undiagnosed somatic illness will be associated with
both an increased prevalence of psychological distress and an
increased risk of mortality. The effect of hidden somatic illness
will diminish with increasing duration of follow-up as people
with such conditions die, potentially resulting in the trend seen
in figure 2. One specific criticism of many prospective studies
considering depression as a causal factor in cardiovascular
disease is that subclinical atherosclerosis is not controlled for,33
and persistent depressive symptoms have been shown to be
associated with coronary atherosclerosis.34 While the current
study did not have any direct measures of atherosclerosis, we
excluded patients with overt cardiovascular disease at baseline
and further exclusion of deaths within five years of follow-up
reduced the possibility that our findings were driven by
subclinical disease.
One study of 4501 adults in primary care reported a
dose-response association between psychological distress
(measured by the GHQ-12) and overall mortality (366 deaths;
GHQ-12 score 1-3: hazard ratio 1.38, 95% confidence interval
1.06 to 1.79; score 4-12: 1.71, 1.32 to 2.23), mainly due to
ischaemic heart disease and respiratory diseases.2 A smaller
study (n=923) found a 16% increase in mortality per point
increase in GHQ-12 score, mainly in men (hazard ratio 1.16,
1.07 to 1.25, P<0.001).35 The Framingham Heart Study found
a direct association between depressive symptoms and all cause
mortality in 3634 people (hazard ratio per tertile increment on
the Center for Epidemiologic Studies depression scale 1.37,
95% confidence interval 1.10 to 1.71; P=0.005 for trend).36 In
the Whitehall II study of 10 000 British civil servants,
psychological distress, measured by a 30 item GHQ scale, was
not associated with death from all cause mortality (355 deaths).37
Therefore, the present study is the largest so far to show a
dose-response relation between psychological distress and
mortality.
The association between depression and mortality is less clear
in later life, but the association remains even with adjustment
for cognitive and functional impairment and social support.
However, the association seems to disappear when people are
followed up over long periods.37-39 This finding is consistent
with our data because the effect estimates were smallest in
participants with the longest follow-up period (the earliest
surveys) compared with those with shorter follow-up (more
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recent surveys; fig 2). Asmentioned above, this differencemight
relate to dilution of the effect of undiagnosed somatic illness at
baseline. Changes in psychological distress during the follow-up
could have attenuated associations with mortality.
As described, prospective studies investigating the association
between psychological distress and cardiovascular disease have
also generally been small and therefore underpowered, none
reporting more than several hundred cardiovascular
events.2 4 9 40-42 However, they all found an increased risk of
cardiovascular disease, one reporting a dose-response association
(137 deaths from all circulatory disease; hazard ratios 1.42 and
1.66 for GHQ-12 scores 1-3 and 4-12, respectively).2 A study
looking at phobic anxiety found an age adjusted relative risk of
fatal coronary heart disease of 3.01 (n=40).34 A meta-analysis
of 21 studies investigating the association between depressive
symptoms and coronary heart disease incidence found a pooled
relative risk of 1.81, similar for fatal and non-fatal outcomes
but greater for clinically diagnosed depression than depressive
symptoms.6 A recent meta-analysis showed a pooled adjusted
hazard ratio of 1.45 (95% confidence interval 1.29 to 1.63) for
depression and stroke.43 These effect estimates are similar to
most published studies investigating depression or depressive
symptoms as aetiological risk factors for cardiovascular disease,
which generally report a relative risk of 1.5 to 2, though the
Whitehall II study only identified an association in men.42 The
results of the current study, using cardiovascular disease death
as the outcome of interest, are comparable to the results of this
recent meta-analysis.43
One large retrospective study found a risk ratio of 1.39 for
myocardial infarction in 12 304 participants with depression.44
However, the absence of data for the presence of prevalent
cardiovascular disease at baseline is an important limitation,
particularly by comparison with the extensive baseline
assessment in the Health Survey for England.
Distress in general is sometimes dismissed as a reaction to the
diagnosis of a serious physical illness. In the present study,
excluding deaths in the first five years of follow-up attenuated
the association between psychological distress and cancer
mortality, suggesting that this might partly explain the
association. However, a meta-analysis of 165 studies found an
association between stress related psychological factors and
cancer incidence in healthy people (P=0.005).7 In addition,
chronic and severe depression is possibly associated with cancer
incidence ,with a stronger association generally found with
disease progression.33
The mechanism of the association between psychological
distress and mortality might be direct or indirect. A direct effect
could be a physiological change associated with an increased
risk of death. For example, acute psychological stress does alter
cardiovascular physiology and is associated with transient
myocardial ischaemia even in the absence of disease.3
Furthermore, both psychological stress and depression could
lead to dysregulation of the hypothalamic-pituitary-adrenal axis,
resulting in a modest increase in inflammatory markers and
cortisol release.45 Depressive symptoms are associated with
altered autonomic functioning, such as 3-methoxy-phenylglycol
(a major metabolite of noradrenaline) response to stressors.41
Depressive symptoms are also associated with increased levels
of inflammatory markers, including C reactive protein,9
interleukin 6, and tumour necrosis factor α.45 Antidepressant
drugs have been shown to suppress the inflammatory response,45
but use of these substances has been associated with increased
systemic inflammation independent of comorbidity46 and
increased cardiovascular disease.47 General population surveys
show that about 3.7% of patients will have taken an
antidepressant during the past year.48 Therefore, it is unlikely
that antidepressant use alone can explain the increased risk of
mortality found with psychological distress.
Psychiatric illness is associated with increased mortality,49 and
part of this association could be mediated by behavioural and
lifestyle factors,50 including physical inactivity and smoking.
However, we were able to incorporate many of the important
behavioural and lifestyle factors into the models in the current
study, and the association between psychological distress and
mortality remained highly significant, suggesting that indirect
mechanisms are unlikely to completely explain this association.
Depression is a serious and debilitating disorder requiring
treatment in its own right, but the finding that any level of
psychological distress is associated with increased mortality
and an increased risk of death from cardiovascular disease,
external causes, and cancer (albeit only at higher levels of
distress) is highly important. Furthermore, only two studies,
much smaller than the present study, have previously
demonstrated a dose-response relation between psychological
distress and all cause35 or cardiovascular disease mortality,2 with
other studies having compared presence and absence of
psychological distress.4 9 40-42 46 However, due to its large sample
size, the present study was able to offer detailed insight into
this dose-response relation. All participants with any
psychological distress, even those with low GHQ-12 scores
(and therefore considered subclinically symptomatic), were at
an increased risk of mortality from all causes, cardiovascular
disease, and external causes. The association between
psychological distress and cancer was not present in
subclinically symptomatic patients. One study has identified
that different aspects of distress (depression, apathy or anergia,
and anxiety measured by the 30 item GHQ) have differential
effects on causes of death.46
While the association between psychological distress and
mortality has attracted a great deal of attention, little evidence
indicates favourable effects, in terms of mortality, with
treatment. Trial evidence has not suggested that treating
depression decreases mortality in patients with existing
cardiovascular disease,51-53 but evidence from the current study
of the increased risk associated with even low levels of
psychological distress in the general population suggests that
the overall picture may be more complex. Further research is
required to investigate whether treating psychological distress,
including overt depression or different aspects of distress, could
have an ameliorating effect on the increased mortality
demonstrated here.
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Evidence indicates an association between symptoms of depression and anxiety (commonly referred to as psychological distress) and
mortality from various major causes
However, previous studies have been underpowered and unable to reliably ascertain thresholds of risk
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That a considerably raised risk of mortality was evident, even at low levels of psychological distress, should prompt research into whether
treatment can modify this increased risk
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85 261504910 887539911 2838684552211 058587510 90510 599No of participants
Age (years)




2910 (57.6)6056 (55.6)3041 (56.3)6267 (55.5)5389 (62.1)2998 (54.3)6079 (55.0)3208 (54.6)5897 (54.1)5824 (54.9)Female
45 243
(55.8)





971 (19.3)2305 (21.2)1215 (22.5)2431 (21.6)1428 (17.7)1245 (22.6)2564 (23.2)1369 (23.3)2528 (23.2)2494 (23.5)Current smoker
13 340
(19.8)
̶§̶§1109 (20.6)2391 (21.2)1134 (16.5)1053 (19.2)2354 (21.3)1175 (20.1)2132 (19.6)1992 (18.8)Drinks more than
recommended
alcohol limit‡
4249 (5.0)226 (4.5)482 (4.4)225 (4.2)566 (5.0)661 (7.6)271 (4.9)500 (4.5)265 (4.5)547 (5.0)506 (4.8)Cardiovascular
disease¶ at
baseline
3248 (3.8)277 (5.5)517 (4.7)221 (4.1)483 (4.3)405 (4.7)206 (3.7)335 (3.0)203 (3.5)324 (3.0)277 (2.6)Diabetes, including
hyperglycaemia, at
baseline
























Data are no (%) of participants unless stated otherwise. Any discrepancies in percentages are due to missing data. SD=standard deviation.
*Table represents all participants in the surveys, irrespective of consent to mortality linkage. All subsequent tables and figures represent only participants who
consented to linkage and were therefore included in the present study.
†Non-manual occupational social class comprises professional, managerial or technical, and skilled non-manual classes (I-IIINM) according to the Registrar
General classification.
‡Calculated using sex specific safe limits: 14 units per week for women and 21 units per week for men.
§In 2003 and 2004, alcohol intake was recorded in a different format to other years in the Health Surveys for England.
¶Including angina, myocardial infarction, and haemorrhagic or thrombotic stroke.
**Total deaths caused by cardiovascular disease, comprising ischaemic heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe





68 2224733520116 76041 528No of participants
68 2223024 (63.9)3209 (61.7)9680 (57.8)21 736 (52.3)Female
68 22253.3 (14.1)54.6 (14.9)55.3 (14.7)55.2 (13.7)Age (mean (SD))
66 8342476 (53.7)2806 (55.7)9436 (57.6)23 595 (57.8)Non-manual occupational social
class*
62 64027.1 (5.4)27.2 (5.0)27.1 (4.8)27.1 (4.5)Body mass index (mean (SD))
52 224134.2 (19.7)135.3 (20.7)136.9 (20.6)137.8 (20.4)Systolic blood pressure† (mm
Hg, mean (SD))
68 2222868 (60.6)3344 (64.3)10 957 (65.4)28 215 (67.9)Physical activity‡
68 1911489 (31.5)1350 (26.0)3890 (23.2)8657 (20.9)Current smoker
55 796759 (19.1)847 (19.3)2883 (20.5)7172 (21.5)Drinks more than
recommended alcohol limit§
68 222185 (3.9)203 (3.9)574 (3.4)1172 (2.8)Diabetes (including
hyperglycaemia)
Data are no (%) of participants unless stated otherwise. Any discrepancies in percentages are due to missing data. SD=standard deviation.
*Non-manual occupational social class comprises professional, managerial or technical, and skilled non-manual classes (I-IIINM) according to the Registrar General
classification.
†Mean of second and third readings.
‡Binary variable: any weekly moderate to vigorous physical activity.
§Calculated using sex specific safe limits: 14 units per week for women and 21 units per week for men.
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<0.0011.21 (1.15 to 1.27)1.94 (1.66 to 2.26)1.43 (1.31 to 1.56)1.20 (1.13 to 1.27)1 (reference)68 2228365Age and sex
adjusted
<0.0011.16 (1.12 to 1.20)1.67 (1.41 to 2.00)1.37 (1.23 to 1.51)1.16 (1.08 to 1.24)141 3624963Fully adjusted†
<0.0011.22 (1.14 to 1.31)2.05 (1.57 to 2.70)1.44 (1.27 to 1.62)1.29 (1.17 to 1.43)1 (reference)68 2223382Age and sex
adjusted
<0.0011.17 (1.12 to 1.22)1.72 (1.44 to 2.06)1.45 (1.23 to 1.71)1.25 (1.08 to 1.44)141 3621956Fully adjusted†
<0.0011.09 (1.04 to 1.13)1.41 (1.22 to 1.64)1.07 (0.89 to 1.29)0.92 (0.84 to 1.01)1 (reference)68 2222552Age and sex
adjusted
0.1411.05 (0.99 to 1.11)1.29 (1.04 to 1.61)1.05 (0.85 to 1.30)0.95 (0.85 to 1.07)141 3621698Fully adjusted†
<0.0011.26 (1.14 to 1.40)2.34 (1.52 to 3.60)1.93 (1.31 to 2.83)1.29 (1.01 to 1.65)1 (reference)68 222386Age and sex
adjusted
0.0011.32 (1.13 to 1.55)3.19 (1.78 to 5.70)2.07 (1.33 to 3.21)1.23 (0.90 to 1.70)141 362241Fully adjusted†
Data are hazard ratio (95% confidence interval) unless indicated otherwise.
*GHQ-12 score standardised with sex specific standard deviations.
†Model adjusted for age, sex, occupational social class, diabetes, body mass index, systolic blood pressure, physical activity, smoking, and alcohol consumption.
‡Cardiovascular disease comprises ischaemic heart disease, stroke, peripheral vascular disease, and heart failure.
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1.15 (1.13 to 1.18)57 86184921.16 (1.12 to 1.20)41 3624963Total
1.14 (1.10 to 1.19)57 86134401.17 (1.12 to 1.22)41 3621956Cardiovascular
disease§
1.05 (1.01 to 1.09)57 86125300.95 (0.85 to 1.07)41 3621698Cancer
1.23 (1.11 to 1.36)57 8613811.32 (1.13 to 1.55)41 362241External cause
Data are hazard ratio (95% confidence interval) unless indicated otherwise.
*Model adjusted for age, sex, occupational social class, diabetes, body mass index, systolic blood pressure, physical activity, smoking, and alcohol consumption.
†GHQ-12 score standardised with sex specific standard deviations.
‡Total no of participants in multiple imputation models excludes the 2003 and 2004 cohort studies since they were excluded from all fully adjusted models owing
to their recording of alcohol consumption in a different format to other years.
§Cardiovascular disease comprises ischaemic heart disease, stroke, peripheral vascular disease, and heart failure.
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Flow chart of participants from initial pooled sample to analytic sample showing subsequent mortality
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Number of participants, total mortality, and deaths plus age and sex adjusted hazard ratios (95% confidence intervals)
per standard deviation disadvantage in GHQ-12 score, by survey year and cause of death
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Association between psychological distress (GHQ-12 score) and risk of cause specific death (age and sex adjusted
hazard ratio (95% confidence interval)). Reference=GHQ-12 score 0; higher GHQ-12 score indicates greater distress
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Appendix Table 1. Survey participants who consented and did not consent to record 
linkage: follow-up of ten cohort studies from the Health Survey for England (N = 
68,222) 
 
Covariate Consented Did not consent p 
N 75936 9325  
Age (mean, SD) 56.1 (14.4) 64.7 (17.7) <0.001 
Female (%) 54.9 64.2 <0.001 
Individual occupational social class (% I-IIINM) 56.4 52.2 <0.001 
Body mass index (kg/m2; mean, SD) 27.2 (4.7) 27.0 (4.8) 0.001 
Systolic blood pressure1 (mmHg, mean, SD) 137.6 (20.6) 136.9 (21.3) 0.096 
Physical activity2 (%) 65.3 71.4 <0.001 
Current smoker (%) 22.3 18.9 <0.001 
Drinks more than recommended alcohol limit3 (%) 16.6 8.2 <0.001 
Cardiovascular disease4 (%) 4.8 6.4 <0.001 
Cancer (%) 2.2 2.6 0.008 
Diabetes (%) 3.7 4.8 <0.001 
    
 
1 Mean of 2nd and 3rd readings 
2 Binary variable: any weekly moderate to vigorous physical activity 
3 Calculated using sex-specific safe limits: ≤14 units per week for women and ≤21 units 
for men 






Appendix Table 2. Survey participants included and excluded from fully-adjusted 
model: follow-up of ten cohort studies from the Health Survey for England (N = 
68,222) 
 
Covariate Complete data  
for all variables 
Missing data in 
≥1 variable 
p 
N 41362 26860  
Age (mean, SD) 54.1 (13.4) 56.5 (15.0) <0.001 
Female (%) 53.3 58.1 <0.001 
Individual occupational social class (% I-IIINM) 57.3 58.0 0.355 
Body mass index (kg/m2; mean, SD) 27.0 (4.6) 27.4 (4.9) <0.001 
Systolic blood pressure1 (mmHg, mean, SD) 137.7 (20.2) 135.1 (21.1) <0.001 
Physical activity2 (%) 72.3 57.6 <0.001 
Current smoker (%) 23.0 22.0 0.001 
Drinks more than recommended alcohol limit3 (%) 21.8 9.9 <0.001 
Diabetes (%) 2.7 3.9 <0.001 
    
 
1 Mean of 2nd and 3rd readings 
2 Binary variable: any weekly moderate to vigorous physical activity 






Appendix Table 3. Sub-group analysis—excluding deaths within five years of follow-
up: follow-up of ten cohort studies from the Health Survey for England (N = 68,222) 
 





GHQ-12 score1 p (trend) 
HR 
Total mortality     
All deaths 8365 68222 1.21 (1.15, 1.27) 
<0.001 
Deaths of individuals who survived >5 years 
 
4011 55845 1.13 (1.10, 1.17) <0.001 
Cardiovascular disease mortality     
All deaths 3382 68222 1.22 (1.14, 1.31) 
<0.001 
Deaths of individuals who survived >5 years 
 
1574 55845 1.17 (1.10, 1.24) <0.001 
Cancer mortality     
All deaths 2552 68222 1.09 (1.04, 1.13) 
<0.001 
Deaths of individuals who survived >5 years 
 
1253 55845 1.03 (0.97, 1.09) 0.359 
      
 
 
1 GHQ-12 score standardised with sex-specific standard deviations 
2 Cardiovascular disease comprises ischaemic heart disease, stroke, peripheral vascular 





Appendix Table 4. Sub-group analysis—Hazard ratios (95% confidence interval) for 
the association of psychological distress with cause-specific mortality with broad and 
narrow definitions1 of disease: follow-up of ten cohort studies from the Health Survey 
for England (N = 68,222) 
 
 Broad case definition1 Narrow case definition1 
 Deaths 
1 SD disadvantage in GHQ-12 
score2 Deaths 
1 SD disadvantage in GHQ-12 
score2 
HR HR 




(1.14, 1.33) 2585 
1.21 
(1.12, 1.30) 




(1.05, 1.14) 2329 
1.07 
(1.03, 1.12) 




(1.14, 1.40) 201 
1.28 
(1.13, 1.44) 
       
 
1 Broad definition indicates any mention of the condition on the death certificate; 
narrow definition indicates that the condition was the underlying cause of death 
2 GHQ-12 score standardised with sex-specific standard deviations 
3 Cardiovascular disease comprises ischaemic heart disease, stroke, peripheral vascular 





Socioeconomic inequalities in cardiovascular disease1 and selected
cancers2 are well recognised. More recently, research attention has
focused on such differentials in mental health, including
depression3 and other common mental disorders such as
dementia.4–6 There is a suggestion that socioeconomic factors
may have a role in the aetiology of dementia including lifetime
manual occupation7 as well as various indicators of socio-
economic status in early life8 and lower educational attainment.8,9
However, because of the paucity of large-scale, well-characterised
studies, the extant evidence is discordant and there has been
inconsistent control for confounding variables. Thus, the precise
nature of the socioeconomic status–dementia relationship remains
unclear. Although individual studies undoubtedly have value in
improving this evidence base, the pooling of raw data from
multiple studies, which would also represent an important
technical advance in this context, has yet to be utilised. We
therefore undertook the first individual participant meta-analysis
using data from 11 large, community-based cohort studies that
held data on socioeconomic status, covariates and dementia death.
The purpose of this paper is twofold: first, as a proof of principle
that this methodology can be applied to the study of the role of
socioeconomic position in the risk of dementia; and second, to
add to the evidence base by further investigating the association
between socioeconomic factors and dementia-related death.
Method
Study samples
Participants were taken from the Health Survey for England,10 a
representative general population-based health examination study
sampling individuals living in households in England. From 1994
to 2004, 11 independent, cross-sectional studies with identical
methodologies were conducted on an annual basis. Consenting
study members (89.6%) were followed up by linkage to the UK
National Health Service mortality registry. Study participants gave
full informed consent and ethical approval was obtained from the
London Research Ethics Council.
Assessment of socioeconomic status
During a household visit, interviewers collected information using
computer-assisted personal interviewing modules. Information
on occupational social class was collected during the interview
and coded according to the Registrar General classification
(professional (I), intermediate (II), skilled non-manual (IIINM),
skilled manual (IIIM), part-skilled (IV) and unskilled (V)), a
standard approach in the UK.11 Age on leaving full-time
education was recorded as 515, 15, 16, 17, 18, 418, never
went to school and still in full-time education. For this study
occupational social class was coded into four groups:
professional/intermediate (the referent), skilled non-manual,
skilled manual and part-skilled/unskilled. Educational attainment
was coded into three groups: 14 years or younger, 15 years old and
16 years or older (the referent).
Assessment of other risk factors and comorbidities
Smoking status (not a current smoker; 55 per day; 5–10 per day;
10–15 per day; 15–20 per day; 420 per day), weekly alcohol
consumption (converted to units of alcohol), and history of
cardiovascular disease and diabetes (including hyperglycaemia)
were collected by self-report at interview. Individuals drinking
above safe limits of alcohol were identified using gender-specific
safe limits (414 units per week for women and 421 units per
week for men).12
Psychological distress was measured using the 12-item version
of the General Health Questionnaire (GHQ-12), a widely used
measure in population studies.13 A score of four is often used as
a threshold to denote psychological distress,14 but since we have
previously shown that even low levels of psychological distress –
that is, scores below four – are associated with an increased risk
10
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of dementia in these cohort studies,15 we adjusted for total
GHQ-12 score as a continuous variable.
Ascertainment of dementia
Causes of death recorded on death certificates were coded using
ICD-916 and ICD-10.17 Any mention of dementia death was
identified using codes 290.0–290.4, 294.9, 331.0–331.2, and
331.9 for ICD-9, and F01, F03, F09, G30 and G31 for ICD-10.
Statistical analyses
We ascertained that the proportional hazards assumption had
not been violated by inspecting the log(–log(survival)) plot. We
then used Cox proportional hazards models18 to compute
study-specific hazard ratios with accompanying 95% confidence
intervals for the association between the measures of socio-
economic status and dementia death. Heterogeneity in the effect
estimates between studies was examined using the I 2 statistic,
which indicates the proportion of the total variation in the
estimates that is due to between-studies variation. It varied
between 0% and 36.9% depending on the measure of socio-
economic status used in the analysis. To obtain a conservative
estimate, we pooled the study-specific effect estimates and their
standard errors in random effects meta-analyses. Calendar time
(days) was the time scale; for participants with no record of an
event, the data were censored at the 15 February 2008.
Models were initially unadjusted, then a series of variables
were added to the multivariable model: age, smoking status,
alcohol consumption (units per week), baseline cardiovascular
disease (yes/no), diabetes (yes/no), psychological distress (GHQ-12
score), occupational social class and educational attainment.
Since, as described, the association between socioeconomic status
and dementia has been reported to be different in men and
women,19 gender-specific analyses were conducted. We compared
the effects of controlling for different covariates/mediators on the
magnitude of the association by examining a change in the size of
hazard ratio rather than a change in significance level.20
Individuals with data missing for one or more variables and
those with no missing data were compared using Student’s t-test
for continuous variables and w2 tests for categorical variables.
The main analysis was based on participants with no missing data.
In the sensitivity analysis, missing values for covariates were
imputed with PASW statistics version 18.0 for Windows using five
imputations based on maximum likelihood estimates. All other
analyses were conducted using R version 2.15.0 for Windows
and the survival and metafor21 packages. The reporting of this
study conforms to the STROBE statement.22
Results
The initial sample comprised 96 605 individuals. The derivation of
the sample is shown in Fig. 1. After removing individuals who
declined linkage to mortality records (n= 10 065) and for whom
survival was incalculable or who had no cause of death recorded
(n= 32) the maximum analytic sample comprised 86 508 people
(mean age 56.1 years, s.d. = 14.4): 39 125 men and 47 383 women.
Data were missing for occupational social class for 2325 individuals
(analytic n= 84 183) and for educational attainment for 61
individuals (analytic n= 86 447). Table 1 shows the characteristics
of study members from the 11 cohorts and pooled summaries.
Table 2 shows the baseline characteristics of the pooled sample
according to occupational social class separately in men and
women. Individuals from a lower occupational social class were
older, were more likely to smoke, and had a somewhat greater
likelihood of baseline cardiovascular disease, diabetes and
psychological distress. There was little association between
occupational social class and alcohol consumption. Individuals
from a lower occupational social class were more likely, as
anticipated, to have spent less time in full-time education (women
r= 0.41, P50.001; men r= 0.43, P50.001). Similar patterns of
association were seen with education as the exposure of interest
(results not shown but available from the authors on request).
Of the 12 952 deaths during a mean follow-up of 8.6 years
(s.d. = 3.5), 622 were ascribed to dementia. Figures 2 and 3 show
the fully adjusted hazard ratios for the association of occupational
social class and educational attainment respectively, with dementia
death for each cohort study, in addition to gender- specific totals
and meta-analysed effects. Overall, relative to study members
from professional/intermediate occupational social classes, there
was no increase in the risk of dementia death among those
belonging to the lower social classes in women (fully adjusted
hazard ratio (HR) for skilled non-manual: HR= 0.88 (95% CI
0.59–1.31); skilled manual: HR= 0.61 (95% CI 0.36–1.06); semi-
skilled and unskilled manual: HR= 0.92 (95% CI 0.62–1.36)) or
men (skilled non-manual: HR= 1.03 (95% CI 0.53–2.00); skilled
manual: HR= 1.03 (95% CI 0.63–1.69); semi-skilled/unskilled
manual: HR= 1.33 (95% CI 0.80–2.21), Fig. 2). Relative to study
members who left school aged 16 or older, there was an increase in
the risk of dementia death among those leaving school earlier in
women (leaving school aged 15: HR= 1.64 (95% CI 1.02–2.65);
leaving school aged 14 or younger: HR= 1.76 (95% CI 1.23–
2.53)) but not in men (leaving school aged 15: HR= 0.98 (95%
CI 0.51–1.88); leaving school aged 14 or younger: HR= 1.20
(95% CI 0.77–1.87), Fig. 3).
Table 3 shows the impact of controlling for covariates on the
association between the two indicators of socioeconomic status
and dementia in women and men. The association between
occupational social class and dementia death seen in age-adjusted
models was completely explained by covariates in women but was
more robust to statistical adjustment in men. The association
between leaving full-time education at an earlier age and later
dementia death observed in the age-adjusted models was fully
11
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Adults in initial sample
n= 96 605

























Fig. 1 Flow chart of participants from initial pooled sample
through to analytic sample showing subsequent mortality:








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Socioeconomic status as a risk factor for dementia death
attenuated on adjustment for covariates in men but remained in
women.
Sensitivity and subgroup analyses
Data were missing for one or more variables in 32.8% (n=28 375)
of the sample. Online Table DS1 shows a comparison of the
characteristics of individuals with complete data for all variables
v. individuals who were missing data for one or more variables.
Individuals with complete data were more likely to be male,
younger, drink more alcohol per week and were more likely to
drink over the recommended limits and a larger proportion were
current smokers. They were less likely to have diabetes and
13
Study Participants HR (95% CI)
Dementia (a) (b) (c)
deaths
0 0.5 1 1.5 2 2.5
Hazard ratio
0 0.5 1 1.5 2 2.5
Hazard ratio
0 0.5 1 1.5 2 2.5
Hazard ratio
0 0.5 1 1.5 2 2.5
Hazard ratio
0 0.5 1 1.5 2 2.5
Hazard ratio




























































































































































Fig. 2 Fully adjusted hazard ratios (HRs) with 95% confidence intervals of dementia death by survey year for individuals, from left to
right, from (a) skilled non-manual, (b) skilled manual and (c) semi-skilled/unskilled manual occupational social classes compared with
professional/intermediate: the Health Survey for England 1994–2004.
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Fig. 3 Fully adjusted hazard ratios (HRs) with 95% confidence intervals of dementia death by survey year for individuals who left full-time
education aged, from left to right, (a) 15 years and (b) 14 years or younger compared with those who left full-time education aged 16 years
or older: the Health Survey for England 1994–2004.





cardiovascular disease at baseline. A slightly larger proportion of
individuals with complete data belonged to a non-manual
occupational social class and women were less likely to have
left school early (the reverse was true of men). Therefore,
individuals with missing data did not always have unfavourable
levels of risk factors. Accounting for missing data by multiple
imputation did not alter our conclusions (online Table DS2).
Similarly, excluding dementia-related deaths occurring within 5
years of follow-up, to explore reverse causality in the case of
current occupational social class, did not affect our results (online
Table DS3).
Discussion
The purposes of the current study were to show that an individual
participant meta-analysis technique can be applied to a socio-
economic risk factor and also to investigate the association
between socioeconomic status and dementia-related death. In
order to achieve the former we used a convenience sample of
11 large UK population-based cohort studies. With regard to
the latter, the main finding of this study was that educational
attainment was associated with dementia death in women but
not in men. In men, we also found that, relative to the highest
two classes, belonging to the lowest two occupational social
classes was associated with an elevated risk of dementia death;
a relationship that did not reach statistical significance at
conventional levels. There was no association between
occupational social class and dementia death in women.
Strengths and limitations
To our knowledge, this study is the first to use an individual
participant meta-analysis methodology to examine the association
between socioeconomic variables and dementia. In contrast to
previous literature-based analyses, an individual participant
meta-analysis has the advantage of providing precise estimates
of risk marker–disease relationships, reliable information on the
shape of a given risk factor–disease relationship (for example
dose–response v. threshold) and a consistent approach to
statistical control for plausible covariates and subgroup analyses.
We used a large, well-characterised sample that is representative
of the general population in England. This provided sufficient
power to allow gender-specific analyses and allowed us to explore
the role of a series of explanatory factors. By including two
measures of socioeconomic status at different time points we offer
some insights into the influence of life-course socioeconomic
status on dementia risk.
This notwithstanding, the data have their limitations. Despite
the large sample and over 12 000 deaths during follow-up, there
were only 622 dementia-related deaths. This is due to the wide
age range of individuals included in the survey at baseline – adults
aged 35 and over. Although this wide age range increases the
generalisability of the findings, it has resulted in a relatively small
proportion of individuals dying with dementia and consequently
wide confidence intervals, limiting the conclusions that can be
drawn. The identified gender differentials should be viewed in
the light of this question of power. The number of dementia-
related deaths in this study is likely to have been additionally
affected by the unavoidable problems of underdiagnosis of
dementia in the community,23 underrecording of dementia on
death certificates24 and diagnoses being inaccurately coded.
Non-recording of dementia on death certificates has been
highlighted as an important issue, but this seems to be improving.
A recent study identified that 71.5% of a clinic sample diagnosed

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Socioeconomic status as a risk factor for dementia death
recorded on their death certificate.25 There was no association in
that sample between correct dementia certification and area
deprivation or premorbid IQ estimated by the National Adult
Reading Test (unpublished results available from the author on
request), suggesting that individuals reported as having dementia
on their death certificate are representative of the population of
people with diagnosed dementia in the community, at least in
terms of intelligence and level of deprivation.
Comparison with previous studies
Dementia was estimated to affect over 24 million people globally
in 2001 and this is expected to rise to over 80 million by 2040.26 In
England and Wales the prevalence of dementia is estimated to vary
from approximately 1.5% at age 65–69 to approximately 25.3%
over the age of 84.27 Dementia incidence ranges from 7.4 (95%
CI 3.6–16.1) per 1000 person-years at age 65–69 to 84.9 (95%
CI 63.0–107.8) per 1000 person-years over the age of 84.28
However, existing prospective studies of socioeconomic factors
have generally been small in scale – only one analysis reported
a combined sample larger than 10 00019 – and few studies
measure socioeconomic status at more than one time point.8
On a related note, the association between education and
dementia risk has been reported to be present in women but
not in men;19 it is therefore important that studies are sufficiently
large to allow gender-specific analyses. In addition, for older
participants – who are most likely to have died with dementia
during follow-up – the social class may have been allocated to
females on the basis of their husband’s occupation, further
muddying the waters.
Factors across the lifespan have been implicated in the
aetiology of dementia. A series of studies confirm a link between
early life socioeconomic status and dementia risk with early
parental death – and, potentially, consequent socioeconomic
hardship – being highlighted as an important risk factor.29
A total of 51 of 88 studies included in a systematic review6
reported a significant association between a basic education and
dementia risk, the remainder reporting no effect. However, only
two previous studies report gender-specific effects, showing an
effect of education on dementia risk in women but not in men,
as found in the current study.
In England, the Education Act 1918 raised the school leaving
age from 12 to 14. It was further increased to 15 in 1947 and to 16
in 1973. Participants in the Health Survey for England came from
all these educational eras and overall approximately half of men
and women stayed on after completion of the compulsory period
of education. However, individuals were much more likely to
remain in education longer if they were born later: 86.7% of
women and 87.2% of men born after 1956 (who therefore had
to remain in school until 16) compared with 17.8% of women
and 18.5% of men born before 1906 and who could therefore leave
school at 12. However, the reference category used, of individuals
who remained in full-time education up to 16 years or later,
exactly matches those who remained in education after the
compulsory school leaving age.
Since children scoring higher on IQ tests, as well as children
from a higher occupational social class, are more likely to be given
the opportunity to remain in education for longer, a number of
studies have investigated the association between childhood
mental ability and dementia. A Scottish study identified 50
participants in the 1932 Scottish Mental Survey who had
developed dementia and ascertained that their scores on the
Moray House Test in 1932 had been significantly lower than their
peers in the same area who did not develop dementia.30 However,
a larger subsequent study confirmed that this was the case for
vascular dementia but not for Alzheimer’s disease.31 On the other
hand, the Nun study identified that low linguistic ability at a mean
age of 22 was associated with Alzheimer’s disease in the 14 study
participants aged 79–96 whose brains were neuropathologically
examined post-mortem.32
Occupation in adulthood has also been shown to be associated
with dementia risk – high ‘occupational attainment’ is associated
with lower dementia risk.33 However, since the pathology of
Alzheimer’s disease and probably vascular dementia develops over
a very long period of time34 risk factors must be measured
sufficiently early in life for them to have an effect, and exposures
immediately before retirement may have little or no effect on
dementia risk.
Few studies measure socioeconomic status across the whole
lifespan. One study to do so identified early parental death,
manual work and physical illness in the spouse or serious illness
in a child, both after the age of 65, to be independent risk factors
for dementia.8 However, many of the socioeconomic factors
measured in studies are closely linked and disentangling their
individual effects can be extremely difficult.
Mechanisms of effect
The role of education and mental ability as potential risk factors
for dementia has been linked to the hypothesis of cognitive reserve
– that certain individuals’ brains are structurally or functionally
more resilient to disease or injury. This sprang from the
observation that there was no clear relationship between the
extent of brain pathology and the clinical manifestations of
dementia in an individual. Cognitive reserve might relate to a
person’s intrinsic make up or could result from external
experience, i.e. education and occupation. Indeed, there is
evidence that occupation is associated with differences in parietal
blood flow in Alzheimer’s disease that could be a marker of
reserve.35
Criticisms of the cognitive reserve hypothesis include the
suggestion that the effect merely reflects performance on cognitive
tests36 or that the effect is mediated by lifestyle factors and
cerebrovascular risk.37 The present study used clinical diagnoses
of dementia recorded on death certificates and two measures of
socioeconomic status at different stages of life. This allows us to
demonstrate that the observed association between education
and dementia in women was not mediated by adult occupation.
Since an individual with more cognitive reserve would have
more advanced pathological changes at the time of diagnosis, it
has been suggested that this could be linked with a swifter decline
and poorer survival. Some studies have found that individuals
with Alzheimer’s disease and higher educational and occupational
attainment declined faster in their performance on cognitive
tests.38 This aspect of the cognitive reserve hypothesis was not
examined by the current study.
Implications
An association between lower educational attainment and
dementia in women but not men has a number of implications.
First, the mechanism of this association, currently hypothesised
to relate to cognitive reserve, must be clarified. Second, the reason
that the association is observed only in women should be
investigated. It may be that fewer women entered further
education and that those who did had to be very intelligent to
do so. Thus, length of education in these cohorts could be
confounded by intelligence in women to a greater extent than
men. However, the identified gender difference may also






of dementia in women, if a modifiable risk (or protective) factor
could be identified. Lastly, if this association were to reflect a
causative link between education and dementia risk, promoting
higher and further education, especially for women, could have
important public health consequences for a common and serious
condition.
In conclusion, this large prospective study shows an
association between leaving full-time education at a younger age
and dementia death in women, but not in men. This relationship
remained after adjustment for alcohol, smoking, cardiovascular
disease, diabetes, psychological distress and occupational social
class. An association between lower occupational social class
and dementia death that did not reach statistical significance
at conventional levels was also observed in men, but not in
women.
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These winter nights lie long and cold
before you, like an icy road
that grants your well worn wheels no hold.
And so you spin
around and round, tossed to and fro,
in frozen sin.
You rev your engine, not to gain
some hoped for ground, instead, to drain
your heart of salted slushy pain.
But it won’t bate.
For what goes round, comes back in veins
and circulates.
Your heart alone can not reduce
your load of pain. You need to use
some organs that change old for new.
Light, warm, fresh air
is waiting where you travel to
on this black glacier.
An astronaut sent through such space,
would, with drugs, dilute to trace
the time and mind the travel takes.
But drugs won’t work.
You’d fall asleep, only to wake
back at the start.
Others sleep without a sound.
You hear their silence all around,
sliding over the frictionless ground.
Blind to night’s stare,
deaf to their own baying hounds.
Life is not fair.
So curse the Gods that made you be
but gave you eyes so you could see,
the distance that exists between
the man you are
and the man they made your eyes to see
as mankind’s par.
But pull and turn this rage inside
to burn the bane of your poor mind.
Your ice will melt. Your time will bide.
The sun goes down.
Another summer sinks behind
the long drawn blackout blind.
& Shaun Love
The British Journal of Psychiatry (2013)







Supplementary Table 1: Survey participants included and excluded from fully-adjusted 
model examining the association between educational attainment and dementia death: 
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Data supplement
Table DS1 Survey participants included and excluded from fully adjusted model examining the association between educational
attainment and dementia death: the Health Survey for England 1994–2004
Included Excluded P
Women
n 31 343 16 040
Age, years: mean (s.d.) 55.8 (14.5) 57.7 (15.3) 50.001
Occupational social class I–IIINM, % 62.4 62.4 1.0
Left school 516 years,a % 52.5 53.0 0.33
Current smoker, % 22.6 21.1 0.003
Drinks more than recommended alcohol limit,b % 14.7 6.4 50.001
Cardiovascular disease,c % 3.8 4.5 50.001
Diabetes, % 2.7 3.6 50.001
General Health Questionnaire (GHQ-12) score, mean (s.d.) 1.7 (2.8) 1.5 (2.7) 50.001
Men
n 26 790 12 335
Age, years: mean (s.d.) 55.4 (13.8) 56.1 (14.0) 50.001
Occupational social class I–IIINM, % 49.3 48.9 0.50
Left school 516 years,a % 52.7 55.9 50.001
Current smoker, % 23.1 23.0 0.79
Drinks more than recommended alcohol limit,b % 27.7 13.7 50.001
Cardiovascular disease,c % 5.7 5.7 0.83
Diabetes, % 3.9 5.3 50.001
General Health Questionnaire (GHQ-12) score, mean (s.d.) 1.3 (2.5) 1.2 (2.4) 50.001
I–IIINM, professional (I), intermediate (II) and skilled non-manual (IIINM).
a. This corresponds with completing only compulsory schooling.
b. Including angina, myocardial infarction and haemorrhagic or thrombotic stroke.




Supplementary Table 2: Sensitivity analysis—fully adjusted hazard ratios (95% 
confidence interval) for the association between occupational social class and 
educational attainment with dementia death with and without multiple imputation:  


















































































































































































































































































































































































































































































































































































































































Supplementary Table 3: Sub-group analysis—excluding deaths within five years of 






Table DS3 Subgroup analysis by occupational social class – excluding deaths within 5 years of follow-up: the Health Survey for
England 1994–2004
Dementia
Hazard ratio (95% CI)
deaths n I–II IIINM IIIM IV–V
Women (age-adjusted model)
All data 358 45 487 1 (ref) 1.05 (0.75–1.48) 0.96 (0.63–1.47) 1.33 (0.97–1.83)
Excluding deaths within 5 years 269 45 487 1 (ref) 0.90 (0.58–1.39) 0.85 (0.52–1.39) 1.29 (0.91–1.84)
Men (age-adjusted model)
All data 210 36 880 1(ref) 1.13 (0.66–1.94) 1.29 (0.89–1.89) 1.52 (1.01–2.29)
Excluding deaths within 5 years 128 36 880 1(ref) 1.15 (0.54–2.44) 1.22 (0.77–1.94) 2.03 (1.23–3.35)
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Abstract: In the absence of successful treatment modalities, there is a need to 
understand dementia aetiology in order to delay or prevent its onset. One route to 
identify potentially modifiable risk factors is examining geographical variation in 
dementia rates. We present two complementary Bayesian disease mapping studies: a 
twin study in Sweden and a study in Scotland with individuals located in early and mid-
life. Both studies show variation in dementia rates of two- to three-fold. These analyses 
are the first to separate genetic and environmental influences on geographical variation 
in dementia rates and identify that this variation is likely to be the result of unshared 
environmental factors which have the majority of their effect in adolescence and 
adulthood. 
 
One Sentence Summary: Dementia risk varies with geography – the risk in the highest 
areas is approximately double that in the low risk areas – and it is environmental factors 
which drive this effect. 
 
Word count: 2882 
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Dementia comprises a group of progressive neurodegenerative and cerebrovascular 
disorders affecting approximately one in twenty adults over the age of 60 years 
worldwide(1). It is characterised by impairments in several domains of cognition, 
prominently memory, in addition to deterioration in day-to-day functioning. Despite 
numerous drug trials, there are no disease-modifying treatments and therefore there is 
an urgent need to understand the aetiology of dementia in order to attempt to delay or 
prevent its onset. Whereas there is a familial aspect of dementia risk,(2) the importance 
of non-genetic factors is clear(3, 4) and these may act at different points throughout the 
life course.(5) Thus, interventions to delay or prevent dementia by modifying these risk 
or protective factors may have to begin in midlife or even earlier.  
 
Studying the geography of diseases and noting which factors might affect their 
distribution is a powerful hypothesis-generating methodology.  Findings can then be 
used to investigate aetiology. The geographical distribution of cases of dementia is not 
random(6) and is likely to result from both genetic and environmental effects.(7) 
However, in order to be more informative about putative risk or protective factors, 
studies must be conducted on small areas – variation in the exposure of interest may be 
masked by covering too large an area.  Such studies are scarce, however, and none have 
adequately investigated the relative contribution of genetic and environmental factors to 
the distribution of dementia.(6) Here, we present two complementary disease-mapping 
studies using data from Sweden (pooling data from four twin studies) and Scotland 
(cohort study) to test several linked research questions: first, is there non-random 
variation in dementia in these countries?; second, in the twin study, is this variation 
completely explained by familial and genetic factors or are environmental factors 
important?; and third, in the cohort study, do different risk or protective factors have 
their effects at different stages of life? To our knowledge, this is the first study to 
attempt to separate genetic and environmental effects on geographical variation in 






Non-random variation of dementia in Swedish twins 
We pooled four Swedish twin studies to give a total sample of 10,683 men and 13,949 
women (mean±SD age 78.2±8.2 and 80.2±8.1 years, respectively). A total of 343 male 
and 650 female dementia cases were identified. Table 1 shows summary statistics from 
age-adjusted Bayesian disease mapping models of the male and female Swedish twins. 
These hierarchical conditional logistic regression models showed substantial variation in 
dementia risk by area in men and women with an increased age-adjusted odds in the 
north compared to the south (Fig. 1). The figure shows area-level effects – individual- 
and twin-level random effects have been removed. Thus, this variation is likely to result 
from non-shared environmental factors because familial and genetic factors will have 
been largely removed with the twin-level random effects. Almost two-thirds of the 
variance of the area effect is spatially structured, as opposed to non-spatially structured 
error. Models using Alzheimer dementia as the outcome showed similar effects (Fig. 
S1). 
 
There were no differences in the twin random effects – which give some indication of 
between-pair variation in dementia odds – between monozygotic and dizygotic twins in 
men or women (t=-0.51, P=0.61 and t=-0.05, P=0.96 respectively) further suggesting 
that genetic factors are not driving the distribution of dementia observed in this study. 
Furthermore, the age-structure and geographical distribution of the twins was similar to 
that of the general population (Kolmogorov-Smirnov test: men D=0.1217, P=0.1217; 
women D=0.0952, P=0.3581) suggesting that the observed findings were not the result 
of an excess of elderly twins in the north of Sweden. 
 
To test formally whether genetic factors explained non-random geographical variation, 
we performed a subgroup analysis including only monozygotic twins that were 
discordant for dementia (i.e. cases and controls were exactly matched by age, sex and 
genetically) with regard to the quartile of dementia risk of the area where they were 
resident (Table 2). We tested whether the proportion of twins with dementia differed 
between the highest and lowest quartiles. We found there was a two- to three-fold risk 




χ2(3)=22.2,  p < 0.001) representing environmental factors, similar to the overall effect 
size of non-random geographical variation observed in the entire sample.  
 
Changes in non-random variation of dementia over the life course 
In the second study investigators traced participants in the 1932 Scottish Mental Survey 
(SMS1932) in which a validated IQ-type test was administered to almost all children 
attending schools in Scotland and born in 1921 (n=87,498)(8). Dementia status was 
ascertained through record linkage to hospital discharge and mortality registers. A total 
of 19272 men (44.3% overall) and 18325 women (42.6% overall) were traced. County of 
schooling was recorded for all participants. Postcode sector of residence at the time of 
first admission to hospital in mid-life was missing or erroneous for 7854 individuals, 
leaving an analytic sample for the mid-life models of 14,864 men and 14,879 women. 
Age 11 IQ data were additionally missing for 804 men and 855 women. Over 
approximately 80 years of follow up, 13,317 male and 13,423 female deaths were 
recorded, leaving 10.4% of men and 9.8% of women alive. A total of 1307 male and 
2298 female dementia cases were identified, through hospital discharge records, death 
certification, or primary care records. 
 
The SMS1932 models using county of schooling aged 11 years show very little 
geographical variation in dementia odds in men or women (Table 1, Fig. 2). On the 
other hand, the models using mid-life location show substantial variation in dementia 
odds in both sexes. Setting aside data from the islands which are more difficult to 
model, the Scottish data mirrored those of Sweden with generally low risk in the south 
of the country increasing further north (Table 1, Fig. 2). Alzheimer dementia models 
using mid-life location gave similar results (Fig. S1). 
 
Sensitivity analyses 
In order to demonstrate that the observed distribution of dementia cases was not the 
result of artefact, we examined a number of possible alternative explanations. Since not 
all original SMS1932 participants were traced, geographical variation in ascertainment 




across the country (Table S1 and Fig. S2) and in only six counties for men and five for 
women (out of 34) were the linkage rates more than 50%. However levels of 
ascertainment did not mirror the dementia odds and it is unlikely that ascertainment 
alone could explain the substantial variation observed, particularly in the mid-life models 
(i.e. maximum to minimum county ascertainment rate ratios were 1.80 for men and 1.56 
for women compared to dementia rates varying by over three times, Fig. 2). 
 
Lower intelligence has been shown to be associated with an increased risk of 
dementia,(9) though perhaps more strongly with vascular dementia than Alzheimer 
disease(10). It is possible that either bias in record linkage related to intelligence or 
geographical variation in baseline intelligence might explain the observed variation in 
dementia odds. Whereas baseline intelligence (IQ based on total score) was higher in 
individuals who were untraced than those identified through record linkage (linked: 
mean±SD 99.7±14.9; untraced: 100.2±15.1; P<0.001), the level of significance is likely 
to result from the large sample size and a difference of 0.03 standard deviations is 
unlikely to be important. There was some variation in the mean intelligence of 
individuals who were and were not successfully identified by record linkage by county of 
schooling aged 11 years (Table S1), but the difference was only statistically significant at 
conventional levels in five counties (Aberdeenshire, Ayr, Dunbarton, Edinburgh, and 
Selkirk) and the largest difference was 3.3 IQ points or 0.2 standard deviations. This 
variation, given the known effect size of IQ on dementia risk,(9) is unlikely to have 
given rise to the substantial variation in dementia observed in the present study. 
Similarly, there was not sufficient variation in baseline intelligence to explain the 
observed variation in dementia rates (Fig. S3). 
 
We next examined the possibility that our findings could relate to under-ascertainment 
of dementia cases. Compared to all sources of case-identification, death certification 
alone missed 233 male cases of dementia (17.8%) and 375 (16.3%) in women (Table S2) 
– better than the 28.5% non-reporting of dementia previously described in a Scottish 
study.(11) Examining SMS1932 participants who were registered with the Greater 
Glasgow & Clyde Nursing Homes Medical Practice showed us that 4/12 men (33.3%) 




record of a dementia diagnosis in 4/8 men (50%) and 3/14 women (21.4%) identified as 
having dementia through record linkage (Table S3). Thus the present methodology did 
not identify all cases of dementia, but primary care records (which would most likely be 
the next source of data consulted) similarly did not identify every case already found by 
record linkage. In order to examine geographical bias of ascertainment by record linkage 
in more detail we calculated the proportion of extra cases of dementia which would be 
identified by using prescriptions for dementia drugs over and above those identified 
using the record linkage methodology in the present study. Figure S4 shows that the 
underascertaiment of dementia identified in this way does vary across the country, but 
that this pattern alone is very unlikely to have resulted in the findings of the present 
study, indeed in the areas with highest dementia odds, it is likely that we under-
ascertained the number of cases of dementia more than in the rest of the country, 
particularly in men. 
 
Discussion 
Our main findings are substantial non-random geographical variation in dementia rates 
in two countries; the general pattern was of higher rates in the north compared to the 
south. This variation is not completely explained by familial or genetic factors, 
confirming the importance of other environmental factors in dementia, and there was a 
doubling of risk between the lowest and highest risk areas shown both in the 90% 
quantile ratios of the main models and in the subgroup analysis of monozygotic Swedish 
twins. The Scottish data suggest that these environmental factors may have the majority 
of their effect in adolescence and adulthood.  
 
An increased risk of dementia in northern areas has previously been described in 
Finland(12, 13) and China.(14) However, to our knowledge, this is the first study to 
attempt to separate genetic and environmental effects on geographical variation in 
dementia in this way. A study in Newfoundland which identified a difference in 
dementia risk in those born on the north side of Bonavista bay compared to the south 
suggested that genetic relatedness might account for a proportion of the effect by 
examining the number of surnames in each group.(15) A Scottish study of young-onset 




kinship and concluded that familial factors partly contributed to the high incidence of 
dementia in Lanarkshire.(7) A recent systematic review of geographical variation in 
dementia based on within-study comparisons did not identify any further studies 
attempting to separate genetic and environmental contributions.(6)  
 
Both of the present studies have limitations but their respective methodologies are 
complementary and we can be reassured by the fact that both studies give similar 
results. Less than half of the SMS1932 cohort was traced via record linkage. It is likely 
that a number of factors related to whether or not an individual was traced, including: 
women changing their name on marriage (though the national records endeavour to 
record maiden name); emigration or death prior to the beginning of the records (1981 
for mortality records), including World War II; and the probabilistic linkage methods 
used may have meant that common names could be associated with a large number of 
potential links and therefore the linkage ‘score’ would fall below the acceptable 
threshold, i.e. when it is uncertain whether two sets of records belong to the same 
person. However in the Swedish twins study – at least in HARMONY which 
constituted the vast majority of the sample – dementia ascertainment approached 
completeness.(16) The Swedish twins study includes individuals of a variety of ages 
which introduces heterogeneity and is likely to mask any cohort effects. On the other 
hand, the SMS1932 study is a narrow age cohort. Furthermore the Swedish twins study 
only has the most recent location available whereas the SMS1932 study has location 
available at two points in life offering some insights into life course effects. Indeed, 
94.2% of a sample of 854 SMS1932 participants (approximately 1% of the cohort) 
whose birth records were examined attended school in the county of their birth or a 
neighbouring county. The use of adjacency matrices recording neighbouring areas in the 
Bayesian disease mapping models means that it is likely that, for the majority of the 
sample, almost all exposures between birth and age 11 will have been captured. 
However, these adjacency matrices make the results for islands more difficult to 
interpret since they have very few automatic neighbours.  
 
Finally, the SMS1932 study does not include information on the genetic relatedness 




known and can be included in the models. A rough comparison of genetic risk in the 
SMS1932 study can be carried out using APOE e4 status in the Aberdeen and Lothian 
Birth Cohort 1921 studies(17, 18) – subsamples of the SMS1932 cohort – which are 
carried out in areas of Scotland shown in the current study to be at high risk and average 
risk, respectively. The prevalence of one or more APOE e4 alleles in the ABC 1921 
study was 24.3%(19) and in the LBC 1921 study was 26.0%(20, 21). 
 
Following the finding that non-random variation in dementia prevalence is unlikely to 
be fully explained by genetic effects, further corroboration could be sought by accessing 
biobank data to create polygenic risk scores across various regions in these two 
countries. Researchers will then need to identify potential risk or protective factors and 
ascertain whether modifying these factors could alter an individual’s risk of developing 
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Table 1. Results from Bayesian disease mapping models  
 
 SWEDEN SCOTLAND 
  Childhood location Mid-life 
location 
MEN    
Total N 10,683 19,272 14,864 
Dementia cases 343 1307 1244 
QR901 (95% CI) 1.49 (1.08, 3.11) 1.17 (1.07, 1.37) 2.48 (1.73, 3.47) 
Fracspatial2, % (95% CI) 66 (4, 99) 42 (3, 90) 96 (78, 100) 
OR per standard deviation 
increase in age (95% CI) -
3 2.10 (1.98, 2.23) 2.04 (1.90, 2.18) 
WOMEN    
Total N 13,949 18,325 14,879 
Dementia cases 650 2298 2207 
QR901 (95% CI) 2.15 (1.10, 6.08) 1.20 (1.07, 1.49) 4.07 (3.07, 5.45) 
Fracspatial2, % (95% CI) 59 (1, 100) 38 (3, 92) 75 (40, 100) 
OR per standard deviation 
increase in age (95% CI) -
3 2.44 (2.31, 2.58) 2.37 (2.22, 2.52) 
1 QR90 = 90% quantile ratio comparing the odds of dementia in the areas on the 5th and 95th centiles 
2 Fracspatial = the fraction of the variance of the area effect which is spatially structured 
3 Since age-adjustment was adjustment for age at diagnosis of dementia for cases and age at death for 





Table 2. Individuals from complete monozygotic Swedish twin pairs discordant for 
dementia allocated to quartiles of dementia odds, according to area of residence 
 
  Dementia odds ratio 








MEN   
No dementia N 19 16 14 18 (%) (76.0) (66.7) (41.2) (35.3) 
Dementia N 6 8 20 33 (%) (24.0) (33.3) (58.8) (64.7) 
WOMEN   
No dementia N 35 19 18 28 (%) (74.5) (61.3) (31.0) (43.8) 










Fig. 1. Odds ratio of dementia in male (A) and female (B) Swedish twins with 




A B  




Fig. 2. Odds ratio of dementia in the SMS1932 cohort by age 11 location 
(men A; women B) and mid-life location (men C; women D) with individual-






Materials and Methods 






Materials and Methods 
Data: Swedish study 
Participants were included from four related studies: the Study of Dementia in Swedish 
Twins (HARMONY);(22) the Swedish Adoption/Twin Study of Aging (SATSA);(23) 
Origins of Variance in the Old-Old: Octogenarian Twins (OCTO-twin);(24) and 
Gender and Health: A Study of Older Unlike-Sex Twins (GENDER)(25). HARMONY 
was a cross-sectional study but the rest are longitudinal in design. The majority of the 
sample came from HARMONY (83.6%; SATSA 11.6%; OCTO-Twin 2.8%; GENDER 
2.0%; twins who participated in HARMONY and another study were recorded as being 
included in the former for the purposes of this study). 
Details of the methodology of these studies is described in detail in the cited articles but, 
briefly, HARMONY involved telephone screening of all twins born before 1959, 
irrespective of co-twin vital status (though twins born before 1926, in the first wave of 
the Swedish Twin Registry, were only registered if both twins were alive and responded 
at the time of compilation of the registry). All individuals screening positive – and their 
co-twin, if still living – were requested to attend for a clinical assessment, in addition to 
a sample of normal control twin pairs. SATSA included same-sex twin pairs from the 
Swedish Twin Registry who reported that they had been reared apart, were born in 1935 
or earlier, and at least one of whom was alive in 1987 and matched control twin pairs 
who had been reared together. Dementia status was identified by in-person cognitive 
testing in a sub-sample, telephone screening, linkage with a psychiatric registry, and 
follow-up every three years for participants not diagnosed with dementia. OCTO-twin 
included twins aged 80 years and older who were alive in the period 1991-3. They 
participated in a comprehensive cognitive test battery administered by a nurse at their 
place of residence. GENDER included unlike-sex twins born in the years 1906-25; only 
same-sex twins had been initially entered onto the Swedish Twin Registry due to the 
technicalities of the genetic models used at the time. These individuals received 
questionnaires about health, demographic, and psychosocial topics. 
The total sample comprised 27,680 individuals, 24.8% of whom were monozygotic. 
Dementia status is known for all participants and their location of residence (5-digit 
zipcode) in 2008 was obtained by linkage to the National Population Registry.  This 
locator was shortened to a 3-digit zipcode, of which areas there are 568 in Sweden. 
Zipcode data were missing or incorrect for 1504 men and 1544 women. Age was 
recorded for all individuals – age at diagnosis for cases and age of death or censoring for 
controls. Thus people with dementia had a lower average age than those without and so 
it was not possible to calculate odds ratios of dementia risk according to age. All 
participants gave informed consent and ethical approval was granted by the Ethics 
Committee of Karolinska Institutet, the USC Institutional Review Board, and the 





Data: Scottish study 
On 1stJune 1932 almost every child aged 11 at school in Scotland and born in 1921 sat 
an identical intelligence test, a version of the Moray House Test No. 12 (N=87,498).(26) 
The purpose of this Scottish Mental Survey (SMS1932) was to examine the distribution 
of intelligence across the whole population. The first name, surname, date of birth, 
school attended, county, and mental ability score were recorded in a ledger. 
In the late 1990s the ledgers for all but three Scottish counties (Angus, Fife and 
Wigtown; 6309 individuals with mental ability scores recorded, 7.2%) were discovered 
and subsamples of the initial population studied in Edinburgh (Lothian; N=550) and 
Aberdeen (N=275) have been followed up in later life to provide insights into, amongst 
other things, the stability of mental ability over the lifespan.(27-29) In contrast, the 
present study is based on record linkage of the entire SMS1932 cohort for whom data 
were available (Total N=86,520 including individuals without mental ability scores; N 
with mental ability scores=81,189 – these data were missing, for example, if the pupil 
had been recorded as attending the school in 1932 but had been absent on 1st June).  
Apart from 73 participants in the Lothian Birth Cohort 1921 study (0.08%) who had 
explicitly withdrawn consent to data linkage, the Information Services Division of NHS 
National Services Scotland (ISD) linked data for all SMS1932 participants using 
probabilistic methods with Scottish Morbidity Records recording every admission to 
general (SMR 01) and psychiatric hospitals (SMR 04) in Scotland since 1981 and death 
certificate data held by the General Register Office for Scotland. Both sources of data 
provide the individual’s age and residential location on admission to hospital or death, 
anonymised to the level of postcode sector, of which there are 953 in Scotland. From 
the original SMS1932 cohort of 86,520, 37,597 were traced (43.5% overall). Residential 
location on first mid-life admission to hospital was used as mid-life location for the 
models. 
All diagnoses recorded in SMR or on death certificates were provided which were coded 
according to the International Classification of Diseases (ICD), 9th(30) and 10th(31) 
revisions. Dementia cases were identified by any mention of codes 290.0 to 290.4, 290.8, 
290.9, 291.1, 291.2, 294.1, 294.2, 294.8, 294.9, and 331.0 to 331.9 for ICD-9 and codes 
F00-F05.1, F09, G30, and G31 for ICD-10. In addition, the Greater Glasgow & Clyde 
Nursing Homes Medical Practice (a primary care medical provider which exclusively 
treats residents of nursing homes) were approached to provide details of all patients on 
their list born in 1921 with details of any clinical dementia diagnosis. These data were 
also linked with the SMS1932 data. 
Place of birth was located for a random sample of approximately 1% of the original 
SMS1932 dataset (N=854) from original birth certificates held by the National Register 
of Scotland (General Register House, Edinburgh). It was not possible to locate records 
for 13.1% (N=112) either because there were no birth records with that name and date 
of birth or there were too many associated with a very common name, such as the 




for whom birth certificates were located, 154 attended school in a different county to 
that of their birth, of whom 111 were born in the neighbouring county to the one in 
which they attended school Thus, 43/742 (5.8%) moved further than to a neighbouring 
county between birth and age 11 years. 
Ethical approval of the Scottish study was granted by South East Scotland Research 
Ethics Committee 3 and the linkage was approved by NHS Caldicott Guardians, the 




We used hierarchical Bayesian disease mapping models to produce area-level odds ratios 
of dementia relative to the average odds in that map with random variation due to small 
numbers smoothed by shrinking the effect estimate for each region towards the mean of 
the surrounding areas.(32-35) We constructed Bernoulli logistic regression models with 
two levels: (a) the individual, including adjustment for individual-level covariates; and (b) 
the area. In order to examine the area effect, we used the Besag-York-Mollie model(36) 
which allows separation of random effects into spatially structured and unstructured 
parts without making a strong spatial assumption and which is widely used in disease 
mapping studies.(37, 38) In the Swedish analyses, we had an additional level between the 
individual and the area – the twin pair; we added separate random effects for the 
monozygotic and dizygotic twins. Syntax for both the Swedish and Scottish models is 
reproduced below. We used R version 2.15.2 and the R2WinBUGS package(39) to run 
Markov chain Monte Carlo simulations in WinBUGS (the Windows implementation of 
Bayesian inference Using Gibbs Sampling).(40-42) Model convergence was diagnosed 
using the Brooks-Gelman-Rubin statistic(43, 44) and models were compared using the 
Deviance Information Criterion (DIC), a Bayesian model comparison criterion 
analogous to the Akaike Information Criterion.(45) We extracted area effects (odds 
ratios with accompanying 95% confidence intervals) computed by exponentiating the 
sum of the two area random effects for men and women separately – i.e. with individual 
or individual and twin-level effects removed.  
We produced unadjusted models and age adjusted models. In the Swedish twins study, 
age at diagnosis was used for cases and age at death or censoring for controls. However, 
in the SMS1932 study, the precise date of diagnosis was not known for cases and so age 
at death or censoring was used for both cases and controls in this study. In preliminary 
analyses the change in DIC indicated that adjusting for age substantially improved the 
models and so the most basic models we report are age-adjusted. We also constructed 
models using Alzheimer disease as the outcome of interest. 
Model results are displayed as maps of odds ratios produced using ArcMap 10 using 
shapefiles from the Swedish Postal Service (http://www.postnummerservice.se; 
accessed 10th April 2013) and the UK BORDERS service, now part of the Economic 




10th April 2013). We also report the fraction of the area-level variance which was 
spatially structured, as opposed to unstructured error. The overall variation in area effect 
in each model is summarized by the 90% quantile ratio (QR90) which compares the 
odds ratio of dementia in the areas on the 5th and 95th centiles.  
Since the models produce a distribution for each outcome of interest (e.g., odds ratio) it 
is possible to examine statistical significance by the proportion of the distribution is 
greater or less than unity. Simulation studies in cancer research have suggested that a cut 
off of 80% is reasonably sensitive in identifying truly raised or decreased risks, though 
this rule is less robust when fewer than 20 cases per area are expected.(46) We follow 
this approach in the present study and produce maps showing the posterior probability 
that the odds ratio for an area is greater than or less than 1 (Fig. S5). 
 
Sensitivity analyses 
In addition to the main analyses, we planned a number of sensitivity and supplementary 
analyses in order to investigate whether our results could be due to a number of factors: 
(A) the geographical distribution of the sample compared to the general population in 
the Swedish twins study; (B) environmental factors by examining the subgroup of 
monozygotic Swedish twins who were discordant for dementia; (C) differential linkage 
rates in different regions in the SMS1932 study; (D) whether the observed geographical 
variation could be caused by variation in mental ability – which has been shown to be 
associated with social class and birth weight in a subsample of the SMS1932 cohort;(47) 
and (E) differential ascertainment of dementia due to the source of diagnoses identified. 
First, we wanted to confirm that results from models using the Swedish twins were 
generalizable to the entire population of Sweden and to confirm that there was no 
consequent geographical bias. We obtained demographic data on the Swedish 
population in 2008 from Statistics Sweden (http://www.scb.se/; accessed 10th April 
2013). We then compared the Swedish twins over the age of 65 years stratified by 
county of residence (geocoded from the 5-digit zipcode using ArcMap 10) and 5-year 
age band to the general population using the Kolmogorov-Smirnov test. There were 
relatively few twins under the age of 65. 
We attempted to confirm a substantial environmental contribution to any observed 
non-random distribution of cases by a subgroup analysis examining individuals within 
monozygotic twin pairs discordant for dementia. These groups of men (N=134) and 
women (N=200) with and without dementia are perfectly matched for age, sex, and 
genotype since each group contains one member of each monozygotic twin pair. We 
allocated these individuals to four groups defined by quartiles of the area-effect (odds 
ratio of dementia) derived from the main disease mapping models and examined the 
proportion of dementia cases in each group.  
In the SMS1932 study we were able to identify from the original dataset (N=86,520) 




allowed us to examine the possibility of a geographical bias resulting from differential 
linkage rates in different areas. Thus we compared linkage rates by county of schooling 
aged 11 years for all survey participants. Additionally we were able to compare mental 
ability scores for individuals with successful record linkage and those without, both at a 
national level and by county. 
Given the relatively low linkage rates, it was important to estimate under-ascertainment 
of dementia in the SMS1932 study and we were able to attempt this in two ways: (1) by 
comparing primary care diagnoses made in the Greater Glasgow & Clyde Nursing 
Homes Medical Practice to the diagnoses identified by record linkage in the linked 
dataset; and (2) by identifying cases of dementia through the Prescribing Information 
System (PIS), a national database for Scotland holding information on prescriptions 
dispensed in the community, by looking for prescriptions for cholinesterase inhibitors 
or memantine. The PIS is indexed by each patient’s Community Health Index number 
(a unique 10-digit identifier used in the National Health Service in Scotland). From 
calendar years 2009 to 2012 the range of yearly CHI capture for dementia prescriptions 
is 80.7%-87.7% and the overall level of CHI completeness on dementia prescriptions 
for the time period is 86.0%. We were not permitted to link the analytic dataset to the 
PIS but we were able to identify all dispensed prescriptions for these drugs to 
individuals born in 1921, which is likely to be a broadly comparable population, during 
2009 to 2012. These prescription data were additionally linked to SMR01, SMR 04, and 
mortality data using deterministic methods. We then calculated the proportion of cases 
of dementia identified from any source which were only identified by PIS for each 
Health Board in Scotland. These data were then mapped with ArcMap 10 using 




WinBUGS code: Swedish model (age-adjusted) 
 
model { 
for(i in 1:NPeople) { 
Y[i] ~ dbern(p[i]) 
logit(p[i]) <- alpha + beta.age*AGE[i]  
+ twin.re[TWIN[i]] + V[AREA[i]] + U[AREA[i]] 
     } 
 
# TWIN-LEVEL RANDOM EFFECTS  
# NTwins = number of twins; NMZ = number of MZ twins 
# Random effects for MZ twins 
for(j in 1:NMZ) { 
 twin.re[j] ~ dnorm(0, prec.mz)  
 }  
# Random effects for DZ twins 
for(k in  (NMZ+1):NTwins) { 
 twin.re[k] ~ dnorm(0, prec.dz)     
} 
 
# AREA-LEVEL EFFECTS 
# Unstructured effects (V) 
for(l in 1:NArea) { 
 V[l] ~ dnorm(0, prec.v)        
 area.effect[l] <- exp(V[l] + U[l])  
} 
  
# Spatially correlated effects (U) 
U[1:NArea] ~ car.normal(adj[], weights[], num[], prec.u)  
for(m in 1:sumNumNeigh) {weights[m] <- 1} 
 
# PRIORS 
alpha ~ dflat()     
beta.age ~ dnorm(0, 0.00001)  
prec.mz ~ dgamma(0.5, 0.0005) 
prec.dz ~ dgamma(0.5, 0.0005) 
prec.v ~ dgamma(0.5, 0.0005) 
sigma2.v <- 1/prec.v    
prec.u ~ dgamma(0.5, 0.0005) 
sigma2.u <- 1/prec.u    
sigma2.u.marginal <- sd(U[]) * sd(U[])  
 
# OUTCOME MEASURES 
OR.age <- exp(beta.age) 
# Fraction of total variation in log odds due to spatial effects 
frac.spatial <- sigma2.u.marginal / (sigma2.u.marginal + sigma2.v) 
# 90 percent quantile ratio 





WinBUGS code: Scottish model (age-adjusted) 
 
model { 
for(i in 1:NPeople) { 
Y[i] ~ dbern(p[i]) 
logit(p[i]) <- alpha + beta.age*AGE[i]  
+ V[AREA[i]] + U[AREA[i]] 
     } 
 
# AREA-LEVEL EFFECTS 
# Unstructured effects (V) 
for(l in 1:NArea) { 
 V[l] ~ dnorm(0, prec.v)       
 area.effect[l] <- exp(V[l] + U[l]) 
} 
 
# Spatially correlated effects (U) 
U[1:NArea] ~ car.normal(adj[], weights[], num[], prec.u) 
for(m in 1:sumNumNeigh) {weights[m] <- 1} 
 
# PRIORS 
alpha ~ dflat() 
beta.age ~ dnorm(0, 0.00001)  
prec.v ~ dgamma(0.5, 0.0005) 
sigma2.v <- 1/prec.v    
prec.u ~ dgamma(0.5, 0.0005) 
sigma2.u <- 1/prec.u    
sigma2.u.marginal <- sd(U[]) * sd(U[])  
 
# OUTCOME MEASURES 
OR.age <- exp(beta.age)  
# Fraction of total variation in log odds due to spatial effects 
frac.spatial <- sigma2.u.marginal / (sigma2.u.marginal + sigma2.v) 
# 90 percent quantile ratio 
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Table S1. Rates of record linkage in men and women and mean intelligence in linked 
and untraced participants (both sexes pooled) in the 1932 Scottish Mental Survey 
Cohort by county of school attended age 11 
 
County 
Linkage rate  Linked Untraced  
Men Women  N mean±SD IQ N mean±SD IQ P 
Aberdeen 51.4 47.8  1993 102.2±14.5 1957 101.5±14.3 0.107 
Aberdeenshire 50.1 50.1  935 97.2±15.0 957 95.7±15.5 0.030 
Argyll 42.1 43.6  495 102.2±16.1 364 101.1±15.9 0.318 
Ayr 46.6 47.8  3901 97.5±16.1 3498 96.1±15.8 <0.001 
Banff 51.4 47.8  586 99.5±15.4 582 99.3±14.3 0.816 
Berwick 39.9 49.8  219 104.8±14.8 183 104.3±15.6 0.767 
Bute 31.4 43.6  142 100.3±15.0 83 103.8±15.0 0.091 
Caithness 42.9 48.6  254 101.5±16.7 211 101.4±16.7 0.905 
Clackmannan 44.3 43.2  348 99.0±15.5 272 98.4±14.7 0.675 
Dumfries 40.9 41.1  850 103.2±15.8 596 104.2±14.8 0.207 
Dunbarton 40.0 42.0  1657 101.6±14.6 1162 102.7±14.0 0.043 
Dundee 44.3 44.6  1675 102.2±14.1 1371 101.8±14.4 0.374 
East Lothian 48.7 51.4  398 100.7±15.0 410 99.5±15.4 0.233 
Edinburgh 41.2 46.2  3750 102.6±14.5 2961 100.9±14.3 <0.001 
Glasgow 39.2 41.3  11276 100.0±15.1 7652 99.8±14.7 0.374 
Inverness 43.8 37.3  445 98.5±16.1 301 99.8±16.2 0.293 
Kincardine 48.3 50.8  233 99.7±15.4 230 99.4±14.0 0.775 
Kinross 46.8 39.6  57 99.7±15.6 41 97.8±14.8 0.532 
Kirkcudbright 39.1 45.2  301 100.4±14.5 226 100.7±14.3 0.832 
Lanark 39.0 43.0  6560 99.5±14.8 4607 99.3±14.5 0.374 
Midlothian 51.3 46.2  863 99.9±15.5 828 98.9±14.4 0.175 
Moray 47.0 49.0  393 101.7±13.9 361 101.9±14.4 0.854 
Nairn 45.0 35.9  80 100.5±14.4 54 97.4±16.2 0.252 
Orkney 56.3 56.1  139 96.7±16.4 177 96.4±15.1 0.857 
Peebles 40.7 48.4  121 100.7±15.6 102 102.3±14.2 0.444 
Perth 42.7 47.4  1010 102.4±15.2 844 101.7±14.6 0.318 
Renfrew 38.8 38.4  3053 99.9±14.7 1956 99.8±14.7 0.804 
Ross & Cromarty 46.6 49.8  519 96.3±16.0 480 96.0±16.0 0.816 
Roxburgh 40.9 44.3  387 102.4±14.2 287 101.8±13.5 0.568 
Selkirk 47.6 47.8  202 100.6±15.5 183 103.9±13.7 0.026 
Stirling 46.0 45.1  1681 100.5±14.8 1414 99.9±13.8 0.251 
Sutherland 47.1 49.6  113 102.2±17.1 106 101.2±13.6 0.626 
West Lothian 47.4 49.9  906 98.0±14.3 858 97.8±15.2 0.789 
Zetland 56.6 53.2  138 100.8±16.1 172 101.1±15.5 0.854 





Table S2. Comparing dementia ascertainment from mortality records with diagnoses 
recorded on hospital discharge 
 
   Hospital discharge data 
   Men  Women 
   No 
dementia 








dementia  17970 233 18203  16040 375 16415 
Dementia  366 703 1069  624 1286 1910 






Table S3. Sensitivity analysis – Scottish models – estimating underdiagnosis of 
dementia using primary care records 
 
   Men  Women 
   Primary care records  Primary care records 
   
No 
dementia Dementia Total  
No 






dementia  6 4 10  12 13 25 
Dementia  4 4 8  3 11 14 
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Fig. S1. Age -adjusted area effects for Alzheimer disease in the Swedish 
Twins  (A male, B female) and in the SMS1932 cohort (mid-life location; C 
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Fig. S2. Rates of record linkage in men (left) and women (right) in the 1932 
Scottish Mental Survey Cohort by county of school attended age 11. Data for 
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Fig. S3. Map of IQ at age 11 by county (whole cohort). Data for Angus, Fife, 
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Fig. S4. Rates of patients born in 1921 with dementia newly identified by the 
Prescribing Information System as having been dispensed one or more 
prescription item for a drug for dementia (a cholinesterase inhibitor or 
memantine) and who were not identified by hospital admission or mortality 
records as having been diagnosed with dementia (A male, B female). The 
definition of dementia used was identical to the one used in the main study 
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Fig. S5. Posterior probability of disease mapping models in Swedish twins (A 
male, B female); the SMS1932 cohort in childhood (C male, D female); and 







R syntax for individual participant meta-analysis 
 
library(survival) # Package for Cox regression 
library(metafor) # Package for meta-analysis 
 
# Create output table with one row for each meta-analytic model 
output = matrix(NA, n, 7) 
 
# Create result table with one row for each study-specific model 
# These will then be meta-analysed to give an overall result 
result = matrix(NA, m, 2) 
 
# Study-specific models with separate datasets 
cox1 = summary(coxph(Surv(survival, dementia==1) ~ covariates, 
 data=dat1)) 
result[1,1] = cox1$coefficients[1,1] 
result[1,2] = cox1$coefficients[1,3] 
... 
coxm = summary(coxph(Surv(survival, dementia==1) ~ covariates, 
 data=datm)) 
result[m,1] = coxm$coefficients[1,1] 
result[m,2] = coxm$coefficients[1,3] 
 
nevent = cox1$nevent + ... + coxm$nevent 
n = cox1$n + ... + coxm$n 
 
# Meta-analyse study-specific effects 
ma = rma(as.numeric(result[,1]), sei=as.numeric(result[,2]), 
 measure="GEN",method="REML") 
 
# Extract coefficients of interest 
output[a,1] = "Model description" 
output[a,2] = nevent # number of disease events 
output[a,3] = n # total N 
output[a,4] = exp(ma$b) # hazard ratio 
output[a,5] = exp(ma$ci.lb) # lower 95% confidence interval 
output[a,6] = exp(ma$ci.ub) # upper 95% confidence interval 
output[a,7] = ma$pval # P value 
